NIH
National Library of Medicine (NLM) Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-032.html
NLM Grants for Scholarly Works in Biomedicine and Health are awarded for the preparation of book-length manuscripts and other works of academic and/or public health policy value to U.S. health professionals, public health officials, biomedical researchers, and historians of the health sciences.    

NIH
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-648.html
The purpose of this grant is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

NIH
Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-926.html
The purpose of this funding opportunity is to support eligible postdoctoral scientists who maintain high productivity in an National Institute of Allergy and Infectious Diseases (NIAID)-funded laboratory while engaging in primary caregiver responsibilities. This program will provide administrative supplements to existing NIAID research grants to hire a full-time or part-time laboratory technician to work with the postdoctoral scientist on his or her project.

NIH
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-906.html
Funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or have become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project.

NIH
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp)
http://grants.nih.gov/grants/guide/pa-files/PA-16-289.html
The Office of Research on Women's Health and participating Institutes and Centers of the NIH announce the continuation of the program for administrative supplements to research grants to support individuals with high potential to re-enter an active research career after an interruption for family responsibilities or other qualifying circumstances. The purpose of these supplements is to encourage such individuals to re-enter research careers within the missions of all the program areas of NIH. This program will provide administrative supplements to existing NIH research grants for the purpose of supporting full-time or part-time research by these individuals to update their existing research skills and knowledge.

NIH
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-023.html
The purpose of this funding opportunity is to encourage revision applications from currently funded NCI R01 research projects proposing to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies program. 

NSF
Established Program to Stimulate Competitive Research (EPSCoR): Workshop Opportunities
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503341
NSF EPSCoR welcomes proposals for workshops in areas of science and engineering that advance the program's major goals and promise to engage a broad community of investigators or practitioners, while including the intentional involvement of the EPSCoR community. NSF EPSCoR workshops aim to bring communities of thought together to discuss recent research or education findings, explore topics in emerging areas of science and engineering, foster innovative collaborations, expose researchers or trainees to new research and education tools or techniques, or respond to NSF EPSCoR calls for workshops on specific topics.

NSF
Frequently Asked Questions for NSF 16-615: Transdisciplinary Research in Principles of Data Scienc Phase 1 (TRIPODS)
https://www.nsf.gov/pubs/2017/nsf17048/nsf17048.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
This website lists frequently asked questions and answers related to the Transdisciplinary Research in Principles of Data Scienc Phase 1 (TRIPODS) program (NSF 16-615).

NSF
Frequently Asked Questions for the Faculty Early Career Development (CAREER) Program for Submission in Years 2017 - 2019
https://www.nsf.gov/pubs/2017/nsf17050/nsf17050.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
This website lists frequently asked questions and answers related to the Faculty Early Career Development (CAREER) Program (NSF 17-537).

NSF
Integrative Strategies for Understanding Neural and Cognitive Systems (NCS)
https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf18533
The NCS program focuses on four aspects of neural and cognitive systems that are current targets of converging interdisciplinary interests: (1) Neuroengineering and Brain-Inspired Concepts and Designs; (2) Individuality and Variation; (3) Cognitive and Neural Processes in Realistic, Complex Environments; and (4) Data-Intensive Neuroscience and Cognitive Science. NCS projects must advance the foundations of one or more of these focus areas. 

NSF
NSF-approved Biographical Sketch Format
https://nugrant.unl.edu/fundingOpps/singleOpportunity?VCRFundingOpID=12710
The National Science Foundation (NSF) has designated the National Institutes of Health's SciENcv (Science Experts Network Curriculum Vitae) as an NSF-approved format for submission of biographical sketch(es) and is encouraging its use to prepare a biographical sketch for inclusion in proposals to NSF.  

NSF and NIH
Smart and Connected Health: Connecting Data, People, and Systems
https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf18541
The goal of this program is to accelerate the development and integration of innovative computer and information science and engineering approaches to support the transformation of health and medicine. Its purpose is to develop next-generation multidisciplinary science that encourages existing and new research communities to focus on breakthrough ideas in a variety of areas of value to health, such as networking, pervasive computing, advanced analytics, sensor integration, privacy and security, modeling of socio-behavioral and cognitive processes, and system and process modeling. 

Robert Wood Johnson Foundation
Equity-Focused Policy Research
https://www.rwjf.org/en/library/funding-opportunities/2019/equity-focused-policy-research-building-evidence-on-early-care-and-education.html
The purpose of this funding opportunity is to support action-oriented research that advances health equity, builds the knowledge base, and informs policymaking to increase access to early care and education for low-income families. Required brief proposals are due July 25, 2019, with invited full proposals due October 10, 2019.

Robert Wood Johnson Foundation
Evidence for Action: Investigator-Initiated Research to Build a Culture of Health (E4A)
http://www.rwjf.org/en/library/funding-opportunities/2015/evidence-for-action-investigator-initiated-research-to-build-a-culture-of-health.html
This program funds research that expands the evidence base needed to build a Culture of Health, particularly rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs, and partnerships. The foundation is especially interested in research examining the health impacts of programmatic or policy interventions that address factors outside the domain of health care services or public health practice.

Applications are accepted on a rolling basis.

Robert Wood Johnson Foundation
Healthy Eating Research
https://www.rwjf.org/en/library/funding-opportunities/2019/healthy-eating-research.html
This program will support actionable research that advances health equity in the areas of nutritional disparities, nutrition, and food security. The aim of this program is to provide advocates, decision-makers, and policymakers with the evidence needed to address the key social determinants of health and inequalities that underlie poor dietary patterns and related health consequences.

Required concept papers are due July 31, 2019, with invited full proposals due October 2, 2019.

Robert Wood Johnson Foundation
Pioneering Ideas Brief Proposals
https://www.rwjf.org/en/how-we-work/submit-a-proposal.html
This program supports projects that explore how cutting-edge ideas and emerging trends could help or hinder our progress toward a Culture of Health. The foundation is open to ideas on a range of topics, from emerging technologies to pioneering strategies for changing norms and behavior.

Submissions are accepted and reviewed on a rolling basis; applications for 2019 are accepted until October 15, 2019. 

USDA
Organic Agriculture Research and Extension Initiative
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313810
This initiative aims to solve critical organic agriculture issues, priorities, or problems through the integration of research, education, and extension activities.

USDA
Specialty Crop Multi-State Program
https://www.ams.usda.gov/sites/default/files/media/2019_SCMP_Final.pdf
Application Deadline: October 1, 2019
The Specialty Crop Multi-State Program offers grants to solely enhance the competitiveness of specialty crops by funding collaborative, multi-state projects that address the following regional or national level specialty crop issues: food safety, plant pests and disease, research, crop-specific projects addressing common issues, and marketing and promotion.

Gerald R. Ford Presidential Foundation
Research Travel Grants Program
http://www.fordlibrarymuseum.gov/library/foundationgrants.asp
Application Deadline: September 15, 2019
These grants support research in the holdings of the Gerald R. Ford Library. Library collections focus on Federal policies, U.S. foreign relations, and national politics in the 1960s and 1970s. There are earlier and later materials depending upon your topic.

Hagley Center for the History of Business, Technology and Society
Exploratory Research Grants and Henry Belin du Pont Research Grants
http://www.hagley.org/library-grants
Application Deadline: March 31, 2020
These grants support study and research at the Hagley Museum and Library, which focuses on the unfolding history of American business, technology, and innovation and its impact on the world. Exploratory Research Grants support one-week visits by scholars who need the opportunity to explore the collections on-site to determine if a Henry Belin du Pont Research Grant application is warranted, which enable scholars to pursue advanced research in Hagley's collections for periods of up to eight weeks.

Applications are due June 30, October 31, or March 31.

Humanities Nebraska
Major Grants
http://humanitiesnebraska.org/grants/opportunities/
Application Deadline: August 1, 2019
Major Grants are given for projects or programs in the humanities that take place in Nebraska and/or have direct significance to Nebraska. Major Grants are for projects or programs costing more than $2,000.

Humanities Nebraska
Mini Grants
http://humanitiesnebraska.org/grants/opportunities/
Mini Grants are given for projects or programs in the humanities that take place in Nebraska and/or have direct significance to Nebraska. Mini Grants are for projects or programs costing $2,000 or less.

Applications are due January 2, 2019; March 1, 2019; May 1, 2019; July 1, 2019; September 2, 2019, and November 1, 2019.

Institute for Humane Studies at George Mason University
Hayek Fund for Scholars
https://theihs.org/funding/hayekfund/
This program supports students and faculty who are researching and teaching the ideas of liberty within the social sciences and humanities by funding a wide range of research- and career-advancing activities. Applications are accepted on a rolling basis.

Institute for Humane Studies at George Mason University
IHS Grant for Free Speech and Open Inquiry
https://theihs.org/ihs-grant-for-free-speech-open-inquiry/
This program supports faculty who are interested in fostering free speech and civil discourse in academia as they undertake research, plan campus events, or develop student curricula exploring the past, present, and future of free speech. 

J.M. Kaplan Fund
Furthermore Grants in Publishing
http://www.furthermore.org/apply.html
Application Deadline: September 1, 2019
Furthermore grants assist nonfiction books having to do with art, architecture, and design; cultural history, the city, and related public issues; and conservation and preservation. Funds apply to such specific publication components as writing, research, editing, indexing, design, illustration, photography, and printing and binding.

Japan Foundation
JFNY Grant for Japanese Studies
http://www.jfny.org/japanese_studies/smallgrant.html
These grants support projects that will enhance further understanding of Japan through academic exploration. Such projects generally take the form of conferences, colloquia, symposia, presentations, and lectures within the United States. Applications are accepted on a rolling basis and must be received at least three months prior to the project's starting date.

John F. Kennedy Library Foundation
Ernest Hemingway Research Grants
http://www.jfklibrary.org/About-Us/Job-Volunteer-Internships/Research-Grants-and-Fellowships/Ernest-Hemingway-Research-Grants.aspx
Application Deadline: November 1, 2019
These grants provide funds to scholars and students interested in researching the Ernest Hemingway Collection at the JFK Presidential Library. Preference is given to dissertation research and projects not supported by major grants from other institutions.

Nebraska Arts Council
Artists in Schools and Communities Sponsor Grants
http://www.artscouncil.nebraska.gov/grants/grant-categories/aisc-artist-residency-program-sponsor-grants.html
This program supports Nebraska Arts Council Roster Artist residencies that include at least 20 contact hours with participants. During residencies, artists share their expertise and work with teachers or staff to help students achieve educational goals in the arts and other academic disciplines. College- and university-based projects may be funded only when participation by the public is sought in significant numbers.

For grant requests of up to $2,500 per artist, applications are accepted on a rolling basis. For grant requests of over $2,500 per artist, the deadline is October 1, 2019.

Nebraska Arts Council
Nebraska Touring Program Sponsor Grants
http://www.artscouncil.nebraska.gov/grants/grant-categories/nebraska-touring-program-sponsor-grants.html
Nebraska Touring Program Sponsor Grants help organizations fund performances or exhibits selected from the Nebraska Arts Council (NAC) Artist Directory, available on the NAC website. Grants applications are accepted on a rolling basis, are due six weeks before the event, and are processed on a first-come, first-served basis.

NEH
Media Projects: Development Grants
http://www.neh.gov/grants/public/media-projects-development-grants
Application Deadline: August 14, 2019
Development Grants support documentary film, television, radio, and podcast projects that engage general audiences with humanities ideas in creative and appealing way. The grants enable media producers to collaborate with scholars to develop humanities content and to prepare programs for production.

NEH
Media Projects: Production Grants
http://www.neh.gov/grants/public/media-projects-production-grants
Application Deadline: August 14, 2019
Production Grants support the production and distribution of documentary films, television, radio, and podcasts that promise to engage general audiences with humanities ideas in creative and appealing ways.

NEH
Public Humanities Projects
http://www.neh.gov/grants/public/public-humanities-projects
Application Deadline: August 14, 2019
These grants support projects that bring the ideas and insights of the humanities to life for general audiences through in-person programming. Projects must engage humanities scholarship to analyze significant themes in disciplines such as history, literature, ethics, and art history. This program supports projects in three categories: exhibitions (permanent, temporary, or traveling); interpretive programs at historic places; and humanities discussions related to the 250th anniversary of the nation's founding.

NEH
Short Documentaries
https://www.neh.gov/grants/listing/short-documentaries
Application Deadline: August 14, 2019
The Short Documentaries program supports documentary films of up to 30 minutes that engage audiences with humanities ideas in appealing ways. The program aims to extend the humanities to new audiences through the medium of short documentary films. Films must be grounded in humanities scholarship.

NSF
Antarctic Artists and Writers Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314007
This program facilitates writing and artistic projects designed to increase the public's understanding and appreciation of the Antarctic and human endeavors on the southernmost continent.

Proposals are due June first, 2019 and annually thereafter.

NSF and NEH
Documenting Endangered Languages (DEL): Data, Infrastructure and Computational Methods
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=12816
Application Deadline: September 16, 2019
This funding partnership between the NSF and NEH supports projects to develop and advance knowledge concerning endangered human languages. Made urgent by the imminent death of roughly half of the approximately 7,000 currently used human languages, this effort aims to exploit advances in information technology to build computational infrastructure for endangered language research.

Omohundro Institute
Scholars Workshop
https://oieahc.wm.edu/fellowships/scholars-workshop/
Application Deadline: November 1, 2019
These awards allow untenured scholars to gather at the Omohundro Institute for two weeks to work both as a group and individually with Omohundro Institute editors and staff on either a manuscript chapter or a journal article in progress. The weeks include seminar-style meetings on conceptual development, manuscript editing, and source verification as well as time for writing, revising, and consulting.

Science History Institute
Library Travel Grants
https://www.sciencehistory.org/fellowships
This program offers travel grants for periods of up to two weeks for research using the primary research materials of the Othmer Library. 

The D. Kim Foundation for the History of Science and Technology in East Asia
Conference/Workshop Grants
http://dkimfoundation.org/wp1/fellowships/
The D. Kim Foundation supports graduate students and young scholars who are working in the history of science and technology in modern East Asia. Comparative studies of East Asia and the West as well as studies in related fields (mathematics, medicine and public health) are also welcome. These grants will support scholars who plan to present papers at international conferences or workshops. The next deadlines are May 1, 2019 and December 1, 2019.

The D. Kim Foundation for the History of Science and Technology in East Asia
Fellowships and Grants
http://dkimfoundation.org/wp1/fellowships/
Application Deadline: December 1, 2019
The Foundation provides fellowships and grants to support graduate students and young scholars who are working in the history of science and technology in modern East Asia. Comparative studies of East Asia and the West as well as studies in related fields (mathematics, medicine, and public health) are also welcome. Postdoctoral fellowships, dissertation fellowships, traveling/research grants, and conference/workshop grants are offered.

The Getty Foundation
Getty Scholar Grants
http://www.getty.edu/foundation/initiatives/residential/getty_scholars.html
Application Deadline: October 1, 2019
Getty Scholar Grants are for established scholars or writers in the arts, humanities, or social sciences who have attained distinction in their fields. Recipients reside at the Getty Research Institute or Getty Villa, where they pursue their own projects free from academic obligations.

The Kress Foundation
Grant Programs
http://www.kressfoundation.org/grants/main/
This program supports scholarly projects that promote the appreciation, interpretation, preservation, study, and teaching of European art from antiquity to the early 19th century in the following areas:

• History of Art: Supports scholarly projects that will enhance the appreciation and understanding of European art and architecture;
• Conservation: Supports the professional practice of art conservation; and
• Digital Resources: Supports efforts to integrate new technologies into the practice of art history and the creation of important online resources for art history.

The next three application deadlines are January 15, 2019 (excluding Digital Resources projects), April 1, 2019, and October 1, 2019.

The Kurt Weill Foundation for Music
The Kurt Weill Foundation Grant Program
http://www.kwf.org/pages/grant-program.html
Application Deadline: November 1, 2019
The program awards financial support for performances of musical works by Kurt Weill and Marc Blitzstein, for scholarly research pertaining to Kurt Weill, Lotte Lenya, and Marc Blitzstein, and for other relevant educational or scholarly initiatives.

The Lyndon Baines Johnson Foundation
Moody Research Grant
http://www.lbjlibrary.org/page/foundation/initiatives/moody-research-grant
Application Deadline: September 15, 2019
The LBJ Foundation awards a limited number of grants for research at the LBJ Library. Grants may be used for research for dissertations, theses, senior papers, publications, and other projects.

The Roosevelt Institute
Roosevelt Institute Research Grants
https://fdrlibrary.org/research-grants
Application Deadline: November 15, 2019
This program provides small grants-in-aid in support of research on the "Roosevelt years" or clearly related subjects. Funds are awarded for the sole purpose of helping to defray living, travel, and related expenses incurred while conducting research at the Franklin D. Roosevelt Presidential Library.

The Terra Foundation for American Art
Academic Workshop and Symposium Grants
http://www.terraamericanart.org/grants/academic-program-grants/
Funding is available for in-person exchanges such as workshops, symposia, and colloquia that advance scholarship in the field of American art (circa 1500-1980) that take place: 1) in Chicago or outside the United States or 2) in the United States and that examine American art within an international context, with at least half of the participants coming from outside the United States.

Letters of Inquiry (LOI) are required, followed by invited full proposals. The next deadlines are December 6, 2019 for the LOI and March 6, 2020 for the full proposal and March 16, 2020 for the LOI and June 15, 2020 for the full proposal.

The Terra Foundation for American Art
Exhibition Grants
http://www.terraamericanart.org/what-we-offer/grant-fellowship-opportunities/exhibition-grants/
These grants support exhibitions that increase the understanding and appreciation of historical American art (circa 1500 and 1980). To be eligible for funding, exhibitions must travel internationally or be co-organized with an international venue.

Required letters of inquiry are due on August 1, 2019, with invited full proposals due October 15, 2019.

The William Nelson Cromwell Foundation
William Nelson Cromwell Foundation Grants
http://cromwellfoundation.org/prizes-fellowships-grants/grants/
Application Deadline: September 1, 2019
These grants support: 1) historical monographs on major questions in American law and legal development, as well as biographies of important legal figures, 2) the publication of important legal documents in American History, and 3) the digitization of materials that are important to American legal history, particularly but not only materials from the late colonial or early national periods.

Truman Library Institute
Research Grants
http://trumanlibraryinstitute.org/research-grants/research-grants/
Application Deadline: October 1, 2019
Research grants enable graduate students, post-doctoral scholars, and other researchers to research at the Harry S. Truman Library and Museum for one to three weeks. The grants provide assistance to scholars whose contributions illuminate the critical issues of Truman's presidency and legacy.

Ucross Foundation
Residency Program
http://www.ucrossfoundation.org/residency-program/
Application Deadline: October 1, 2019
This program provides uninterrupted time, individual work space, and living accommodations to competitively selected visual artists, writers, and composers. Residencies vary in length from two weeks to six weeks.

Virginia Center for the Creative Arts
Residencies
https://vcca.com/main/apply
This center offers working retreats for exceptional national and international artists, writers, and composers. For anywhere from two weeks to two months (depending on the fellowship), awardees come to the center for intense periods of work, free from the distractions of day-to-day life.

Upcoming deadlines are September 15, 2019; January 15, 2020; and May 15, 2020.

Women's Studio Workshop
Art-in-Education Artists Book Residency Grant
http://www.wsworkshop.org/residencies/art-in-ed-artists-book-residency-grant/
Application Deadline: November 15, 2019
The Art-in-Education Artist's Book Grant is an eight- to ten-week residency awarded to artists to create a new artist's book and then teach young people in the Women's Studio Workshop.

Women's Studio Workshop
Artists Book Residency Grant
http://www.wsworkshop.org/residencies/artists-book-residency-grant/
Application Deadline: November 15, 2019
The Artist's Book Grant is a six- to eight-week residency for artists to produce a limited edition book work. Working intensively in the Women's Studio Workshop studios, artists print and bind their own books.

Women's Studio Workshop
Parent Residency Grant
https://wsworkshop.org/residencies/parent-residency-grant/
Application Deadline: October 15, 2019
The Parent Grant is a four-week residency for an artist with at least one dependent child under the age of 18. Artists may choose to work in any of the Women's Studio Workshop's disciplines: intaglio, letterpress, papermaking, screenprinting, photography, or ceramics.

NIH
Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-20-002.html
Application Deadline: November 14, 2019
This opportunity invites applications for Comprehensive Alcohol Research Centers using the P60 mechanism which requires a dissemination core to initiate and expand community education related to the activities of the center. The overall purpose of the Alcohol Research Center program is to provide leadership in conducting and fostering interdisciplinary, collaborative research on a wide variety of topics relevant to the Institute's mission.

NIH
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-657.html
This announcement encourages applications for Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence. The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. 

NIH
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-833.html
The National Institute of Mental Health (NIMH) Division of AIDS Research encourages applications for Center Core grants (P30) to support Developmental AIDS Research Centers (D-ARC). The D-ARC is intended to provide infrastructural support that facilitates the development of high impact science in HIV/AIDS and mental health that is relevant to the NIMH mission. This FOA intends to support innovative, interdisciplinary research in several areas, including basic, neurological (i.e., neuro-HIV), behavioral and social, integrated biobehavioral, applied, clinical, translational, and implementation science.

NIH
Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-020.html
Application Deadline: October 21, 2019
This opportunity aims to support the Nathan Shock Centers of Excellence in Basic Biology of Aging. These Center grants will provide funding for leadership, training, and research activities that will increase and disseminate scientific knowledge in the research areas supported by the National Institute of Aging's Division of Aging Biology.

NIH
National Institute on Drug Abuse (NIDA) Research Center of Excellence Grant Program (P50 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-259.html
This opportunity provides support for research Centers that (1) conduct drug abuse and addiction research in any area of NIDA's mission, (2) have outstanding innovative science, (3) are multidisciplinary, thematically integrated, synergistic, and (4) serve as national resource(s) to provide educational and outreach activities to drug abuse research communities, educational organizations, the general public, and policy makers in the NIDA research fields. 

NIH
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-225.html
NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. 

NIH
NIDA Core "Center of Excellence" Grant Program (P30)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-121.html
NIDA Core Center of Excellence Grants (P30) are intended to bring together investigators currently funded by NIH or other Federal or non-Federal sources, to enhance the effectiveness of existing research and also to extend the focus of research to drug abuse and addiction. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are encouraged. An application should integrate and promote research in existing funded projects, to achieve new and creative directions. It is expected that individual core activities reflect a relationship to the integrating theme of the Center and the Center is expected to provide research opportunities and experiences to new investigators, and share findings, data and their resources, consistent with achieving the goals of the program. 

NIH
NIDA Program Project Grant Applications (P01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-393.html
This solicitation announces the availability of support for collaborative research by multi-disciplinary teams that is of high priority to NIDA and leads to synergistic outcomes based on the synthesis of multiple research approaches. Funds will support research in which the funding of three or more highly meritorious projects as a group enriches both the component projects and the overall program to offer significant scientific advantages over supporting the same projects as individual research grants (i.e., synergy). For the duration of the award, each Program must consist of a minimum of three research projects focused on issues critical to advance the mission and goals of NIDA. 

NIH
Specialized Alcohol Research Centers (P50 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AA-20-001.html
Application Deadline: November 14, 2019
This opportunity invites applications for specialized Alcohol Research Centers using the P50 mechanism. The overall purpose of the Alcohol Research Center program is to provide leadership in conducting and fostering interdisciplinary, collaborative research on a wide variety of topics relevant to the Institute's mission.

NSF
Centers for Chemical Innovation
https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf19576
Application Deadline: February 19, 2020

USDA
Conservation Innovation Grants (CIG) National Competition
https://drive.google.com/file/d/1QoN4u0FSw-pd_vqmPPoWYEzwz5s15ZSm/view?usp=sharing
Application Deadline: July 30, 2019
The purpose of CIG is to stimulate the development and adoption of innovative conservation approaches and technologies in conjunction with agricultural production. CIG projects are expected to lead to the transfer of conservation technologies, management systems, and innovative approaches (such as market-based systems) to agricultural producers, into Natural Resources Conservation Service technical manuals and guides, or to the private sector.

Department of Defense
Bone Marrow Failure Research Program
https://cdmrp.army.mil/funding/bmfrp
Application Deadline: September 5, 2019
The Bone Marrow Failure Research Program Idea Development Award supports innovative ideas and high-impact approaches based on scientifically sound evidence in order to move toward the vision to understand and cure bone marrow failure (BMF) diseases.

Pre-applications are required and due June 12, 2019.

Department of Defense
Breast Cancer Research Program
http://cdmrp.army.mil/funding/bcrp
Breast Cancer Research Program (BCRP) is currently accepting applications for seven award mechanisms: Breakthrough Award Levels 1 to 4, Breakthrough Fellowship Award, Distinguished Investigator Award, Era of Hope Scholar Award, and Innovator Award. The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. Pre-applications are required. Deadlines vary by award mechanism.

Department of Defense
Clinical and Rehabilitative Medicine Research Program
https://cdmrp.army.mil/funding/jpc8
Application Deadline: November 20, 2019
This program is accepting applications for the Regenerative Medicine Focused Research Award to support the development of regenerative medicine solutions. Particular areas of focus are peripheral nerve regeneration or skeletal muscle regeneration.

Preproposals are due August 7, 2019.

Department of Defense
Development of Quantum Algorithms
https://www.grants.gov/web/grants/view-opportunity.html?oppId=315279
Application Deadline: August 1, 2019
The U.S. Army Research Office together with the National Security Agency is soliciting proposals to develop new quantum computing algorithms for hard computational problems, develop insights into the power of quantum computation, and consider issues of quantum complexity and computability.

Department of Defense
Duchenne Muscular Dystrophy Research Program
https://cdmrp.army.mil/funding/dmdrp
Application Deadline: December 4, 2019
The Duchenne Muscular Dystrophy Research Program is currently accepting applications for the Idea Development Award. The program seeks to better support discovery and development of therapeutics, devices, and other interventions, and to promote their rigorous clinical testing. 

Department of Defense
ERDC Broad Agency Announcement
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312615
Application Deadline: January 31, 2020
The U.S. Army Engineer Research and Development Center (ERDC) has issued a Broad Agency Announcement (BAA) for various research and development topic areas. The ERDC is responsible for conducting research in the broad fields of hydraulics, dredging, coastal engineering, instrumentation, oceanography, remote sensing, geotechnical engineering, earthquake engineering, soil effects, vehicle mobility, self-contained munitions, military engineering, geophysics, pavements, protective structures, aquatic plants, water quality, dredged material, treatment of hazardous waste, wetlands, physical/mechanical/chemical properties of snow and other frozen precipitation, infrastructure and environmental issues for installations, computer science, telecommunications management, energy, facilities maintenance, materials and structures, engineering processes, environmental processes, land and heritage conservation, and ecological processes.

Department of Defense
Gulf War Illness Research Program
https://cdmrp.army.mil/funding/gwirp
Application Deadline: October 3, 2019
The Gulf War Illness Research Program (GWIRP) is currently accepting applications for six award mechanisms. GWIRP supports research of exceptional scientific merit to study the health effects of deployment on U.S. Warfighters during the 1990-1991 Persian Gulf War. The GWIRP challenges the scientific community to design high-impact research that will improve the health and lives of Veterans who have Gulf War Illness (GWI).

Submission of a pre-application (due July 12, 2019) is required; application submission is by invitation only.

Department of Defense
Health Services Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=317512
Application Deadline: August 23, 2019
The goal of Health Services Research (HSR) is to identify the factors that influence the delivery of care. This funding opportunity seeks rigorous HSR that supports and builds capability for the evolution of the military health system through collaboration and innovation. Research funded through this funding opportunity is intended to benefit and inform military health care delivery with potential implications for civilian health care.

Department of Defense
Hearing Restoration Research Program
https://cdmrp.army.mil/funding/hrrp
Application Deadline: November 14, 2019
The Hearing Restoration Research Program (HRRP) is currently accepting applications for the Focus Research Award. The HRRP seeks to pursue promising, necessary research for treatment of burdensome and very prevalent auditory system injury. 

Department of Defense
Kidney Cancer Research Program
https://cdmrp.army.mil/funding/kcrp
Application Deadline: October 1, 2019
The Kidney Cancer Research Program (KCRP) is currently accepting applications for six award mechanisms. The mission of KCRP is to to promote rigorous, innovative, high impact research in kidney cancer.  

Department of Defense
Long Range BAA
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311508
Application Deadline: September 30, 2019
This is an announcement to declare Office of Naval Research's broad role in competitive funding of meritorious research across a spectrum of science and engineering disciplines.

Department of Defense
Lung Cancer Research Program
https://cdmrp.army.mil/funding/lcrp
The Lung Cancer Research Program (LCRP) is currently accepting applications for five award mechanisms: Concept Award; Career Development Award; Idea Development Award; Investigator-Initiated Translational Research Award; and Translational Research Partnership Award. LCRP supports research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer. Preapplications are required. Deadlines vary by award mechanism.

Department of Defense
Lupus Research Program
https://cdmrp.army.mil/funding/lrp
Application Deadline: September 4, 2019
The Lupus Research Program (LRP) is currently accepting applications for two award mechanisms: Concept Award and Impact Award. LRP funds research to understand, prevent, and diagnose lupus and to improve treatments and quality of life of patients.

Pre-applications are due June 7, 2019.

Department of Defense
Melanoma Research Program
https://cdmrp.army.mil/funding/mrp
Application Deadline: October 23, 2019
The Melanoma Research Program is currently accepting applications for four award mechanisms: Concept Award, Idea Award, Team Science Award, and Translational Research Award. The program funds research focusing on the prevention, detection, diagnosis, and treatment of melanoma. 

Department of Defense
Military Medical Photonics Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313509

Department of Defense
Minerva Research Initiative
https://www.grants.gov/web/grants/view-opportunity.html?oppId=315583
Application Deadline: September 26, 2019
The Minerva Research Initiative seeks to increase the Department of Defense (DOD)'s intellectual capital in the social sciences and improve its ability to address future challenges by supporting multidisciplinary and cross-institutional projects addressing specific interest areas determined by the DOD.  This competition is for research related to nine (9) topics: 1) Peer/Near-peer Statecraft, Influence, and Regional Balance of Power; 2) Power, Deterrence, and Escalation Management; 3) Alliances and Burden Sharing; 4) Economic Interdependence and Security; 5) Economic Viability, Resilience, and Sustainability of Logistics Infrastructure; 6) Multi-Domain Behavioral Complexity and Computational Social Modeling; 7) Autonomy, Artificial Intelligence, Machine Ethics, and Social Interactions; 8) Models and Methods for Understanding Covert Online Influence; and 9) Automated Cyber Vulnerability Analysis. 

Department of Defense
Multiple Sclerosis Research Program
https://cdmrp.army.mil/funding/msrp
Application Deadline: September 19, 2019
The Multiple Sclerosis Research Program (MSRP) is currently accepting applications for two award mechanisms: Investigator Initiated Research Award and Exploration - Hypothesis Development Award. The mission of MSRP is to support pioneering concepts and high impact research relevant to the prevention, etiology, pathogenesis, assessment, and treatment of multiple sclerosis.

A pre-proposal is required by May 21, 2019. Submission of a full application is by invitation only.

Department of Defense
Naval Air Systems Command Digital Office Office-Wide Broad Agency Announcement
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310499
Application Deadline: November 18, 2019
The Naval Air Systems Command (NAVAIR) Digital Office is interested in receiving white papers for Science and Technology Projects which offer potential for advancements and improvements applicable to the digitization of NAVAIR / U.S. Naval Operations.

Department of Defense
Naval Air Warfare Center Aircraft Division Office-Wide
https://www.grants.gov/web/grants/view-opportunity.html?oppId=316838
Application Deadline: June 6, 2020
This opportunity is accepting white papers for Research and Development Projects which offer potential for advancement and improvement of Naval Air Warfare Center Aircraft Division operations.

Department of Defense
Orthotics and Prosthetics Outcomes Research Program
https://cdmrp.army.mil/funding/oporp
Application Deadline: August 7, 2019
The Orthotics and Prosthetics Outcomes Research Program is currently accepting applications for two award mechanisms: Clinical Research Award and Clinical Trial Award. The mission of the program is to advance evidence based research in prosthetic and orthotic devices, treatment, rehabilitation, and the prevention of negative secondary health effects of military-related neuromusculoskeletal injury.

Letters of Intent are due July 24, 2019.

Department of Defense
Ovarian Cancer Research Program
https://cdmrp.army.mil/funding/ocrp

Department of Defense
Parkinson's Research Program
https://cdmrp.army.mil/funding/prp
Application Deadline: July 24, 2019
The Parkinson's Research Program is currently accepting applications for two award mechanisms: Early Investigator Research Award and Investigator-Initiated Research Award. The program supports research to understand, prevent, diagnose, and treat Parkinson's disease.

Letters of Intent are due July 9, 2019.

Department of Defense
Peer Reviewed Cancer Research Program
https://cdmrp.army.mil/funding/prcrp
Application Deadline: September 11, 2019
The Peer Reviewed Cancer Research Program (PRCRP) is currently accepting applications for five award mechanisms. The PRCRP mission is to successfully promote high-impact research for cancer prevention, detection, treatment, and survivorship. The application process includes:

1. A letter of intent (Deadline: August 21, 2019) followed by an application for the Career Development Award and Horizon Award.

2. A pre-proposal (Deadline: May 22, 2019) followed by an invited application for the Impact Award; Idea Award with Special Focus; and Translational Team Science Award.

Department of Defense
Peer Reviewed Orthopaedic Research Program
https://cdmrp.army.mil/funding/prorp
Application Deadline: September 18, 2019
The Peer Reviewed Orthopaedic Research Program is currently accepting applications for three award mechanisms: Applied Research Award, Clinical Trial Award, and Clinical Translational Research Award. The program funds high-impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat and combat-related activities. 

Department of Defense
Pharmacotherapies for Alcohol and Substance Abuse Consortium
https://pasa.rti.org/About/Grant-Program
The goal of the Pharmacotherapies for Alcohol and Substance Abuse Consortium is to fund study applications for developing new medications that can be brought to therapeutic use to improve treatment outcomes for alcohol and substance use disorders (ASUD), especially as related to post-traumatic stress disorder and traumatic brain injury. The program is currently accepting applications for two opportunities: Planning Grants (Letter of Intent Due: April 22, 2019; Deadline: June 23, 2019) and Preclinical Study Implementation (Letter of Intent Due: May 13, 2019; Application Deadline: July 22, 2019).

Department of Defense
Prostate Cancer Research Program
https://cdmrp.army.mil/funding/pcrp
The  Prostate Cancer Research Program (PCRP) is currently accepting applications for seven award mechanisms. The PCRP prioritizes research that will 1) distinguish aggressive from indolent disease in men newly diagnosed with prostate cancer, 2) develop strategies to prevent progression to lethal prostate cancer, 3) develop effective treatments and address mechanisms of resistance for men with high risk or metastatic prostate cancer, and 4) develop strategies to optimize the physical and mental health of men with prostate cancer. 

Department of Defense
Psychological Health/Traumatic Brain Injury Research Program
https://cdmrp.army.mil/funding/phtbi
Application Deadline: August 1, 2019
The Psychological Health/Traumatic Brain Injury Research Program is currently accepting applications for the Federal Interagency Traumatic Brain Injury Research Analysis Award. The program seeks to prevent, mitigate, and treat the effects of traumatic stress and traumatic brain injury on function, wellness, and overall quality of life. 

Department of Defense
Reconstructive Transplant Research Program
https://cdmrp.army.mil/funding/rtrp
Application Deadline: October 16, 2019
The Reconstructive Transplant Research Program is currently accepting applications for two award mechanisms: Idea Discovery Award and Investigator-Initiated Research Award. The program seeks to advance the science and execution of complex hand, face and other vascularized composite allotransplantation procedures. 

Department of Defense
Research for Integrated Vehicle Aerodynamic Technologies
https://www.grants.gov/web/grants/view-opportunity.html?oppId=315667
This opportunity provides funding to conduct vehicle aerodynamic research in the following areas: 1) Fundamental and Applied Fluid Dynamics; 2) Aircraft Design and System Enhancements; 3) Flow Control Applications; 4) Weapons Integration and Cavity Flow; 5) Propulsion Integration; 6) Aero-Optics Interactions; and 7) Technology Applications and Operational Analysis. 

Department of Defense
Research Interests of the Air Force Office of Scientific Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314753
The focus of the Air Force Office of Scientific Research is on research areas that offer significant and comprehensive benefits to our national war fighting and peacekeeping capabilities. These areas are organized and managed in two scientific Departments: Engineering and Information Science and Physical and Biological Sciences. 

Department of Defense
Robust and Efficient Computing Architectures, Algorithms and Applications for Embedded Deep Learning
https://www.fbo.gov/index.php?s=opportunity&mode=form&id=c7fb258377187a7bb851bcb73a2c747a&tab=core&_cview=0
This opportunity seeks to fund innovative research to develop advanced efficient computing architectures and systems, as well as robust algorithms and applications, in order to achieve orders of magnitude improvement in size, weight and power, for deploying robust artificial intelligence and machine learning capabilities in an embedded computing environment. Concept papers are required. Full proposals are by invitation only.

Department of Defense
Spinal Cord Injury Research Program
https://cdmrp.army.mil/funding/scirp
Application Deadline: August 27, 2019
The  Spinal Cord Injury Research Program (SCIRP) is currently accepting applications for three award mechanisms: Clinical Trial Award, Investigator-Initiated Research Award, and Translational Research Award. The SCIRP supports research for regenerating/repairing damaged spinal cords and improving rehabilitation therapies. Preapplications are due May 29, 2019.

Department of Defense
Strengthening Teamwork for Robust Operations in Novel Groups
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310010
The U.S. Army Research Laboratory has established this new collaborative program, Strengthening Teamwork for Robust Operations in Novel Groups (STRONG), with the goal of developing the foundation for enhanced teamwork within heterogeneous human-intelligent agent teams. STRONG will be executed through a series of eight annual program cycles (i.e., Cycles 1-8). The FOA will be amended annually to identify a specific problem statement, or topic, for that specific Cycle.

Department of Defense
Structural Integrity Research Collaborations for Aircraft
https://www.grants.gov/web/grants/view-opportunity.html?oppId=309814
The objective of the Structural Integrity Research Collaborations for Aircraft program is to enable collaborative research partnerships between the Air Force Research Laboratory, Academia, and Industry, in areas relevant to aircraft structural integrity including, but not limited to, risk and reliability, metal fatigue and fracture, and composite damage modeling. White papers are required and will be accepted until October 23, 2023.

Department of Defense
Tick-Borne Disease Research Program
https://cdmrp.army.mil/funding/tbdrp.aspx
Application Deadline: August 22, 2019
The Tick-Borne Disease Research Program (TBDRP) is currently accepting applications for three award mechanisms: Career Development Award, Idea Award, and Investigator-Initiated Research Award. The mission of TBDRP is to understand the pathogenesis of Lyme disease and other tick-borne illnesses and to deliver innovative solutions to prevent, diagnose, and treat their manifestations.

Pre-applications are due May 22, 2019.

Department of Defense
Trapped Ion Quantum Computing Systems
https://www.grants.gov/web/grants/view-opportunity.html?oppId=315262
Application Deadline: August 16, 2019
The U.S. Army Research Office in partnership with the National Security Agency is soliciting proposals for research in Trapped Ion Qubits. This program has three research goals; (a) substantially reduce noise levels detrimental to high fidelity gates in trapped ion systems and to improve the stability of these gates once achieved; (b) explore novel quantum information encoding schemes and/or entanglement generation schemes with trapped ion systems; (c) development of critical supporting technology required for successful highly stable high fidelity trapped ion systems.

Department of Defense
Tuberous Sclerosis Complex Research Program
https://cdmrp.army.mil/funding/tscrp
Application Deadline: July 25, 2019
The Tuberous Sclerosis Complex Research Program (TSCRP) is currently accepting applications for three award mechanisms: Exploration Hypothesis Development Award, Idea Award, and Clinical Translational Research Award. The mission of TSCRP is to fund exploratory, pioneering and transformative science that promotes discoveries in TSC, from mechanistic insights to clinical application. 

Department of Defense
Vision Research Program
https://cdmrp.army.mil/funding/vrp
Application Deadline: December 6, 2019
The Vision Research Program is currently accepting applications for three award mechanisms: Focused Translational Team Science Award; Investigator-Initiated Research Award; and Translational Research Award. The program supports innovative, military relevant research related to eye injuries and vision dysfunction. 

DOD
Advanced Research and Development of Mission-Focused Analytics for a Decision Advantage Program
https://www.fbo.gov/index?s=opportunity&mode=form&id=0b63dcb943df55562b36808852570b23&tab=core&_cview=1
This mechanism seeks to provide research and development for forming a revolutionary approach to information fusion and analysis by leveraging service-oriented architecture, open standards, and cutting-edge fusion and analytical algorithms to provide real-time (or near real-time) intelligence for decision makers. 

DOD
Behavioral and Social Sciences Broad Agency Announcement for Basic, Applied, and Advanced Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=304462
The U.S. Army Research Institute for the Behavioral and Social Sciences (ARI) announces the ARI FY18-23 Broad Agency Announcement for Basic, Applied, and Advanced Scientific Research. Those contemplating submission of a proposal are encouraged to contact the ARI Technical Point of Contact for the respective topic area cited in the BAA.  If the R&D warrants further inquiry and funding is available, submission of a proposal will be entertained. The recommended three-step sequence is (1) telephone call to the ARI TPOC or responsible ARI Manager, (2) white paper submission, (3) full proposal submission.

DOD
Decentralized Classification and Coordination with Non-Permissive Communications
https://www.fbo.gov/index?s=opportunity&mode=form&id=b5cacb6f8b8c8049bdb23159b6d66005&tab=core&_cview=0
Applications may be submitted on a rolling basis until September 30, 2021. Only concept papers will be accepted as initial submissions; formal proposals will be accepted by invitation only.

DOD
Domain Agnostic Technologies for Automated Indications and Warning Program
https://www.fbo.gov/index?s=opportunity&mode=form&id=4e1c9e7628839fe3ac9cee4ad59843cf&tab=core&_cview=1
This program seeks proposals to research, develop, demonstrate, integrate, and test innovative technologies for both tactical and strategic automated indications and warnings. 

DOD
Extensible End-to-End Machine Learning System and Advanced Learning Algorithm Development
https://www.fbo.gov/index?s=opportunity&mode=form&id=f69d3f60b2097e8aa88211f68e5b4ab5&tab=core&_cview=1
The Information Directorate of the Air Force Research Laboratory, Rome Research Site, is seeking innovative research proposals for the development of an open, end-to-end machine learning framework to revolutionize how the Department of Defense designs, develops, trains, evaluates, and deploys machine learning capabilities. 

DOD
Extramural Biomedical Research and Development
https://www.grants.gov/web/grants/view-opportunity.html?oppId=307754
Application Deadline: July 31, 2023
A primary emphasis of the program is to identify and develop techniques, knowledge products, and materiel (medical devices, drugs, and biologics) for early intervention in life-threatening injuries, prolonged field care, human performance optimization, and canine medicine/performance. This Broad Agency Announcement (BAA) is continuously open for a 5-year period, from August 1, 2018 to July 31, 2023. A pre-proposal/pre-application is required and may be submitted at any time prior to the BAA closing date.

DOD
Forensic Analysis of Organic and Inorganic Compounds Associated with Microelectronics
https://www.grants.gov/web/grants/view-opportunity.html?oppId=298549&utm_source=Funding+Supplement&utm_campaign=e9875060b9-EMAIL_CAMPAIGN_2017_11_15&utm_medium=email&utm_term=0_8d6cbefc3d-e9875060b9-212708225
Application Deadline: December 8, 2017
This program is interested in the research and development of advanced microelectronics screening techniques for counterfeit detection. In particular, research using mass spectrometry for forensic analyses of organic and inorganic compounds associated with microelectronics, especially the compounds and materials associated with plastic-encapsulated microelectronics. 

DOD
Research and Development Projects Leading to Defense Threat Reduction
https://www.fbo.gov/index?s=opportunity&mode=form&id=ad159f2bda69d90e735610c0c6cc76e1&tab=core&_cview=1
Applications will be accepted on a rolling basis until October 31, 2021. 

DOD
Research and Development Projects on Emerging Computing Architectures and Applications
https://www.fbo.gov/spg/USAF/AFMC/AFRLRRS/BAA-RIK-14-05/listing.html
This program seeks proposals that can provide revolutionary computational capabilities which enable greater system adaptability, autonomy and intelligence while improving information availability throughout the command, control, communications, computers, intelligence, surveillance, and reconnaissance enterprise. 

DOD
Research Projects in the Areas of Engineering and Information Science and Physical and Biological Sciences
https://www.grants.gov/web/grants/view-opportunity.html?oppId=298498&utm_source=Funding+Supplement&utm_campaign=e9875060b9-EMAIL_CAMPAIGN_2017_11_15&utm_medium=email&utm_term=0_8d6cbefc3d-e9875060b9-212708225
This program seeks proposals related to research areas that offer significant and comprehensive benefits to our national war fighting and peacekeeping capabilities. These areas are organized and managed in two scientific departments: 1) Engineering and Information Science; and 2) Physical and Biological Sciences. 

DOD
Strategic Environmental Research and Development Core Program
https://www.fbo.gov/index?s=opportunity&mode=form&id=6c6924838b43d23dcd43b6983527a004&tab=core&_cview=1
Application Deadline: January 4, 2018
This program seeks pre-proposals for research related to the areas of environmental restoration, munitions response, resource conservation and resiliency, and weapons systems and platforms technologies.

Full applications may be submitted after invitation only.

Department of Education
Mental Health Service Professional Demonstration Grant Program
https://www.govinfo.gov/content/pkg/FR-2019-06-21/pdf/2019-13289.pdf
Application Deadline: August 5, 2019
This program provides competitive grants to support and demonstrate innovative partnerships to train school-based mental health services providers for employment in schools and local educational agencies (LEAs). The goal of this program is to expand the pipeline of high-quality, trained providers to address the shortages of mental health service professionals in schools served by high-need LEAs. The partnerships must include (1) one or more high-need LEAs or a State educational agency on behalf of one or more high-need LEAs and (2) one or more eligible institutions of higher education.

Department of Education
Minority Science and Engineering Improvement Program
https://www.govinfo.gov/content/pkg/FR-2019-06-19/pdf/2019-13008.pdf
Application Deadline: July 19, 2019
The Minority Science and Engineering Improvement Program is designed to effect long-range improvement in science and engineering education at predominantly minority institutions and to increase the flow of underrepresented ethnic minorities, particularly minority women, into scientific and technological careers.

Department of Education
Model Demonstration Projects for Early Identification of Students with Dyslexia in Elementary School
https://www.govinfo.gov/content/pkg/FR-2019-07-05/pdf/2019-14270.pdf
Application Deadline: August 5, 2019
The Model Demonstration Projects for Early Identification of Students with Dyslexia in Elementary School will provide support to professionals to collaborate with parents in establishing and meeting high expectations for each student with, or at risk for, dyslexia. 

Department of Education
Personnel Development To Improve Services and Results for Children With Disabilities: Doctoral Training Consortia Associated With High Intensity Needs
https://www.govinfo.gov/content/pkg/FR-2019-06-12/pdf/2019-12317.pdf
Application Deadline: July 29, 2019
The purposes of this program are to (1) help address State-identified needs for personnel preparation in special education, early intervention, related services, and regular education to work with children, including infants and toddlers, with disabilities; and (2) ensure that those personnel have the necessary skills and knowledge, derived from practices that have been determined through scientifically based research and experience, to be successful in serving those children.

Department of Education
Rehabilitation Long-Term Training Program Rehabilitation Specialty Areas
https://www.govinfo.gov/content/pkg/FR-2019-07-05/pdf/2019-14371.pdf
Application Deadline: August 5, 2019
The Rehabilitation Long-Term Training Program is designed to support projects that provide academic training in areas of personnel shortages identified by the Secretary to increase the number of personnel trained in providing vocational rehabilitation services to individuals with disabilities. In FY 2019, the Department plans to make awards in four areas: Rehabilitation Counseling, Rehabilitation of Individuals Who Are Mentally Ill, Rehabilitation of Individuals Who are Blind or Have Vision Impairments, and Rehabilitation of Individuals Who are Deaf or Hard of Hearing. 

Department of Transportation
National Summer Transportation Institute
https://www.grants.gov/web/grants/view-opportunity.html?oppId=308558
The National Summer Transportation Institute Program creates awareness and stimulates interest in middle and high school students about educational and career opportunities in transportation. 

This is a multiyear solicitation for FY 2018 thru FY 2020. The closing date each year will be as promulgated by the applicable State's Federal Highway Administration Division Office for each State or Territory, but no later than the 1st business day after November 30th.

NIH
Cancer Research Education Grants Program - Courses for Skills Development (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-477.html
The goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. This announcement will support creative educational activities with a primary focus on Courses for Skills Development. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, or treatment of cancer; rehabilitation from cancer; or the continuing care of cancer patients and the families of cancer patients.

NIH
Cancer Research Education Grants Program - Curriculum or Methods Development (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-476.html
The goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. This announcement will support creative educational activities with a primary focus on Curriculum or Methods Development. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer; rehabilitation from cancer; and the continuing care of cancer patients and the families of cancer patients.

NIH
Cancer Research Education Grants Program - Research Experiences (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-478.html
The goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. This announcement will support creative educational activities with a primary focus on Research Experiences. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer; rehabilitation from cancer; and the continuing care of cancer patients and the families of cancer patients, in accordance with the overall mission of the NCI.

NIH
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-244.html
The goal of this program is to support educational activities that foster a better understanding of biomedical, behavioral, and clinical research and its implications.

NIH
National Cancer Institute Youth Enjoy Science Research Education Program (R25)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-059.html
The NIH Research Education Program supports research education activities in the mission areas of NIH. The overarching goal of this NCI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral, and clinical research workforce. 

NIH
National Institute on Drug Abuse Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-258.html
This opportunity is intended to support research education activities that enhance the knowledge of substance use and substance use disorder research. The program is intended for those in clinically focused careers and/or those training for careers as clinicians/health service providers, clinical researchers, or optimally a combination of the two. This opportunity will support creative educational activities with a primary focus on Courses for Skills Development and Research Experiences. The proposed research education programs must include both courses for skills development and research experiences with primary emphasis on research experiences. Proposed courses should be developed in conjunction with and support research experiences to enhance skills development. 

NIH
NIAID Research Education Program (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-455.html
 The overarching goal of this NIAID R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs in NIAID mission areas. To accomplish this goal, this announcement will support creative educational activities with a primary focus on Courses for Skills Development, Research Experiences, and Mentoring Activities related to NIAID's mission areas. 

NIH
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-030.html
The over-arching goal of this NIDDK R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. To accomplish the stated over-arching goal, this opportunity will support creative educational activities with a primary focus on courses for skills development and research experiences.

NIH
NIMH Research Education Mentoring Programs for HIV/AIDS Researchers (R25)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-485.html
The NIH Research Education Program supports research education activities in the mission areas of the NIH. The overarching goal of this National Institute of Mental Health R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral, and clinical research needs and advance the priorities outlined in the Office of AIDS Research Annual Strategic Plan and the research program priorities of the NIMH Division of AIDS Research.

NIH
NINDS Research Education Opportunities (R25 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-782.html
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NINDS R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. Specifically, this announcement will support creative educational activities with a primary focus on Courses for Skills Development and Research Experiences.

NIH
Research to Understand and Inform Interventions that Promote the Research Careers of Individuals in the Biomedical Sciences (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-295.html
This opportunity encourages applications that propose research designed to test training, mentoring, and networking interventions intended to enhance research-oriented individuals' interest, motivation, persistence, and preparedness for careers in the biomedical research workforce. Funded projects are expected to produce research findings that will guide the design and implementation of interventions in a variety of academic settings and career levels to enhance the diversity of the biomedical research workforce.

NIH
Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-197.html
This funding opportunity will support creative educational activities with a primary focus on research experiences for high school or undergraduate students or science teachers during the summer academic break. 

NIH
Undergraduate Research Education Program to Enhance Diversity in the Environmental Health Sciences (R25 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-19-010.html
Application Deadline: August 30, 2019
This program supports research education activities in the mission areas of the NIH. The over-arching goal of this program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research. 

NIH
Workshops on the Use of Adolescent Brain Cognitive Development Data (R25 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-001.html
Application Deadline: October 17, 2019
This opportunity supports creative educational activities with a primary focus on courses for skills development. Short-term workshops that will allow participants to explore the hands-on use of adolescent brain cognitive development data, through cooperative or competitive approaches, are of particular interest.

NSF
Improving Undergraduate STEM Education: Education and Human Resources (IUSE: EHR)
https://www.nsf.gov/publications/pub_summ.jsp?ods_key=nsf17590
Multiple deadlines apply. See the solicitation for details.

NSF
Innovative Technology Experiences for Students and Teachers (ITEST)
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5467
Application Deadline: August 19, 2019
ITEST is an applied research and development program providing direct student learning opportunities in pre-kindergarten through high school. The learning opportunities are based on innovative use of technology to strengthen knowledge and interest in science, technology, engineering, and mathematics (STEM) and information and communication technology (ICT) careers. To achieve this purpose, ITEST supports projects that engage students in technology-rich experiences that: (1) increase awareness and interest of STEM and ICT occupations; (2) motivate students to pursue appropriate education pathways to those occupations; and (3) develop STEM-specific disciplinary content knowledge and practices that promote critical thinking, reasoning, and communication skills needed for entering the STEM and ICT workforce of the future.

NSF
International Research Experiences for Students (IRES)
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505656
The IRES program supports international research and research-related activities for U.S. science and engineering students. Proposers are required to select one of the following tracks to submit their proposal: 1) Track I focuses on the development of world-class research skills in international cohort experiences; 2) Track II is dedicated to targeted, intensive learning and training opportunities that leverage international knowledge at the frontiers of research; and 3) Track III supports U.S. institutional collaborations to develop, implement, and evaluate innovative models for high-impact, large-scale international research and professional development experiences for U.S. graduate students.

NSF
Research Experiences for Undergraduates
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5517
Application Deadline: August 28, 2019
The Research Experiences for Undergraduates (REU) program supports active research participation by undergraduate students in any of the areas of research funded by the National Science Foundation. This solicitation features two mechanisms for support of student research: (1) REU Sites are based on independent proposals to initiate and conduct projects that engage a number of students in research. REU Sites may be based in a single discipline or academic department or may offer interdisciplinary or multi-department research opportunities with a coherent intellectual theme. (2) REU Supplements may be included as a component of proposals for new or renewal NSF grants or cooperative agreements or may be requested for ongoing NSF-funded research projects.

NSF
Webinar: How to Use InformalScience.org to Make Your Case
https://www.nsf.gov/events/event_summ.jsp?cntn_id=242924&WT.mc_id=USNSF_13&WT.mc_ev=click
InformalScience.org is a curated collection of project, research, and evaluation resources designed to support the informal STEM education community working in a variety of learning environments. This session will provide useful tips and suggestions for using the site while developing proposals, from conducting literature searches to identifying potential collaborators.

NSF
Webinar: How to Write a Competitive AISL Proposal
https://www.nsf.gov/events/event_summ.jsp?cntn_id=242925&WT.mc_id=USNSF_13&WT.mc_ev=click
In this webinar, program officers from the Advancing Informal STEM Learning (AISL) program will highlight: (1) essential elements that should be in every strong AISL proposal, (2) proposal deficiencies to avoid, and (3) key differences between a highly competitive proposal and a proposal that is not competitive. This will also be an opportunity to ask questions and receive responses from AISL program officers in real time.

The National Education Association (NEA) Foundation
Learning and Leadership Grants
http://www.neafoundation.org/pages/learning-leadership-grants/
These grants are given to NEA members for one of the following two purposes: (1) individual grants to fund participation in high-quality professional development experiences, such as summer institutes, conferences, seminars, travel abroad programs, or action research; or (2) group grants to fund collegial study, including study groups, action research, lesson plan development, or mentoring experiences for faculty or staff.  

Applications may be submitted at any time and are reviewed three times per year after February 1, June 1, and October 15.

USDA
Military Families Learning Network
https://nifa.usda.gov/funding-opportunity/military-families-learning-network
Application Deadline: August 2, 2019
The purpose of the Military Families Learning Network is to develop, utilize, and disseminate innovative and effective resources and programming that would support the professional development needs of providers in both the traditional Military Family Support Program and civilian communities.

USDA
Promoting the Holistic Approach on Nutrition Policy
https://drive.google.com/file/d/1C4N-P-ScgB8ItVz6IK68CR_XKWHc6A3P/view?usp=sharing
Application Deadline: July 25, 2019
This opportunity is for multi-year cooperative agreement proposals to design, plan, and implement nutrition workshops and seminars for foreign regulatory officials on the margins of international meetings and in key trade countries or regions. The workshops and seminars will inform foreign regulators and policy-makers on options to promote an evidence-based approach to nutrition policy as they tackle diet related non-communicable diseases such as obesity. The seminars should focus on science- and evidence-based approaches to improve healthy eating in their countries by broadening the bucket of options beyond the trade-restrictive regulations that are being increasingly adopted around the world. 

USDA
Youth Support and Internship Program
https://nifa.usda.gov/sites/default/files/rfa/fy-19-youth-support-internship-program-rfa-20190620.pdf
Application Deadline: July 25, 2019
The National Institute of Food and Agriculture requests applications to implement the Youth Support and Internship Program for fiscal year 2019 to support a fully developed and orchestrated national internship program that engages college students motivated to serve the needs of National Guard and Reserve Component military families during all phases of deployment. 

Department of Energy
Bioenergy Technologies Office Mulit-topic Funding Opportunity Announcement
https://www.grants.gov/web/grants/view-opportunity.html?oppId=315575
Application Deadline: July 22, 2019
This Funding Opportunity Announcement will provide funding to address the highest priority R&D areas within biofuel technologies, bioproducts, and biopower. It includes Areas of Interest (AOIs) from all five Bioenergy Technologies Office (BETO) programs: Feedstock Supply and Logistics; Advanced Algal Systems; Conversion; Advanced Development and Optimization; and Sustainability and Strategic Analysis. Each AOI supports BETO's objectives to reduce the minimum selling price of drop-in biofuels, lower the cost of biopower, enable high-value products from biomass or waste resources, and improve the quality of feedstock characterization and reliability of biorefinery operations. 

Department of Energy
Electric Grid of Things
https://www.grants.gov/web/grants/view-opportunity.html?oppId=317189
Application Deadline: September 9, 2019

Department of Energy
Solar Energy Technologies Office Fiscal Year 2019 Funding Program
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314252
Application Deadline: July 25, 2019
The Solar Energy Technologies Office works across the solar energy technology spectrum with the goal of improving the affordability, reliability, and performance of solar technologies on the grid. With this opportunity, the office intends to fund high-impact, early-stage research in the following areas: Topic Area 1: Photovoltaics Research and Development; Topic Area 2: Concentrating Solar-Thermal Power Research and Development; Topic Area 3: Balance of Systems Soft Costs Reduction; Topic Area 4: Innovations in Manufacturing: Hardware Incubator; and Topic Area 5: Advanced Solar Systems Integration Technologies. Letters of Intent are required and due May 7, 2019.

Department of Energy
Solicitation on Topics Informing New Program Areas
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311427
Application Deadline: December 19, 2019
The Advanced Research Projects Agency - Energy (ARPA-E) of the Department of Energy is soliciting topics under this opportunity that will explore new areas of technology development. Applications to this solicitation must have the potential for high impact - if successful, it could create a new class or new trajectory for an energy technology, with the potential to make a significant impact on ARPA-E's mission areas.

Department of Energy
Solutions to Improve the Energy Efficiency of U.S. Small and Medium Commercial Buildings
https://eere-exchange.energy.gov/#FoaIdd77384ed-97f9-49e9-ba00-94ac05201041
Through this program, the Department of Energy seeks to fund the scale-up of promising solutions to the market barriers that hinder the growth of energy efficiency in small and medium commercial buildings and tenant spaces. The objective of this funding is to build a path for market-ready solutions to be used at scale across the United States to improve commercial building energy efficiency. 

Concept papers (required) are due December 4, 2015.

Applicants may submit only one concept paper and one full application for consideration under this funding opportunity announcement.

DOD
Agent Based Systems
https://www.fbo.gov/index?s=opportunity&mode=form&id=dce3a52a2d901591300feb89eec02feb&tab=core&_cview=0
Application Deadline: September 30, 2022
Concept papers are being accepted on a rolling basis by the Air Force Research Laboratory for innovative research, development, integration, testing, and evaluation of technologies/techniques to rapidly design, build, and field autonomous systems.

DOD
Army Research Laboratory Broad Agency Announcement for Basic and Applied Scientific Research (FY 2017 - 2022)
https://www.grants.gov/web/grants/view-opportunity.html?oppId=292896
The program seeks proposals for basic research in the fields of computational science, materials research, sciences for maneuver, information science, science for lethality and protection, human sciences, and assessment and analysis. 

DOD
Defense Threat Reduction Agency Science and Technology New Initiatives Program
https://www.fbo.gov/index?s=opportunity&mode=form&id=228413edcd329a1561ec6039e2040c09&tab=core&_cview=1
This program seeks to discover and accelerate innovations through three broad technical approaches that contribute to safeguarding America and its allies from weapons of mass destruction and provide capabilities to reduce, eliminate, and counter their effects. 

DOD
Directed Energy and Space Vehicles Cooperative Agreement
http://www.grants.gov/web/grants/view-opportunity.html?oppId=280237
Application Deadline: November 23, 2020
The objective of this effort is to establish a combined cooperative agreement vehicle to efficiently award research funds to investigate new concepts as well as the ancillary supporting technologies for directed energy and space vehicles and to enhance theoretical analyses, exploratory studies, or experiments conducted by educational institutions.

DOD
Emerging Computing Architectures and Applications
https://www.fbo.gov/index?s=opportunity&mode=form&id=e10fb45d00b2e070cca27c4494140fb6&tab=core&_cview=1

The Air Force Research Laboratory invites proposals for research projects on innovative technologies in six technical areas that explore and develop cutting-edge computational capabilities with greater sophistication, autonomy, intelligence, and assurance.

White papers are due June 16, 2014; March 2, 2015; March 1, 2016; March 1, 2017; March 1, 2018; and September 30, 2019.

 

DOD
Enabling Technologies for High-speed Operable Systems
https://www.fbo.gov/index?s=opportunity&mode=form&id=6720537f5592c2528055f12d20966c8b&tab=core&_cview=1
Required concept papers are accepted on a rolling basis until January 18, 2024. Full proposals will be solicited upon request after concept paper review.

DOD
Fundamental Research to Counter Weapons of Mass Destruction
http://www.grants.gov/web/grants/view-opportunity.html?oppId=275322
Pre-application white papers are required and can be submitted on an open basis until September 1, 2024. Full applications may be submitted only after sponsor invitation.

DOD
Global Operational Tactical Information Technology
https://www.fbo.gov/index?s=opportunity&mode=form&id=5346f250a4f5c8a3f53907c7bc54168a&tab=core&_cview=1
This program funds research on innovative technologies to enable the effective management of information for military operations. Applications will be accepted in the four technical areas described in the announcement. 

DOD
High-Powered Electromagnetics (HPEM) Research Program
https://www.fbo.gov/spg/USAF/AFMC/AFRLPLDED/BAA-RVKD-2014-0003/listing.html

AFRL invites proposals for the HPEM Research Program to support research in six technical areas described in the announcement. 

Applications will be accepted on a continuing basis until May 5, 2020.

DOD
Intelligence and Information Warfare BAA
https://www.fbo.gov/notices/e2855aca8cabab2207d5797c04bb38c7

The Communications-Electronics, Research Development and Engineering Center invites proposals to support research and development in areas related to intelligence and information warfare.

Applications will be accepted until August 25, 2019.

DOD
Methods and Technologies for Personalized Learning, Modeling and Assessment
http://www.grants.gov/web/grants/view-opportunity.html?oppId=271531

This program deals with science and technology development, experimentation, and demonstration in the areas of improving and personalizing individual, team, and larger group instructional training methods for airmen. The approaches relate to competency definition and requirements analysis, training and rehearsal strategies, and models and environments that support learning and proficiency achievement and sustainment during non-practice of under novel contexts. This effort focuses on measuring, diagnosing, and modeling airman expertise and performance, rapid development of models of airman cognition and specifying and validating, both empirically and practically, new classes of synthetic, computer-generated agents and teammates.

The closing date for submission of white papers is November 17, 2019.

DOD
Multi-Domain Aerial Warfighting Network Capabilities
https://www.fbo.gov/index?s=opportunity&mode=form&id=e831159ec0fa9b0ac27c732801a0bfb5&tab=core&_cview=0
Application Deadline: September 30, 2022
Concept papers are being solicited on a rolling submission basis for research to develop and demonstrate innovative and affordable technologies that provide agile and secure information transmission, network, and dissemination capabilities to aerial platforms that enable the sharing of quality information within resource and policy constraints. 

DOD
Radio Frequency Communications Systems Research, Development, Test, and Evaluation
https://www.fbo.gov/index?s=opportunity&mode=form&id=019233dec6007bc134fdda0b8c3d63ae&tab=core&_cview=1
The Air Force Research Laboratory Information Directorate is soliciting white papers under this broad agency announcement for research, design, development, concept testing, evaluation, and experimentation in the area of radio frequency communications systems for command, control, communications, and computers/intelligence. Efforts in this area may include technologies and techniques to control, monitor, configure, and analyze the radio frequency and spectrum environment as well as assessment, instrumentation, configuration, and control of experimental systems. 

DOD
Unmanned Aircraft System Airspace Integration
http://www.grants.gov/web/grants/view-opportunity.html?oppId=261268

The objective of this effort is to conduct basic, applied, advanced, and demonstration/validation research to develop, demonstrate, integrate, and transition new unmanned aircraft system airspace integration technologies to the warfighter.

Applications will be accepted until August 6, 2019.

DOD
Very Low Frequency/Low Frequency Communications Technologies Research
https://www.fbo.gov/index?s=opportunity&mode=form&id=ba864ca7ba6d0bcf01acde0d05d5f9ba&tab=core&_cview=1
This program's objective is solicit research resulting in significant advances in science and technology that could solve urgent problems in very low frequency communications technologies. 

NIH
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-530.html
The purpose of this announcement is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. 

NIH
Academic-Industrial Partnerships to Translate and Validate In Vivo Cancer Imaging Systems (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-093.html
The purpose of this announcement is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status. A distinguishing feature of each application will be formation of an academic-industrial partnership, which is a strategic alliance of investigators in academic, industrial, and any other entities who work together as partners to identify and translate a technological solution or mitigation of a cancer-related problem.

NIH
Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-023.html

NIH
Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-024.html
The purpose of this opportunity is to encourage grant applications from the scientific community that develop and test tools to address symptoms in caregivers. The key to this announcement is the focus on the caregiver, regardless of patient symptoms or conditions. Research is needed to enhance symptom recognition and assessment in caregivers and to promote technological strategies to alleviate distress in caregiver symptoms. 

NIH
Bioengineering Research Grants (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-158.html
The purpose of this announcement is to encourage collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem and 2) integrate, optimize, validate, translate, or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science.

NIH
BRAIN Initiative Cell Census Network (BICCN) Scalable Technologies and Tools for Brain Cell Census (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-148.html
This funding opportunity intends to accelerate the integration and use of scalable technologies and tools to enhance brain cell census research, including the development of technology platforms and/or resources that will enable a swift and comprehensive survey of brain cell types and circuits. 

NIH
BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-020.html
Understanding the dynamic activity of neural circuits is central to the NIH BRAIN Initiative. This solicitation seeks applications for proof-of-concept testing and development of new technologies and novel approaches for large-scale recording and manipulation of neural activity to enable transformative understanding of dynamic signaling in the nervous system. 

NIH
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-001.html
This opportunity seeks applications to assemble diverse, integrated, multi-disciplinary teams that cross boundaries of interdisciplinary collaboration to investigate high-impact questions in human neuroscience. Projects should maximize opportunities to conduct innovative in vivo neuroscience research made available by direct access to brain recording and stimulating from invasive surgical procedures. 

NIH
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-006.html
This opportunity supports efforts to disseminate resources and to integrate them into neuroscience research practice. Projects should engage in one or more of the following activities: distribution of tools and reagents; user training on the usage of new technologies or techniques; providing access to existing technology platforms and specialized facilities; minor improvements to increase the scale/efficiency of resource production and delivery; minor adaptations to meet the needs of a user community. 

NIH
BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-003.html
This opportunity will support integrated, interdisciplinary research teams from prior BRAIN technology and/or integrated approaches teams, and/or new projects from the research community that focus on examining circuit functions related to behavior using advanced and innovative technologies. 

NIH
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-113.html
This announcement will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research. Collaborative, multidisciplinary projects that engage the fields of regenerative medicine, tissue engineering, biomaterials, and bioengineering with cancer biology will be essential for generating novel experimental models that mimic cancer pathophysiology. The projects supported will establish and collectively participate in the Cancer Tissue Engineering Collaborative Research Program.

NIH
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-266.html
This announcement invites research grant applications from organizations/institutions that propose the development of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain, and that incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. 

NIH
Exploratory Research for Technology Development (R21 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-254.html
This funding opportunity supports exploratory research leading to the development of innovative technologies for biomedical research. Projects should entail a high degree of risk or novelty, which will be offset by a correspondingly high potential impact. 

NIH
Exploratory/Developmental Bioengineering Research Grants (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-149.html
The purpose of this engineering-oriented funding opportunity announcement is to encourage submissions of exploratory/developmental Bioengineering Research Grant applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.    

NIH
Focused Technology Research and Development (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-253.html
This funding opportunity supports projects that focus solely on development of technologies with the potential to enable acquisition of basic biomedical knowledge. Projects should be justified in terms of technical innovation, and utility for future biomedical impact.

NIH
HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-18-003.html

NIH
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-021.html
This funding opportunity announcement solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. 

NIH
Innovative Measurement Tools for Community Engaged Research Efforts (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-13-209.html

Standard deadline dates apply. See solicitation for details.

NIH
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-019.html
This funding opportunity announcement solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research.

NIH
Innovative Research in Cancer Nanotechnology (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-240.html
This announcement encourages applications for the development of innovative research projects in cancer nanotechnology. This initiative, to be known as Innovative Research in Cancer Nanotechnology (IRCN), is a component of a broader program that is the NCI Alliance for Nanotechnology in Cancer. IRCN awards are designed to enable multidisciplinary research and transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. 

NIH
Medical Simulators for Practicing Patient Care Providers: Skill Acquisition, Outcomes Assessment, and Technology Development (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-065.html
The purpose of the funding opportunity is to promote the assessment and further development of simulation technologies intended to improve patient safety and healthcare outcomes provided by practicing patient care providers and experienced (not trainee) physicians. 

NIH
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-907.html
The purpose of this opportunity is to support the development of advanced computational, bioinformatic, and statistical tools to determine the functional relevance of genetic variants associated with mental disorders of complex etiologies identified through genome-wide association or sequencing studies. The overarching goal of this initiative is to support the development of innovative computational methods that facilitate the elucidation of the functionality of genetic variants associated with mental illness, taking into account the added complexities and nuances of brain diseases, and to ultimately inform novel treatment development based on human biology. This opportunity should be used when two or more sites are needed to complete the study. 

NIH
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-908.html
The purpose of this opportunity is to support the development of advanced computational, bioinformatic, and statistical tools to determine the functional relevance of genetic variants associated with mental disorders of complex etiologies identified through genome-wide association or sequencing studies. The overarching goal of this initiative is to support the development of innovative computational methods that facilitate the elucidation of the functionality of genetic variants associated with mental illness, taking into account the added complexities and nuances of brain diseases, and to ultimately inform novel treatment development based on human biology.

NIH
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-209.html
The objective of this funding opportunity announcement is to support the development of new and innovative on-demand, event-driven and long-acting systemic and non-systemic multipurpose prevention technologies (MPT). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy, and (HIV/STI) and non-HIV STI MPTs in cis and trans males and females of all ages.

NIH
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01- Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-533.html
This announcment is intended to provide an avenue for basic scientists, clinicians, and clinical scientists to jointly initiate and conduct translational research projects that translate basic research findings into clinical tools for better human health. 

NIH
NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-542.html
This announcement supports the development of therapeutic biotechnology products and biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, cell therapies, and novel emerging therapies) for disorders identified under the NINDS mission. 

NIH
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-896.html
This announcement is designed to support innovative research in biomedical informatics and data science. The scope of interest in the research domain of informatics is broad and interdisciplinary.

Standard application dates apply. See solicitation for details.

NIH
Novel Genomic Technology Development (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-777.html
This announcement seeks grant applications to develop major advances in genomic technologies. Advances in genomics and more broadly in biomedical research have been greatly facilitated by significant and sustained genomics technology throughput increases, cost decreases, and improvements in ease of use. The proposed technology development work should allow comprehensive genomic analysis of features not assayable today or an increase of no less than an order of magnitude improvement in an existing technology in terms of data quality, throughput, efficiency or comprehensiveness (individually or in combination). This announcement explicitly excludes the development of novel technologies for DNA sequencing and for direct RNA sequencing. Those projects should respond to a parallel set of announcements (RFA-HG-18-001, RFA-HG-18-002, and RFA-HG-18-003).

Application dates vary. See solicitation for details.

NIH
Novel Genomic Technology Development (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-778.html
This announcement seeks applications to develop major advances in genomic technologies. Advances in genomics and more broadly in biomedical research have been greatly facilitated by significant and sustained genomics technology throughput increases, cost decreases, and improvements in ease of use. The proposed technology development work should allow comprehensive genomic analysis of features not assayable today, or an increase of no less than an order of magnitude improvement in an existing technology in terms of data quality, throughput, efficiency, or comprehensiveness (individually or in combination). This announcement explicitly excludes the development of novel technologies for DNA sequencing and for direct RNA sequencing. Those projects should respond to a parallel set of announcements (RFA-HG-18-001, RFA-HG-18-002, and RFA-HG-18-003).

Application dates vary. See solicitation for details.

NIH
Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-001.html
This announcement solicits R01 applications to develop novel technologies that will enable no less than one order of magnitude improvement in DNA sequencing and practical methods for direct RNA sequencing.

Application dates vary. See solicitation for details.

NIH
Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-002.html
This announcement solicits R21 applications to develop novel technologies that will enable substantive (no less than an order of magnitude) improvement in DNA sequencing and practical methods for direct RNA sequencing.

Application dates vary. See solicitation for details.

NIH
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-128.html
This announcement encourages research project applications under the cooperative agreement mechanism to address the development, optimization, and validation of quantitative imaging software tools and methods for prediction and/or measurement of response to cancer therapies or for planning and validating radiation therapy treatment strategies in clinical trials.

NIH
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-146.html
This announcement seeks clinical research on self-management interventions and technologies that improve health and quality of life in persons needing assistance to optimize and maintain existing functional capabilities, prevent/delay disabilities and navigate their environment. The research focus encompasses maintenance/restorative care that can be tailored to individuals existing functional abilities and interests and is intended to enhance physical, sensory, motor, and mental capabilities. Of particular interest is research designed to maintain functional capabilities in such conditions as cardiac and respiratory insufficiency, movement impairment associated with arthritis, chronic back pain, stroke, and other physical or cognitive disabilities.

NIH
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-17-012.html
This announcement seeks clinical research on self-management interventions and technologies that improve health and quality of life in persons needing assistance to optimize and maintain existing functional capabilities, prevent/delay disabilities, and navigate their environment. The research focus encompasses maintenance/restorative care that can be tailored to individuals existing functional abilities and interests and is intended to enhance physical, sensory, motor, and mental capabilities. 

NIH
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-164.html
This announcement seeks clinical research on self-management interventions and technologies that improve health and quality of life in persons needing assistance to optimize and maintain existing functional capabilities, prevent/delay disabilities, and navigate their environment. The research focus encompasses maintenance/restorative care that can be tailored to individuals existing functional abilities and interests and is intended to enhance physical, sensory, motor, and mental capabilities. Of particular interest is research designed to maintain functional capabilities in such conditions as cardiac and respiratory insufficiency, movement impairment associated with arthritis, chronic back pain, stroke, and other physical or cognitive disabilities.

NIH
Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-17-011.html
This announcement seeks clinical research on self-management interventions and technologies that improve health and quality of life in persons needing assistance to optimize and maintain existing functional capabilities, prevent/delay disabilities and navigate their environment. The research focus encompasses maintenance/restorative care that can be tailored to individuals existing functional abilities and interests and is intended to enhance physical, sensory, motor, and mental capabilities. 

NIH
Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-434.html
This announcement invites applications to conduct research to advance the understanding and application of synthetic biology for human health. It will support 1) the development of innovative tools and technologies in synthetic biology and 2) their application in biomedical research and human health. An integrative research plan based on collaborations of synthetic biologists with computational scientists, cell biologists, engineers, and/or physician scientists is strongly recommended. Early Stage Investigators in synthetic biology are especially encouraged to apply.

NIH
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-145.html
This announcement seeks clinical research focused on the development and utilization of technologies that can help address patient outcomes. Relevant areas of technology include remote healthcare delivery to patients via telehealth, robotics to enhance medication adherence, on-site (e.g., clinical or home setting) care delivery, mobile heath to increase access and adherence, web-based decision support tools, and others. Research projects may focus on assessment, diagnosis, intervention development, or intervention implementation. Research projects that a) incorporate emerging and cutting edge technologies to explain and predict patient trajectories, b) inform interventions, c) support real-time clinical decision making, and d) facilitate effective long-term management of chronic illness are especially needed. Proposed research should identify specific patient outcomes expected to improve from technological approaches. The specific tools or interventions proposed should clearly indicate how they will enhance patient benefits in environments, such as clinical settings, and/or in the home and community.

NIH
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-163.html
This announcement seeks clinical research focused on the development and utilization of technologies that can help address patient outcomes. Relevant areas of technology include remote healthcare delivery to patients via telehealth, robotics to enhance medication adherence, on-site (e.g., clinical or home setting) care delivery, mobile heath to increase access and adherence, web-based decision support tools, and others. Research projects may focus on assessment, diagnosis, intervention development, or intervention implementation. Research projects that a) incorporate emerging and cutting-edge technologies to explain and predict patient trajectories, b) inform interventions, c) support real-time clinical decision making, and d) facilitate effective long-term management of chronic illness are especially needed. Proposed research should identify specific patient outcomes expected to improve from technological approaches. The specific tools or interventions proposed should clearly indicate how they will enhance patient benefits in environments, such as clinical settings, and/or in the home and community.

NIH
Use of Technology to Enhance Patient Outcomes and Prevent Illness (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-17-009.html
This announcement seeks clinical research focused on the development and utilization of technologies that can help address patient outcomes. Relevant areas of technology include remote healthcare delivery to patients via telehealth, robotics to enhance medication adherence, on-site (e.g., clinical or home setting) care delivery, mobile heath to increase access and adherence, web-based decision support tools, and others. Research projects may focus on assessment, diagnosis, intervention development, or intervention implementation. 

NSF
Advanced Manufacturing
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505572
The Advanced Manufacturing program accelerates advances in manufacturing technologies with emphasis on multidisciplinary research that fundamentally alters and transforms manufacturing capabilities, methods, and practices. Proposals should address issues related to national prosperity and security, and advancing knowledge to sustain global leadership.

NSF
Broadening Participation in Engineering
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314104
This program aims to support the development of a diverse and well-prepared engineering workforce by supporting research activities will provide scientific evidence that engineering educators, employers, and policy makers need to make informed decisions to design effective programs that broaden the participation of persons from historically underrepresented groups in the engineering workforce

NSF
Computer and Information Science and Engineering (CISE) Research Initiation Initiative (CRII)
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=504952
Application Deadline: August 14, 2019
CISE seeks to award grants intended to support research independence among early-career academicians who specifically lack access to adequate organizational or other resources. Importantly, the CRII program seeks to provide essential resources to enable early-career PIs to launch their research careers. For the purposes of this program, CISE defines "essential resources" as those that (a) the PI does not otherwise have, including through organizational or other funding; and (b) are critical for the PI to conduct early-career research that will enable research independence. 

NSF
Computer and Information Science and Engineering (CISE): Core Programs
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505667
CISE supports transformative research and education projects that develop new knowledge in all aspects of computing, communications, and information science and engineering, as well as advanced cyberinfrastructure, through the following core programs: the Office of Advanced Cyberinfrastructure Core Research program; the Algorithmic Foundations program; the Communications and Information Foundations program; the Foundations of Emerging Technologies program; the Software and Hardware Foundations program; the Division of Computer and Network Systems Core program; the Cyber-Human Systems program; the Information Integration and Informatics program; and the Robust Intelligence program. 

NSF
Cyber-Physical Systems
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312827
This program aims to develop the core research needed to engineer systems that are built from, and depend upon, the seamless integration of computation and physical components.

NSF
Cyberinfrastructure for Sustained Scientific Innovation (CSSI): Elements and Framework Implementations
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312713
The CSSI umbrella program seeks to enable funding opportunities that are flexible and responsive to the evolving and emerging needs in cyberinfrastructure. This program continues the CSSI program by removing the distinction between software and data elements/framework implementations, and instead emphasizing integrated cyberinfrastructure services, quantitative metrics with targets for delivery and usage of these services, and community creation.

NSF
Dear Colleague Letter - Collaborative Supplemental Funding Opportunity in Graphene and 2D Layered Materials and Devices under the U.S. NSF/ENG - US-EC International Opportunity
http://www.nsf.gov/pubs/2016/nsf16102/nsf16102.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
This Dear Colleague Letter (DCL) invites applications for supplemental funding requests to support collaborations in graphene and 2D layered materials and devices between the U.S. and international research communities.

NSF
Dear Colleague Letter: Removal of Deadlines for the Biological and Environmental Interactions of Nanoscale Materials Program in the Division of Chemical, Biological, Environmental, and Transport Systems (CBET) in the Directorate for Engineering
https://www.nsf.gov/pubs/2017/nsf17085/nsf17085.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
The Biological and Environmental Interactions of Nanoscale Materials Program in the CBET Division has, as of April 2017, eliminated target dates and will accept proposals for consideration at any time. To allow time to adapt to the "open submission - no deadline" guidelines, new proposals will be considered for review after July 20, 2017.

NSF
Dear Colleague Letter: Stimulating Collaboration Between U.S. and European Union Robotics Researchers
http://www.nsf.gov/pubs/2015/nsf15011/nsf15011.jsp?WT.mc_id=USNSF_25&WT.mc_ev=click
Application Deadline: January 1, 2015

In order to stimulate collaboration between U.S. and EU robotics researchers, this Dear Colleague Letter announces NSF's intention to provide supplemental funding to existing Robust Intelligence and National Robotics Initiative awards that are focused on robotics. Funds will be used to pay for the travel of U.S. researchers, as well as stipends and travel support for graduate students and postdocs visiting their EU collaborators. Funds can also be used to pay stipends of visiting EU students and postdocs who have visiting appointments at U.S. institutions.

NSF
Expeditions in Computing
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503169
The Expeditions in Computing (Expeditions) aims to tap the great reservoir of opportunities that fundamental research advances in computer and information science and engineering promise for the future. The program is designed to inspire the computer and information science and engineering research and education community to be as creative and imaginative as possible in the design of bold Expeditions projects that explore new scientific frontiers.

NSF
Growing Convergence Research
https://www.grants.gov/web/grants/view-opportunity.html?oppId=312774
This program supports team research that crosses directorate or division boundaries and is currently not supported by NSF programs, initiatives and research-focused Big Ideas. This research should address a specific challenge or opportunity, whether it arises from deep scientific questions or pressing societal needs.

Proposal due dates are May 8, 2019, February 3, 2020, and the first Monday in February annually thereafter.

NSF
Leading Engineering for America's Prosperity, Health, and Infrastructure (LEAP HI)
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505475
Application Deadline: September 16, 2019
The LEAP HI program challenges the engineering research community to take a leadership role in addressing demanding, urgent, and consequential challenges for advancing America's prosperity, health, and infrastructure. LEAP HI proposals confront engineering problems that are too complex to yield to the efforts of a single investigator -- problems that require sustained and coordinated effort from interdisciplinary research teams, with goals that are not achievable through a series of smaller, short-term projects. LEAP HI projects perform fundamental research that may lead to disruptive technologies and methods, lay the foundation for new and strengthened industries, enable notable improvements in quality of life, or reimagine and revitalize the built environment.

NSF
Mechanics of Materials and Structures
https://www.grants.gov/web/grants/view-opportunity.html?oppId=306172
The Mechanics of Materials and Structures program supports fundamental research in mechanics as related to the behavior of deformable solid materials and structures under internal and external actions. The program supports a diverse spectrum of research with emphasis on transformative advances in experimental, theoretical, and computational methods. Proposals accepted anytime.

NSF
Mid-scale Research Infrastructure-2
https://www.grants.gov/web/grants/view-opportunity.html?oppId=311063
This program supports implementation of projects that comprise any combination of equipment, instrumentation, computational hardware and software, and the necessary commissioning and human capital in support of implementation of the same. 

NSF
Mind, Machine, and Motor Nexus
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505402

NSF
National Robotics Initiative 2.0: Ubiquitous Collaborative Robots
https://www.grants.gov/web/grants/view-opportunity.html?oppId=310513
Application Deadline: November 19, 2019
This program builds upon the original National Robotics Initiative (NRI) program to support fundamental research in the United States that will accelerate the development and use of collaborative robots (co-robots) that work beside or cooperatively with people. The focus of the NRI-2.0 program is on ubiquity, which in this context means seamless integration of co-robots to assist humans in every aspect of life.

NSF
Next Generation Networks for Neuroscience
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313460
The goal of this solicitation is to support collaborative networks comprised of international teams of disciplinarily diverse experimentalists, theorists, and research resource (including technology and cyberinfrastructure) developers working on a common foundational question in neuroscience.

NSF
Quantum Leap Challenge Institutes
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313033
Quantum Leap Challenge Institutes are large-scale interdisciplinary research projects that aim to advance the frontiers of quantum information science and engineering. Two types of awards will be supported under this program: (i) 12-month Conceptualization Grants to support teams envisioning subsequent Institute proposals and (ii) 5-year Challenge Institute awards to establish and operate Quantum Leap Challenge Institutes.

NSF
Secure and Trustworthy Cyberspace Frontiers
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314432
This program aims to support ambitious and potentially transformative center-scale projects in the area of security and privacy.

NSF
Smart and Connected Communities
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313513
This program supports integrative research that addresses fundamental technological and social science dimensions of smart and connected communities and pilots solutions together with communities.

Required letters of intent are due August 6, 2019. Full proposals are due September 6, 2019.

Department of Energy
Nuclear Energy University Programs - Fellowship and Scholarship Support
https://nugrant.unl.edu/fundingOpps/singleOpportunity?VCRFundingOpID=7839
Application Deadline: January 31, 2021
The purpose of this Funding Opportunity Announcement is to award multiple cooperative agreements to accredited U.S. two- and four-year colleges and universities to receive and administer scholarship and fellowship funding provided through the Integrated University Program and administered by the Department of Energy on behalf of selected students attending these universities.

For a copy of this solicitation, please contact Tiffany Lee at tlee9@unl.edu.

Department of Transportation
Dwight David Eisenhower Transportation Fellowship Program Grants for Research Fellowship
https://www.grants.gov/web/grants/view-opportunity.html?oppId=316883
Application Deadline: July 25, 2019
This program provides funding for students to pursue master's or doctoral degrees in transportation-related disciplines. The goals of these Grants are to 1) attract the nation's brightest minds to the field of transportation, 2) enhance the careers of transportation professionals by encouraging them to seek advanced degrees, and 3) bring and retain top talent in the transportation industry of the United States.

Ezra Jack Keats Foundation
Ezra Jack Keats Book Award
http://www.ezra-jack-keats.org/h/about-the-ezra-jack-keats-book-award/
Application Deadline: December 31, 2019
This award is given annually to an outstanding new writer and new illustrator in the field of children's books. The program seeks to award books that portray the universal qualities of childhood, a strong and supportive family, and the multicultural nature of our world.

Fred W. Smith National Library for the Study of George Washington
Research Fellowships
http://www.mountvernon.org/library/research-library/fellows-program/
Application Deadline: December 31, 2019
Fellowships will support short-term (up to three months) or long-term (up to six months) residential research at the Library focused on the life and leadership of George Washington and his place in the development of American civic life and culture. The program also welcomes projects related to the broad themes and historical problems of Colonial America, the Revolutionary Era, and the Early Republic, as well as the history of the arts, material culture, and society which help us better understand the greater legacy of George Washington and his home, Mount Vernon. Finally, projects related to national memory, philanthropy, and the history of historic preservation are also encouraged.

Hagley Center for the History of Business, Technology and Society
Henry Belin du Pont Dissertation Fellowships
https://www.hagley.org/henry-belin-du-pont-dissertation-fellowships
Application Deadline: November 15, 2019
These four-month residential fellowships are designed for graduate students who have completed all course work for the doctoral degree, are conducting research for their dissertation on important historical questions, and would benefit from use of Hagley's research collections.

Hagley Center for the History of Business, Technology and Society
NEH-Hagley Fellowship on Business, Culture, and Society
https://www.hagley.org/neh-hagley-postdoctoral-fellowship-business-culture-and-society
Application Deadline: December 1, 2019
These eight- or four-month fellowships support residencies in Hagley's Center for the History of Business, Technology, and Society by scholars who have received their doctoral degrees by the application deadline.

Harry S. Truman Library Institute
Scholar's Awards
http://trumanlibraryinstitute.org/research-grants/scholars-award/
Application Deadline: December 15, 2019
Grants are made to post-doctoral scholars engaged in work on some aspect of the life and career of Harry S. Truman or of the public and foreign policy issues which were prominent during the Truman years. The award is intended to free a scholar from teaching or other employment for a substantial period of time, and an applicant's work should be intended to result in the publication of a book-length manuscript.

Harvard Business School
The Alfred D. Chandler Jr. Travel Fellowships
http://www.hbs.edu/businesshistory/fellowships/Pages/default.aspx
Application Deadline: November 5, 2019
These fellowships facilitate library and archival research in business or economic history for graduate students or non-tenured faculty in history, economics, or business administration whose research requires travel to Baker Library and other local archives.

Harvard Business School
The Harvard-Newcomen Postdoctoral Fellowship in Business History
http://www.hbs.edu/businesshistory/fellowships/Pages/default.aspx
Application Deadline: October 15, 2019
These fellowships for 12 months' residence, study, and research at the Harvard Business School are open to scholars who, within the last ten years, have received a Ph.D. in history, economics, or a related discipline.

Harvard Business School
The Thomas K. McCraw Fellowship in U.S. Business History
http://www.hbs.edu/businesshistory/fellowships/Pages/default.aspx
Application Deadline: October 15, 2019
These residential fellowships enable established scholars from around the world whose primary interest is the business and economic history of the United States to conduct research in the archives of Baker Library or in other Boston-area libraries, present his or her work at a seminar, and interact with Harvard Business School faculty. Fellows are expected to be in residence for a minimum of two months.

John F. Kennedy Library Foundation
Research Fellowships
http://www.jfklibrary.org/About-Us/Job-Volunteer-Internships/Research-Grants-and-Fellowships.aspx
Application Deadline: September 30, 2019
Several research fellowships are offered, which are intended to support scholars and students who wish to make use of the archival holdings (including audiovisual materials) of the John F. Kennedy Presidential Library and Museum. Topics of interest include foreign intelligence and the presidency or a related topic; the foreign policy of the Kennedy Presidency or the Kennedy Administration's domestic policy; immigration, naturalization, or refugee policy; and domestic policy, political journalism, polling, or press relations.

Lewis Center for the Arts at Princeton University
Hodder Fellowship
http://arts.princeton.edu/fellowships/hodder-fellowship/
Application Deadline: September 17, 2019
The Hodder Fellowship will be given to artists and writers of exceptional promise to pursue independent projects at Princeton University during the academic year.

Lewis Center for the Arts at Princeton University
Princeton Arts Fellowship
http://arts.princeton.edu/fellowships/princeton-arts-fellowship/
Application Deadline: September 17, 2019
Princeton Arts Fellowships will be awarded to early career artists whose achievements have been recognized as demonstrating extraordinary promise in any area of artistic practice and teaching. Fellows will spend two consecutive academic years (September 1-July 1) at Princeton University, and formal teaching will be expected.

Library of Congress
Kluge Fellowship in Digital Studies
https://www.loc.gov/programs/john-w-kluge-center/chairs-fellowships/fellowships/kluge-fellowships-in-digital-studies/
Application Deadline: December 6, 2019
This program supports up to 11 months of residential research at the Library of Congress that will generate deep, empirically-grounded understanding of the consequences of the digital revolution on how people think, how society functions, and how international relations shift.

National Gallery of Art
A. W. Mellon Postdoctoral Fellowship Program
http://www.nga.gov/content/ngaweb/research/casva/fellowships/mellon-postdoctoral-fellowships.html
Application Deadline: October 15, 2019
The A. W. Mellon Postdoctoral Fellowship for 2020-2022 will support research in the history, theory, and criticism of the visual arts of any time period or culture. One fellowship is awarded biennially for two consecutive academic years, and the fellow will reside at the Center for Advanced Study in the Visual Arts in Washington, D.C.

National Gallery of Art
Senior Fellowship Program
http://www.nga.gov/content/ngaweb/research/casva/fellowships/senior-fellowships.html
Application Deadline: October 15, 2019
Senior Fellowships are for full-time research, and scholars are expected to reside in Washington and to participate in the activities of the Center for Advanced Study in the Visual Arts throughout the fellowship period. Fellowships are intended to support research in areas such as: the history, theory, and criticism of the visual arts of any geographical area and of any period; European art before the early 19th century; modern and contemporary art; artifacts; or analysis and criticism of form.

National Gallery of Art
Visiting Senior Fellowship Program
http://www.nga.gov/content/ngaweb/research/casva/fellowships/visiting-senior-fellowships.html
Application Deadline: September 21, 2019
Visiting Senior Fellowships are for full-time research for periods of up to two months, and scholars are expected to reside in Washington and participate in the activities of the Center for Advanced Study in the Visual Arts. The fellowships support research in the history, theory, and criticism of the visual arts of any geographical area and of any period or work that examines artifacts or has implications for the analysis and criticism of visual form.

Nebraska Arts Council
Individual Artist Fellowships
http://www.artscouncil.nebraska.gov/grants/grant-categories/individual-artist-fellowships.html
Application Deadline: November 15, 2019
The Individual Artist Fellowship program recognizes exemplary work by Nebraska artists and provides support through public recognition and monetary awards. The artistic disciplines being highlighted in 2020 are performing arts/filmmaking.

New York Foundation for the Arts
Recharge Foundation Fellowship for New Surrealist Art
https://www.nyfa.org/Content/Show/The-Recharge-Foundation-Fellowship-for-New-Surrealist-Art
Application Deadline: August 7, 2019
These fellowships support painters who are working in the New Surrealist style.

NIH
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-916.html
This funding opportunity seeks to facilitate the entry of both newly independent and early career investigators to the area of drug use and use disorder research and HIV/AIDS. This opportunity encourages Small Research Grant (R03) applications to support research projects on drug misuse and/or use disorder and HIV/AIDS that can be carried out in a short period of time with limited resources. 

NIH
Alcohol Research Resource Awards (R24)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-170.html
This funding opportunity announcement encourages non-hypothesis-driven grant applications to support investigator-initiated research projects that will maintain and expand the availability of resources to serve biomedical research within NIAAA's priority areas.

NIH
Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-004.html
The Avenir Award Program for Research on Substance Abuse and HIV/AIDS looks toward the future by supporting early stage investigators proposing highly innovative studies that address NIH HIV/AIDS Research Priorities. Specifically, the program will support research approaches, both basic and clinical, that have the potential to benefit substance using populations with or at risk for HIV/AIDS by reducing HIV incidence, improving therapies for HIV, reducing the impact of comorbid conditions, and ultimately eradicating HIV.

NIH
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Clinical Trial Required)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-813.html
The purpose of this program is to increase workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators by enhancing the pool of individuals from nationally underrepresented groups in BRAIN Initiative research areas. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track, or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers.

See solicitation for application due dates.

NIH
BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-814.html
The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds in BRAIN Initiative research areas. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition in order to help awardees to launch competitive, independent research careers. Funds are specifically for applicants proposing research that does not involve leading a clinical trial, a clinical trial feasibility study, or ancillary clinical trial.

See solicitation for application due dates.

NIH
Chemical Discovery (CHEM) Award (R21/R33)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-384.html
The purpose of this announcement is to support the development of chemical probes that aid basic research investigations on substance use disorders (SUDs) or identify new lead chemical scaffolds with potential for structure activity relationship (SAR) studies on SUDs. In the long term, it is hoped that these lead chemical scaffolds will provide a greater number of pharmacological tools for basic research and possible drug candidates for medications development.

NIH
Chemistry Science Track Award for Rapid Transition (C/START) (R03)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-383.html
NIDA seeks to facilitate the entry of new/early stage investigators (ESIs) into substance use disorder (SUD) research. ESIs are invited to submit applications for small scale, innovative chemical/pharmacological pilot research projects. Importantly, the C/START award is intended to enable an ESI the opportunity to gather preliminary data in support of subsequent research grants (e.g., R21/R33 [CHEM], R21 or R01) or drug development funding opportunities that, in the long term, help to launch the ESIs scientific career. 

NIH
Cutting-Edge Basic Research Awards (R21-Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-437.html
This award is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders.

NIH
Genomic Innovator Award (R35 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-006.html
This program aims to support researchers to do highly innovative work on important problems in genomics. The PD/PIs should be creative investigators, early in their careers, who are part of consortia, large research groups, or other team-science efforts. They should have New Investigator status and have shown the potential to make important contributions to the field of genomics. PD/PIs will have flexibility to take their research in novel directions as scientific opportunities arise during this award. 

NIH
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-918.html
This opportunity encourages Small Research Grant (R03) applications to facilitate the entry of investigators to the area of neuroimaging, including both new investigators and established investigators seeking to adopt neuroimaging methodologies in their research programs to enable the conduct of small "proof of concept" studies. 

NIH
K01 Mentored Research Scientist Development Award
https://grants.nih.gov/grants/guide/pa-files/PAR-18-799.html
The purpose of the K01 grant program is to provide support and dedicated time for a supervised (mentored) career development experience in occupational safety and health research, leading to research independence. This grant program also is to help ensure the availability of adequate numbers of highly trained scientists and educators to address critical issues in occupational safety and health.

NIH
Maximizing Investigators' Research Award for Early Stage Investigators (R35)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-190.html
The Maximizing Investigators' Research Award (MIRA) is a grant to provide support for the program of research in an early stage investigator's laboratory that falls within the mission of NIGMS. A program of research is the collection of projects in the investigator's lab that are relevant to the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding. 

NIH
Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-894.html
The purpose of this funding opportunity is to enhance the diversity of the mental health research workforce by providing dissertation awards in all research areas within the strategic priorities of the NIMH to individuals from groups underrepresented in biomedical, behavioral, clinical, and social sciences research. This award supports the completion of the doctoral research project.

NIH
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-19-026.html

NIH
Mentored Quantitative Research Development Award (Parent K25 - No Independent Clinical Trials)
https://grants.nih.gov/grants/guide/pa-files/PA-19-124.html
The purpose of this award is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research.

NIH
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-18-005.html
The purpose of this award is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in research in biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing and that will lead to research independence.

NIH
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-126.html
The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and "protected time" (three to five years) for an intensive, supervised career development experience in the biomedical, behavioral, or clinical sciences leading to research independence. 

NIH
National Heart, Lung, and Blood Institute (NHLBI) Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-012.html
The purpose of the NHLBI EIA is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrate their ability to make major contributions to heart, lung, blood and sleep research. The EIA is intended to support a research program, rather than a research project, by providing the primary and most likely sole source of NHLBI funding on individual grant awards.

NIH
National Heart, Lung, and Blood Institute (NHLBI) Outstanding Investigator Award (R35 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-011.html
The purpose of the NHLBI Outstanding Investigator Award is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood, and sleep research.

NIH
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-290.html
Application Deadline: October 18, 2019
This opportunity invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This opportunity is specifically for core/shared resource/central scientific support scientists.

NIH
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-291.html
Application Deadline: October 18, 2019
 This opportunity invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This opportunity is specifically for laboratory-based scientists.

NIH
NIA Academic Leadership Career Award (K07)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-287.html
The objective of this award is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.

NIH
NIAID Career Transition Award (K22)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-434.html
The purpose of this program is to assist postdoctoral fellows' transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist.

NIH
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-296.html
The NIAID New Innovator Awards supports post-doctoral investigators of exceptional creativity who propose highly innovative bold new research with the potential to produce a major impact on broad, important problems in biomedical research of priority to NIAID. Applications from individuals with diverse backgrounds and in any topic relevant to the mission of NIAID are welcome.

NIH
NIBIB Trailblazer Award for New and Early Stage Investigators (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-390.html
This award is an opportunity for new and early stage investigators to pursue research programs of high interest to NIBIB that integrate engineering and the physical sciences with the life and behavioral sciences. Applications are invited from researchers who are at the early stage of their independent careers or those who have not had substantial prior NIH funding. A Trailblazer project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven. Applicants are expected to propose research approaches for which there are minimal or no preliminary data.

NIH
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-019.html
This program supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. The term avant-garde is used to describe highly innovative approaches that have the potential to be transformative. 

NIH
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-001.html
The NIDA Avant-Garde Award Program for HIV/AIDS Research supports individual scientists of exceptional creativity who propose high-impact research that will open new areas of HIV/AIDS research relevant to drug abuse and/or lead to new avenues for prevention and treatment of HIV/AIDS among drug abusers. 

NIH
NIDCD Early Career Research Award (R21 - Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-487.html
This award is intended to support both basic and clinical research from scientists who are beginning to establish an independent research career. The research must be focused on one or more of the areas within the biomedical and behavioral scientific mission of the NIDCD: hearing, balance, smell, taste, voice, speech, or language. 

NIH
NIDCD Research Career Enhancement Award for Established Investigators (K18)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-346.html
The purpose of this award is to enable established, proven investigators to augment or redirect their research programs through the acquisition of new research skills to answer questions relevant to the hearing, balance, smell, taste, voice, speech, and language sciences. 

NIH
NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-011.html
The purpose of the NIH Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award is to support a defined pathway across career stages for outstanding graduate students from diverse backgrounds, including those from groups underrepresented in biomedical and behavioral sciences. This two-phase award will facilitate completion of the doctoral dissertation and transition of talented graduate students to strong neuroscience research postdoctoral positions and will provide career development opportunities relevant to their long-term career goal of becoming independent neuroscience researchers.

NIH
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-006.html
Application Deadline: August 26, 2019
The NIH Director's New Innovator Award Program supports early stage investigators of exceptional creativity who propose highly innovative research projects with the potential to produce a major impact on broad, important problems relevant to the mission of NIH. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research.

NIH
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-005.html
Application Deadline: September 9, 2019
The NIH Director's Pioneer Award Program supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative research towards the ultimate goal of enhancing human health. Individuals from diverse backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply. In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research. To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator's research program or elsewhere.

NIH
NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-469.html
This award is designed to enhance the participation of highly trained early career investigators from diverse backgrounds underrepresented in neuroscience research. This opportunity provides individuals from diverse backgrounds with strong training in neuroscience with the resources and tools that will help facilitate a transition to a stable and productive independent research position. 

NIH
NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-685.html
The purpose of this award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. 

NIH
NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-686.html
The purpose of this award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. 

NIH
NINDS Postdoctoral Mentored Career Development Award (K01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-145.html
The purpose of this award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program. 

NIH
Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-052.html
This program invites applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal of the program is to allow Alzheimer's Disease (AD) researchers to expand their expertise to become more effective in leading cross-disciplinary, translational, team-science projects in AD or AD-related dementias (ADRD). This award will also allow data scientists to redirect their expertise toward the study of AD and ADRD.

NIH
Research Program Award (R35 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-037.html
Application Deadline: July 30, 2019
This award provides longer-term support and increased flexibility to Program Directors and Principal Investigators whose records of research achievement demonstrate their ability to make major contributions to neuroscience. Each award will support the overall research programs of National Institute of Health-funded investigators for up to 8 years.

NIH
Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship (Parent F32)
https://grants.nih.gov/grants/guide/pa-files/PA-19-188.html
The purpose of this fellowship is to enhance the research training of promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers.

NIH
Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship (Parent F31)
https://grants.nih.gov/grants/guide/pa-files/PA-19-195.html
The purpose of this fellowship award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the applicants dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist.

NIH
Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)
https://grants.nih.gov/grants/guide/pa-files/PA-19-196.html
The purpose of this award is to enhance the diversity of the health-related research workforce by supporting the research training of predoctoral students from diverse backgrounds, including those from groups that are underrepresented in the biomedical, behavioral, or clinical research workforce.

NIH
Ruth L. Kirschstein National Research Service Award Individual Senior Fellowship (Parent F33)
https://grants.nih.gov/grants/guide/pa-files/PA-19-187.html
NIH awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers. This announcement is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

NIH
Short-term Mentored Career Enhancement Awards in Mobile and Wireless Health Technology and Data Analytics: Cross-Training at the Intersection of Behavioral and Social Sciences and STEM Disciplines (K18 Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-881.html
The goal of the program is to support the development of research capability in mobile and wireless health technology (e.g., wearable devices, mobile applications, electronic health records, data analytics). Special emphasis will be given to independent behavioral and social sciences investigators who seek to train in a STEM discipline (e.g., big data analysis, computational modeling, engineering, computer science, and mathematics) or to STEM scientists who which to train in a behavioral and social science discipline.

NIH
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-467.html
This announcement represents the continuation of an NCI program to facilitate the transition of investigators in mentored, non-independent cancer research positions to independent faculty cancer research positions. This goal is achieved by providing protected time through salary and research support for the initial three years of the first independent tenure-track faculty position, or its equivalent, beginning at the time when the candidate starts a tenure-track faculty position.

NIH
Transition to Aging Research Award for Predoctoral Students (F99/K00)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-009.html
Application Deadline: October 22, 2019
This award aims to increase, retain, and diversify the pool of trainees in aging and geriatric research. This two-phase award will allow awardees to complete doctoral dissertation projects and provide a variety of training supports to facilitate smooth transition of doctoral graduates into competitive, aging-focused postdoctoral positions.

NIH
Transition to Independent Environmental Health Research Career Transition Award (K01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-360.html
This award is a three-year bridge scholar development program for newly independent faculty who intend to pursue research careers in environmental health sciences. At the conclusion of the career development period the candidates are expected to demonstrate they can successfully compete for research funding in the environmental health sciences.

NSF
Atmospheric and Geospace Sciences Postdoctoral Research Fellowships
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314573

Omohundro Institute
Georgian Papers Programme Fellowships
https://oieahc.wm.edu/digital-projects/georgian-papers-programme/fellowships/
Application Deadline: November 1, 2019
The Omohundro Institute has entered into an international partnership for research in the extraordinary trove of Georgian materials housed at the Royal Archives in Windsor Castle's Round Tower. These month-long Georgian Papers fellowships support research on transatlantic and early American topics. Fellows explore the collections for their own research while offering invaluable information for the team of archivists and librarians working on archival organization and cataloguing.

Omohundro Institute
Lapidus Initiative Fellowships for Digital Collections
https://oieahc.wm.edu/digital-projects/digital-collections-fellowships/
Application Deadline: November 1, 2019
These fellowships are intended to bring scholars and collections specialists together to make collections available for digital scholarship. The fellowships make awards to the holding library and to the scholar whose research relies on, or will be greatly enhanced by, the digitization of a collection or partial collection of materials related to early America, broadly conceived, before 1820. Scholars must partner with special collections libraries that will digitize the needed materials with the funds from the fellowship.

Omohundro Institute
Lapidus-OI Fellowship for Graduate Research in Early American Print Culture
https://oieahc.wm.edu/fellowships/predoctoral/lapidus/
Application Deadline: November 1, 2019
These fellowships support advanced graduate student research related to early American and transatlantic print culture.

Omohundro Institute
Omohundro Institute-NEH Postdoctoral Fellowships
https://oieahc.wm.edu/fellowships/neh/
Application Deadline: November 1, 2019
This is a two-year residential postdoctoral fellowship in any area of early American studies. The Institute's scope encompasses the history and cultures of North America's indigenous and immigrant peoples during the colonial, Revolutionary, and early national periods of the United States and the related histories of Canada, the Caribbean, Latin America, the British Isles, Europe, and Africa to approximately 1820.

Omohundro Institute and the Folger Institute at the Folger Shakespeare Library
Short-term Fellowships
https://oieahc.wm.edu/fellowships/short-term/folger-institute/
Application Deadline: November 1, 2019
These fellowships supports scholars - from advanced graduate students to senior scholars - with strong interests in early America, broadly understood. Scholars of Atlantic history, colonial history, literary studies, performance history, and material culture are encouraged to apply. Fellows make use of the collections at the Folger Shakespeare Library for one month as well as participate in the Folger Institute's intellectual community.

Omohundro Institute and the Jamestown Rediscovery Foundation
Short-term Visiting Fellowships
https://oieahc.wm.edu/fellowships/short-term/jamestown-foundation/
Application Deadline: November 1, 2019
These fellowships are offered to scholars - from advanced graduate students to senior scholars - with strong interests in colonial history, historical archaeology, Atlantic history, Native American history, African American studies, early Jamestown, the Chesapeake, and material culture from 1500-1720. Fellows make use of William and Mary's Swem Library and collections at Historic Jamestowne as well as other resources in the Historic Triangle and Richmond region.

Organization of American Historians (OAH)
John Higham Research Fellowship
http://www.oah.org/programs/awards/john-higham-fellowship/
Application Deadline: December 2, 2019
This fellowship is open to all graduate students writing doctoral dissertations for a Ph.D. in American history.

Radcliffe Institute for Advanced Study at Harvard University
Fellowship Program
https://www.radcliffe.harvard.edu/fellowship-program/how-apply
These residential fellowships are offered to scholars, scientists, and artists to work on individual projects, or in clusters, to generate new research, publications, art, and more. Fellows receive office or studio space and access to libraries and other resources of Harvard University during the fellowship year, which extends from early September 2020 through May 2021.

The deadline for individual applications in the creative arts, humanities, and social sciences is September 12, 2019. For applications in science, engineering, and mathematics, the deadline is October 3, 2019.

Rockefeller Archive Center
Research Stipend Program
http://www.rockarch.org/grants/generalgia.php
This program provides awards for travel and accommodation in conjunction with research conducted at the Rockefeller Archive Center. The Center makes available for research the archival collections from members of the Rockefeller family, institutions and organizations founded by Rockefeller family members, and other philanthropic and service organizations.

Applicants are required to contact the Archive Center's staff no later than October 15, 2019 with a description of the research project for which they seek support. Full applications are due November 1, 2019.

Simons Foundation
Simons Fellowship in Mathematics
https://www.simonsfoundation.org/grant/simons-fellows-in-mathematics/
Application Deadline: September 27, 2018
The Simons Foundation's Mathematics and Physical Sciences division invites applications for the Simons Fellows in Mathematics program, which is intended to make sabbatical leaves more productive by extending them to a full academic year for those that hold a tenured position within a mathematics department.

Society of Architectural Historians
H. Allen Brooks Travelling Fellowship
http://www.sah.org/jobs-and-careers/sah-fellowships-and-grants/h-allen-brooks-travelling-fellowship
Application Deadline: September 30, 2019
The fellowship will allow a recent graduate or emerging scholar in a field related to the built environment to study by travel for one year. The fellowship is not for the purpose of doing research for an advanced academic degree or publication but, instead, is for travel and contemplation while observing, reading, writing, or sketching.

The Dorothy and Lewis B. Cullman Center for Scholars and Writers
Cullman Center Fellowships
http://www.nypl.org/help/about-nypl/fellowships-institutes/center-for-scholars-and-writers
Application Deadline: September 27, 2019
This international fellowship program is open to people whose work will benefit directly from access to the collections at the Stephen A. Schwarzman Building, including academics, independent scholars, and creative writers (novelists, playwrights, poets), as well as visual artists at work on a book project. The Center appoints 15 fellows a year for a nine-month term at the Library, from September through May.

The Kennan Institute
George F. Kennan Fellowship
http://www.wilsoncenter.org/opportunity/george-f-kennan-fellowship
Application Deadline: September 1, 2019
The Kennan Institute seeks fellowship applications to examine important political, social, economic, cultural, and historical issues in Russia, Ukraine, and the region. Fellows will be based at the Wilson Center in Washington, D.C. for three-month residencies. Individuals and research teams of two or three applicants (with citizens from at least two different countries) are allowed.

The Library Company of Philadelphia
NEH Post-Doctoral Fellowships
https://librarycompany.org/academic-programs/fellowships/postdoc/
Application Deadline: November 1, 2019
These fellowships support research in residence at the Library Company on any subject relevant to its collections, which are capable of supporting research in a variety of fields and disciplines relating to the history of America and the Atlantic world form the 17th through the 19th centuries.

The Library Company of Philadelphia
Program in Early American Economy and Society Post-Doctoral Fellowships
https://librarycompany.org/academic-programs/fellowships/postdoc/
Application Deadline: November 1, 2019
These fellowships support research in the collections of the Library Company and other nearby institutions into the origins and development of the early American economy, broadly conceived, to roughly 1850.

The Lyndon Baines Johnson Foundation
Harry Middleton Fellowship in Presidential Studies
http://www.lbjlibrary.org/page/foundation/initiatives/harry-middleton-fellowship-in-presidential-studies
Application Deadline: September 15, 2019
The Harry Middleton Fellowship supports scholarly work in presidential studies for doctoral students and postdoctoral fellows. Fellowship recipients must conduct research at the LBJ Library and at least one other facility of the National Archives and Records Administration.

The MacDowell Colony
MacDowell Fellowship
https://www.macdowellcolony.org/application-guidelines
These fellowships consist of exclusive use of a studio, accommodations, and three prepared meals a day for up to eight weeks at the MacDowell Colony. The Colony accepts applications from artists working in the following disciplines: architecture, film/video arts, interdisciplinary arts, literature, music composition, theatre, and visual arts.

The next two deadlines are April 15, 2019 and September 15, 2019.

The Renaissance Society of America
Fellowships
https://rsa.site-ym.com/page/fellowships
Application Deadline: September 15, 2019
The Society awards a number of competitive fellowships to members each year supporting individual research projects and publications that advance scholarly knowledge about the period 1300-1700. The purpose of the fellowships, both residential and non-residential, is to support members who need to travel to archives, libraries, and historic sites to conduct short-term research (usually one to two months), and then to publish their results for the scholarly community and the general public.

The Social Science Research Council and the Japan Foundation Center for Global Partnership
Abe Fellowship
http://www.ssrc.org/fellowships/view/abe-fellowship/
Application Deadline: September 1, 2019
The Abe Fellowship is designed to encourage international, multidisciplinary research on topics of pressing global concern in the social sciences and related disciplines. The program seeks to foster the development of a new generation of researchers who are interested in policy-relevant topics of long-range importance, and it strives especially to promote a new level of intellectual cooperation between the Japanese and American academic and professional communities.

USAID
Jefferson Science Fellowships
http://sites.nationalacademies.org/pga/jefferson/index.htm
Application Deadline: October 31, 2019
The National Academies of Sciences, Engineering, and Medicine are soliciting applications for the Jefferson Science Fellowship, for scientists with experience identifying and articulating science and technology to the general public to serve one year on assignment at the U.S. Department of State or USAID contributing to the work of foreign policy or international development issues. During the one-year fellowship, the salary and benefits of the Fellow will be paid by the academic institution where the appointment is held, and all the rights and privileges of that position will be maintained. The fellow will receive a stipend of approximately $50,000 to cover local living expenses and a $10,000 travel budget for fellowship-related travel.

Library of Congress
Baruch S. Blumberg NASA/Library of Congress Chair in Astrobiology
https://www.loc.gov/programs/john-w-kluge-center/chairs-fellowships/chairs/blumberg-nasa-chair-in-astrobiology/
Application Deadline: December 1, 2019
This program supports the exploration of issues surrounding life's future in the universe, for humans and other species, on Earth and beyond. One researcher is appointed annually to be in residence at The John W. Kluge Center, to make use of the Library of Congress collections, as well as to convene programs that ensure the subject of astrobiology's role in culture and society receives considered treatment each year in Washington, D.C.

NASA
Service Network Hub for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-010.html
Application Deadline: November 12, 2019
The purpose of this initiative is to advance the application of cryoelectron tomography, a powerful new method for directly visualizing macromolecular associations and organization in native cells. This opportunity will establish one service center that will serve as the network's central hub.

NIH
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-426.html
The purpose of this announcement is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. 

NIH
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-425.html
The purpose of this announcement is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies that are now a leading cause of death in HIV-infected individuals. 

NIH
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-077.html
The purpose of this funding opportunity is to support early phase translational research that will generate new malaria vaccine candidates suitable for further downstream development and clinical evaluation. This research opportunity encourages studies that will lead to discovery of new vaccine candidates that prevent infection, ameliorate disease, and/or interrupt transmission caused by human malaria parasites, especially P. falciparum and P. vivax.

NIH
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-162.html
The ABCD Study is collecting data on health and mental health, cognitive function, substance use, cultural and environmental factors, and brain structure and function from youth starting when they are 9-10 years-old and following them longitudinally to early adulthood. These data will be made available to the scientific community through the National Institute of Mental Health Data Archive. The purpose of this funding opportunity is to encourage applications proposing the analysis of this public use dataset to increase knowledge of adolescent health and development. 

NIH
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-163.html
The ABCD Study is collecting data on health and mental health, cognitive function, substance use, cultural and environmental factors, and brain structure and function from youth starting when they are 9-10 years-old and following them longitudinally to early adulthood. These data will be made available to the scientific community through the National Institute of Mental Health Data Archive. The purpose of this funding opportunity is to encourage applications proposing the analysis of this public use dataset to increase knowledge of adolescent health and development. 

NIH
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-172.html
This funding opportunity announcement encourages state-of-the-art, systematic research approaches to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases. 

NIH
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-173.html
This funding opportunity announcement encourages state-of-the-art, systematic research approaches to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial diseases. 

NIH
Acute Kidney Injury in Older Adults (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-13-141.html

Standard deadline dates apply. See solicitation for details.

NIH
Addressing Chronic Wound Trajectories Through Social Genomics Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-17-492.html
The purpose of this announcement is to stimulate clinical research that applies a social genomics approach to chronic wound risk, presence, progression, and healing. The field of social genomics focuses on how the social environment influences gene expression, and how this gene expression may in turn impact health outcomes. 

NIH
Addressing Chronic Wound Trajectories Through Social Genomics Research (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-17-493.html
The purpose of this announcement is to stimulate clinical research that applies a social genomics approach to chronic wound risk, presence, progression, and healing. The field of social genomics focuses on how the social environment influences gene expression, and how this gene expression may in turn impact health outcomes. 

NIH
Adipogenesis, Adipocyte Function and Obesity Following HIV Infection, Antiretroviral Therapy, or Pre-Exposure Prophylaxis (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-008.html
Application Deadline: November 7, 2019
This opportunity seeks applications to elucidate the underlying mechanisms of how HIV and antiretroviral drugs used for therapy or pre-exposure prophylaxis contribute to the development of obesity and alter adipocyte and adipose tissue function as well as the effects of these processes on metabolic and physiological processes within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases.

NIH
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-368.html
This announcement invites applications that propose to support advanced-stage development and utilization of novel research infrastructure to advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. Specifically, this announcement will use the NIH Exploratory/Developmental Grants Phase II mechanism to provide support for expanded activities. Applicants are expected to have an existing research infrastructure developed either through PA-12-064 or with other NIH or non-NIH support. Through this award, investigators will develop a mature and sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.

NIH
Advancing Basic Neurobiology Toward Translation Through Assay Development (R01 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-505.html
This announcement encourages research grant applications to develop novel, robust assays to reveal changes in neuronal and/or glial function. The goal is to adapt state-of-the-art measures of basic cellular processes or molecular events that are key mediators of nervous system function into phenotypic assays, with the intent to probe mechanisms or perturbations in an unbiased and efficient manner. These novel assays would provide opportunities to measure neurobiological endpoints to accelerate basic discovery and support target identification and therapeutic development efforts.

NIH
Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-036.html
Application Deadline: July 30, 2019
The objective of this funding opportunity announcement is to advance non-sputum-based tuberculosis (TB) diagnostics for use in HIV-1 infected and HIV-1 exposed uninfected children for improved, simplified, rapid, and decentralized diagnosis of TB disease. This opportunity will support discovery and validation of novel biomarkers useful for TB diagnosis or the development/optimization and early validation of novel TB diagnostic technologies.

NIH
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-080.html

NIH
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-081.html
The purpose of this funding opportunity is to support the development of rapid, sensitive, specific, simple, and cost-effective fungal diagnostics for primary health-care settings (hospitals and point-of-care).

NIH
Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-002.html
This announcement supports highly innovative R01 applications on HIV/AIDS and drug abuse and complements the Avant-Garde Award Program for HIV/AIDS and Drug Use Research and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS. 

NIH
Advancing Exceptional Research on HIV/AIDS and Substance Abuse (R01, Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-022.html
This solicitation supports highly innovative R01 applications on HIV/AIDS and drug abuse and complements the Avant-Garde Award Program for HIV/AIDS and Drug Use Research and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS. 

NIH
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-876.html#_3._Additional_Information
The purpose of this funding opportunity is twofold: (1) to stimulate basic and mechanistic science that facilitates the development of effective probiotics or pre-/probiotic combinations of relevance to human health and disease; and (2) to determine biological outcomes for the evaluation of efficacy of pre/probiotics in appropriate test systems and animal models. This opportunity encourages basic and mechanistic studies using in vitro, in vivo, ex vivo, and in silico models that focus on prebiotic/probiotic strain selectivity, interaction, and function. It will also encourage inter and multidisciplinary collaborations among scientists in a wide range of disciplines including nutritional science, immunology, microbiomics, genomics, other '-omic' sciences, biotechnology, and bioinformatics.

NIH
Advancing Novel Research Models to Study Idiopathic Pulmonary Fibrosis (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-007.html
Application Deadline: October 1, 2019
This opportunity supports the development of collaborative research projects to establish a set of complementary model systems that reproduce essential disease-defining features of human idiopathic pulmonary fibrosis.

NIH
Advancing Our Understanding of the Brain Epitranscriptome (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-152.html
The purpose of this initiative is to stimulate research into the functions of modified RNAs in the brain and in the associated modification proteins that act on RNA (readers, writers, and erasers) that play a role in basic neurobiological and behavioral processes implicated in mental and substance use disorders. 

NIH
Advancing our Understanding of the Brain Epitranscriptomics (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-153.html
The purpose of this initiative is to stimulate research into the functions of modified RNAs in the brain and/or the associated modification proteins that act on RNA (readers, writers, and erasers) and play a role in basic neurobiological and behavioral processes implicated in mental and substance use disorders. 

NIH
Advancing Research in Augmentative and Alternative Communication (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-047.html
This funding opportunity announcement solicits applications on augmentative and alternative communication to advance our scientific knowledge in the evaluation and treatment of individuals with complex communication needs or with severe speech and physical impairments.

NIH
Advancing Research in Augmentative and Alternative Communication (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-046.html
This funding opportunity announcement solicits applications on augmentative and alternative communication to advance our scientific knowledge in the evaluation and treatment of individuals with complex communication needs or with severe speech and physical impairments. 

NIH
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-902.html
The purpose of this funding opportunity is twofold: 1. to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable functional benefits of probiotic/prebiotic components and/or their combinations; and; 2. to understand the underlying mechanisms of their action(s), and variability in responses to these interventions. 

NIH
Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-031.html
The purpose of this announcement is to stimulate investigations, including translational, epidemiologic and clinical studies and trials, that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. 

NIH
Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-032.html
The purpose of this announcement is to stimulate investigations, including translational, epidemiologic and clinical studies and trials, that improve the understanding, prevention and clinical outcomes of non-HIV infections transmitted from women to their offspring during pregnancy, labor and delivery, and breastfeeding. 

NIH
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-738.html
The overall purpose of this opportunity is to assess the role of the microbiome in health and disease during aging. 

NIH
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-739.html
The overall purpose of this announcement is to assess the role of the microbiome in health and disease during aging. 

NIH
Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-022.html
Application Deadline: October 22, 2019
This opportunity invites applications to conduct new research on automobile technology for signaling early signs of cognitive impairment in older drivers. Specifically, applications should propose research on using automobile technology coupled with other modes of assessing an individual's health and/or functional status to detect early signs of cognitive impairment.

NIH
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-863.html
The purpose of this funding announcement issued by the National Institute on Alcohol Abuse and Alcoholism is to encourage research grant applications that explore whether and how alcohol and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.

NIH
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-861.html
The purpose of this funding announcement issued by the National Institute on Alcohol Abuse and Alcoholism is to encourage research grant applications that explore whether and how alcohol and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.

NIH
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-862.html
The purpose of this funding announcement issued by the National Institute on Alcohol Abuse and Alcoholism is to encourage research grant applications that explore whether and how alcohol and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.

NIH
Alcohol-Induced Effects on Tissue Injury and Repair (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-297.html
This announcement encourages R01 applications to study molecular and cellular mechanisms of tissue injury and repair associated with alcohol use in humans. 

NIH
Alcohol-Induced Effects on Tissue Injury and Repair (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-296.html
This announcement encourages R21 applications to study molecular and cellular mechanisms of tissue injury and repair associated with alcohol use in humans. 

NIH
Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-823.html
The National Institute on Aging (NIA) invites applications for research projects (R01) involving secondary analyses of data and/or stored biospecimens from the CALERIE (Comprehensive Assessment of Long- term Effects of Reducing Intake of Energy) trial. The goal of this funding opportunity announcement (FOA) is to encourage analyses that will lead to a more detailed understanding of the effects of caloric restriction (CR) on risk factors for chronic diseases, as well as, the cellular/molecular mechanisms mediating the effects of sustained CR in humans.

Standard application dates apply. See solicitation for details.

NIH
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-046.html
The overarching purpose of this funding opportunity is to promote the validation of strong candidate biomarkers and endpoints for pain that can be used to facilitate the development of non-opioid pain therapeutics from discovery through Phase II clinical trials.  

NIH
Basic and Translation Research on Decision Making in Aging and Alzheimer's Disease (R21 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-538.html
This announcement invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease.

NIH
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-251.html
The objective of this funding opportunity is to support innovative research on adducts to cellular macromolecules as indicators of exposures to endogenous and exogenous cancer risk factors relevant to exposures in human populations.

NIH
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-252.html
The objective of this funding opportunity is to support innovative research on adducts to cellular macromolecules as indicators of exposures to endogenous and exogenous cancer risk factors relevant to exposures in human populations.

NIH
Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-544.html
This announcement invites applications for basic research to better characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease.

NIH
Basic Mechanisms of Brain Development Mediating Substance Use and Dependence (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-119.html
This announcement encourages applications from investigators that propose to study the developing brain or brain areas that play significant roles in mediating emotional and motivated behavior and in substance use and dependence. All stages of brain development are of interest, but a new emphasis of the current reissue of this initiative is to support basic neuroscience research on fundamental mechanisms of brain development during prepuberty and the adolescent period in relation to the problems of substance abuse and co-morbidity with psychiatric disorders. 

NIH
Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-654.html
This announcement encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. 

NIH
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-655.html
This announcement encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. 

NIH
Biology of Aging in Reproductive Tissues (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-036.html
Application Deadline: January 29, 2020
This opportunity invites research applications addressing cellular and molecular mechanisms that regulate aging of the reproductive tissues, including the niche, in gonads, reproductive accessory organs, and the reproductive neuroendocrine system.

NIH
Biology of Bladder Cancer (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-183.html
This funding opportunity announcement encourages applications investigating the biology and underlying mechanisms of bladder cancer.

NIH
Biology of Bladder Cancer (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-184.html
This funding opportunity announcement seeks applications investigating the biology and underlying mechanisms of bladder cancer.

NIH
Biology of Lung, and Head and Neck Preneoplasias (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-459.html
This announcement seeks applications investigating mechanistic and biological aspects of preneoplasia leading to lung and head and neck (HN) cancers. Despite improved therapies and a deeper molecular understanding of lung and HN cancers, these tumors remain a major health problem. While molecular markers of early injury to the aerodigestive epithelial field have been found, relatively little is known about the molecular mechanisms that initiate these preneoplasias and drive their progression to invasive cancer. A functional understanding of the key molecular changes involved in the formation and progression of lung and HN preneoplasias will enhance our knowledge of oncogenic progression and accelerate development of effective preventive and therapeutic strategies.

NIH
Biology of Lung, and Head and Neck Preneoplasias (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-460.html
This announcement seeks applications investigating mechanistic and biological aspects of preneoplasia leading to lung and head and neck (HN) cancers. Despite improved therapies and a deeper molecular understanding of lung and HN cancers, these tumors remain a major health problem in the United States and globally. While molecular markers of early injury to the aerodigestive epithelial field have been found, relatively little is known about the molecular mechanisms that initiate these preneoplasias and drive their progression to invasive cancer. A functional understanding of the key molecular changes involved in the formation and progression of lung and HN preneoplasias will enhance our knowledge of oncogenic progression and accelerate development of effective preventive and therapeutic strategies.

NIH
Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-123.html
This announcement will provide support for assays (and associated data analysis) of repository-held samples for studies focused on an NIDDK relevant disease. 

NIH
Biomarkers: Bridging Pediatric and Adult Therapeutics (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-169.html
This announcement encourages grant applications that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity, and response to therapy. 

NIH
BRAIN Initiative Cell Census Network (BICCN) Specialized Collaboratory on Human and Non-Human Primate Brain Cell Atlases (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-149.html
This funding opportunity intends to support a group of specialized collaboratories that will adopt scalable technology platforms and streamlined workflows to accelerate progress towards establishing comprehensive molecular and anatomical reference cell atlases of human brain and/or non-human primate brains. A central goal of this opportunity is to build a brain cell census resource that can be widely used throughout the research community. 

NIH
BRAIN Initiative: Biology and Biophysics of Neural Stimulation (R01 - Clinical Trials Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-018.html
A central goal of the BRAIN Initiative is to develop new and improved perturbation technologies suitable for controlling specified cell types and circuits to modulate function in the central nervous system. This solicitation seeks applications to systematically characterize, model, and validate the membrane, cellular, circuit, and adaptive-biological responses of neuronal and non-neuronal cells to various types of stimulation. 

NIH
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-145.html
This funding opportunity announcement (FOA) solicits applications to develop web-accessible data archives to capture, store, and curate data related to BRAIN Initiative activities. The data archives will work with the research community to incorporate tools that allow users to analyze and visualize the data, but the creation of such tools is not part of this FOA. The data archives will use appropriate standards to describe the data, but the creation of such standards is not part of this FOA. A goal of this program is to advance research by creating a community resource data archive with appropriate standards and summary information that is broadly available and accessible to the research community for furthering research.

NIH
BRAIN Initiative: Development of Next Generation Human Brain Imaging Tools and Technologies (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-19-002.html
This opportunity aims to support full development of entirely new or next generation noninvasive human brain imaging tools and methods that will lead to transformative advances in our understanding of the human brain. This opportunity seeks innovative applications that are ready for full-scale development of breakthrough technologies with the intention of delivering working tools.

NIH
BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-135.html
The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative funding opportunity is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis and manipulation of complex circuits in large brains. Neuroscience has experienced an impressive influx of exciting new research tools in the past decade, especially since the launch of the BRAIN Initiative. However, the majority of these cutting-edge tools have been developed for use in model organisms, primarily rodents, fish, and flies. These cutting-edge tools, such as viral delivery of genetic constructs, are increasingly adaptable to larger mammalian brains and more importantly are emerging as potential human therapeutic strategies for brain disorders. A pressing need to develop tools for use in large brains or those that are more directly relevant to the human brain is the focus of this initiative. 

NIH
BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-147.html
This funding opportunity solicits applications to develop informatics tools for analyzing, visualizing, and integrating data related to the BRAIN Initiative or to enhance our understanding of the brain.

NIH
BRAIN Initiative: New Concepts and Early-stage Research for Large-scale Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-EY-18-001.html
This announcement seeks applications for unique and innovative technologies that are in an even earlier stage of development than that sought in other announcements under the BRAIN Initiative, including new and untested ideas that are in the initial stages of conceptualization. In addition to experimental approaches, the support provided under this announcement might enable calculations, simulations, computational models, or other mathematical techniques for demonstrating that the signal sources and/or measurement technologies are theoretically capable of meeting the demands of large-scale recording or manipulation of circuit activity in humans or in animal models. The support might also be used for building and testing phantoms, prototypes, in-vitro, or other bench-top models in order to validate underlying theoretical assumptions in preparation for future announcement aimed at testing in animal models.

NIH
BRAIN Initiative: Non-Invasive Neuromodulation - New Tools and Techniques for Spatiotemporal Precision (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-310.html
This opportunity solicits grant applications in two related but distinct areas. The first area is in the development and testing of novel tools and methods of neuromodulation that go beyond the existing forms of neural stimulation. The second distinct area is the optimization of existing stimulation methods.

NIH
BRAIN Initiative: Proof of Concept Development of Early Stage Next Generation Human Brain Imaging (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-19-001.html
Application Deadline: September 3, 2019
This opportunity announcement aims to support early stage development of entirely new and novel noninvasive human brain imaging technologies and methods that will lead to transformative advances in our understanding of the human brain. 

NIH
BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-120.html
This opportunity encourages secondary analysis of existing data related to the BRAIN Initiative with the goal of promoting studies that will significantly advance new discoveries and accelerate the pace of research of the BRAIN Initiative through harnessing the big data and machine learning opportunities.

NIH
BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-19-146.html
This funding opportunity solicits applications to develop standards that describe experimental protocols that are being conducted as part of the BRAIN Initiative. It is expected that applications will solicit community input at all stages of the process. It is recommended that the first step of standard development will involve sharing data between different key groups in the experimental community in order to ensure that the developing standard will cover the way that all of those groups are collecting data. The developed standard is expected to be made widely available.

NIH
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-EB-17-005.html
This solicitation requests new theories, computational models, and statistical tools to derive understanding of brain function from complex neuroscience data. 

NIH
BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-135.html
The purpose of this initiative is to encourage applications that will develop and validate tools and resources to facilitate the detailed analysis of brain microconnectivity.

NIH
Bridges to the Doctorate Research Training Program (T32)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-300.html
The goal of this program is to develop a diverse pool of scientists earning a Ph.D., who have the skills to successfully transition into careers in the biomedical research workforce. This opportunity provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise.

NIH
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-289.html
This opportunity supports basic and translational neuroscientists who are committed to improving the efficiency and scientific value of the therapeutic development pipeline by advancing the discovery of in vivo physiological and behavioral measures reflecting circuit engagement as tools for early phase target validation and therapeutic screening for mental illness treatment development. The efforts supported by this initiative focus on measures in animals as a first step in generating translational assay measures that are adaptable across early therapeutic screens in animals to evaluation in humans.

NIH
Capturing Complexity in the Molecular and Cellular Mechanisms Involved in the Etiology of Alzheimer's Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-15-358.html
Application Deadline: December 10, 2015
The goal of this announcement is to support innovative research focused on understanding the molecular and cellular mechanisms underlying the heterogeneity and multifactorial nature of Alzheimer's Disease (AD) with the potential to create new or challenge existing scientific paradigms. This announcement encourages individual or collaborative research projects that propose innovative approaches to understand the complex biology of AD aimed to fill critical knowledge gaps. 

NIH
Cellular and Molecular Biology of Complex Brain Disorders (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-309.html
This announcement encourages applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function. 

NIH
Cellular and Molecular Biology of Complex Brain Disorders (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-310.html
This announcement encourages research grant applications directed toward the discovery of the impact of alterations associated with complex brain disorders on the fundamental cellular and molecular substrates of neuronal function. 

NIH
Centers Without Walls for Collaborative Research in the Epilepsies: Functional Evaluation of Human Genetic Variants (U54 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-019.html
Application Deadline: August 27, 2019

NIH
Changes in Cellular Architecture During Aging (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-442.html
This announcement seeks applications that propose innovative research strategies aimed at increasing the understanding of the changes in cellular architecture that occur during the aging process. 

NIH
Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-007.html
Application Deadline: October 22, 2019
The primary aim of this opportunity is to facilitate the characterization of the marmoset as a laboratory animal for research on aging and age-related disease, with a focus on filling the identified gaps in knowledge related to the optimization of the marmoset for the study of aging. 

NIH
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-923.html
The purpose of this opportunity is to support innovative studies to identify and understand the immunological responses that mediate protection from Mycobacterium tuberculosis infection or following vaccination with Bacillus Calmette-Guérin or investigational vaccines. Studies may focus on any stage of mycobacterial infection and may include HIV-infected or uninfected individuals. Development of novel functional assays to assess host response and inclusion of immune profiling and systems biology approaches are encouraged.

NIH
Characterization of the Adolescent Reproductive Transition (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-314.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of puberty and the trajectory of sexual development. Research using new technologies and approaches is needed to fill knowledge gaps and advance understanding of normative sexual development in both males and females. It is anticipated that the findings of studies supported by this announcement will advance knowledge of puberty and the establishment of reproductive competence. 

NIH
Characterization of the Adolescent Reproductive Transition (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-16-316.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of puberty and the trajectory of sexual development. New technologies and approaches are needed to fill knowledge gaps and advance understanding of normative sexual development in both males and females. It is anticipated that the findings of studies supported by this announcement will advance knowledge of puberty and the establishment of reproductive competence.

NIH
Characterization of the Adolescent Reproductive Transition (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-315.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of puberty and the trajectory of sexual development. New technologies and approaches are needed to fill knowledge gaps and advance understanding of normative sexual development in both males and females. It is anticipated that the findings of studies supported by this announcement will advance knowledge of puberty and the establishment of reproductive competence.

NIH
Cigar Tobacco Reference Products Program (UC2) Clinical Trials Not Allowed
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-20-002.html
Application Deadline: September 10, 2019
This opportunity seeks to develop a cigar tobacco reference products program that will require significant collaboration and research efforts with outside organizations. The selected organization(s) will develop tobacco reference products representing at minimum three categories of commercially available cigars to be used for investigational nonclinical purposes by tobacco manufacturers, contract and government laboratories, and academic institutions.

NIH
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-029.html
This announcement invites applications that focus on clarifying the relationship between delirium and Alzheimer's disease and related dementias. 

NIH
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-038.html
This announcement invites applications that focus on clarifying the relationship between delirium and Alzheimer's disease and related dementias (ADRD). Specifically sought is research focusing on understanding why persons with ADRD are at increased risk to develop delirium, often with a worse prognosis compared to those without antecedent ADRD, and why patients who experience delirium are at higher risk to develop subsequent short- and/or long-term mild cognitive impairment or ADRD, often with an accelerated rate of cognitive decline compared to those without preceding delirium. 

NIH
Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-181.html
This announcement invites applications that focus on clarifying the relationship between delirium and Alzheimer's disease and related dementias (ADRD). Specifically sought is research focusing on understanding why persons with ADRD are at increased risk to develop delirium, often with a worse prognosis compared to those without antecedent ADRD, and why patients who experience delirium are at higher risk to develop subsequent short- and/or long-term mild cognitive impairment or ADRD, often with an accelerated rate of cognitive decline compared to those without preceding delirium. 

NIH
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-952.html
This opportunity invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare disease research by enabling efficient and effective movement of candidate therapeutics or diagnostics toward clinical trials and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.

NIH
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-953.html

NIH
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-220.html
This funding opportunity announcement invites researchers to submit applications for support of clinical studies that address critical needs for clinical trial readiness in rare neurological and neuromuscular diseases. These studies should result in clinically validated biomarkers and clinical outcome assessment measures appropriate for use in upcoming clinical trials. 

NIH
Clinical Validation of Candidate Biomarkers for Neurological Diseases (U01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-664.html
The purpose of this announcement is to support rigorous clinical validation of a candidate biomarker using retrospective and/or prospective methods in a manner that is consistent with the purpose of the biomarker. This announcement assumes that: (1) a candidate biomarker has already been identified, (2) an analytical method has been developed and validated that is consistent with the purpose of the biomarker, and (3) a working hypothesis regarding context of use is in place. The goal of this announcement is to facilitate the advancement of robust and reliable biomarkers of neurological disease for use in multi-site clinical trials and clinical practice.

NIH
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-895.html
The purpose of this funding opportunity is to support studies with a focus on developing drug delivery strategies that target the Central Nervous System for better suppression of Human Immunodeficiency Virus and reservoir reduction. 

NIH
Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-269.html
This opportunity solicits proposals for Artificial Intelligence, Machine Learning, and/or Deep Learning approaches, collectively referred to here as "cognitive systems," that lead to the identification of gene mutations/variants that cause or contribute to the risk of or protection against the development of Alzheimer's disease and Alzheimer's disease related dementias via analysis of a variety of genetic, genomic, and biomarker data that are currently available to the research community.

NIH
Collaborative Cross Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 - Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-781.html
The purpose of this announcement is to support the use of Collaborative Cross (CC) mouse lines to advance understanding of the host genetics involved in immune regulation and function and to further develop CC mouse lines that more faithfully reproduce human immune responses. Research areas supported by this announcement include: immune system development, function, or regulation; mechanisms governing immune response to infectious pathogens, vaccines, or adjuvants; host susceptibility factors and mechanisms of pathogen-induced immunopathology; and immune mechanisms involved in the development and progression of immune-mediated diseases, such as allergy/asthma, autoimmunity, primary immunodeficiency, inflammation, and cell/organ/tissue transplant rejection or tolerance.

NIH
Comparative Biology of Neurodegeneration (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-039.html
This announcement invites exploratory comparative biology research projects assessing how different animal species respond to challenges and damage to cellular physiology pathways that might influence the onset of Alzheimer's and other neurodegenerative diseases as well as resilience to them, such as adaptation to stress, macromolecular damage, proteostasis, and stem cell function and regeneration. 

NIH
Comparative Genomics Research Program (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-482.html
Application Deadline: January 8, 2021
Applications for research developing comparative approaches that can be used to understand genome structure and function and the relationship between genomic features and phenotypes. This program supports studies that enable the use of a diverse array of species to advance our ability to understand basic biological processes related to human health and disease, as well as studies that develop novel analytical tools and resources for the comparative genomics research community. 

NIH
Complex Integrated Multi-Component Projects in Aging Research (U19)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-143.html
This announcement requests applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions.

NIH
Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-MH-20-300.html
Application Deadline: September 3, 2019
The purpose of this opportunity is to support the development or application of advanced computational and statistical tools to integrate brain tissue and single-cell genomic data in order to advance our understanding of the cell type-specific gene regulatory networks and biological pathways involved in the pathogenesis and pathophysiology of major mental disorders.

NIH
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-096.html

NIH
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-039.html
This opportunity encourages applications for CounterACT Cooperative Agreement Research Projects for research on the identification of small molecule or biologic lead compounds that are excellent candidates for therapeutic development.

NIH
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-040.html
This opportunity encourages applications for CounterACT Cooperative Agreement Research Projects for research on the optimization of small molecule or biologic compounds that are excellent candidates for therapeutic development.

NIH
Detection of HIV for Self-Testing (R61/R33)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-471.html
The purpose of this announcement is to support bi-phasic developmental, discovery-driven, or hypothesis-driven research focused on innovative strategies to detect HIV either within the first two weeks of infection or to monitor viral rebound after stopping or developing resistance to antiretroviral therapy. Applications should propose simple diagnostic tools that would be feasible for a self-testing platform to allow untrained individuals to detect HIV. Interdisciplinary collaborations that include biomedical, physical, and behavioral sciences are highly encouraged. 

NIH
Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-307.html
The purpose of this announcement is to fund highly innovative and promising research aimed at developing multi-level physical activity intervention programs acting on at least two levels of the socioecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity and 2) that could be made scalable and sustainable for broad use across the nation. This announcement provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by a possible transition to expanded research support (R33 phase) for optimizing the intervention and conducting larger-scale feasibility studies. 

NIH
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 -Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-917.html
The purpose of this funding opportunity is to support projects that will elucidate the therapeutic potential of the cannabinoids and endocannabinoid system in the development of mechanism-based therapies for pain. 

NIH
Development of Clinical Outcome Assessments for Clinical Trials in Substance Use Disorders as FDA-qualified Drug Development Tools (U01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-015.html
Application Deadline: October 23, 2019
The purpose of this opportunity is to support the development of Clinical Outcome Assessments (COAs) for Substance Use Disorders aiming to be qualified by the Food and Drug Administration as Drug Development Tools. Applications may focus on the creation and development of a new COA, or on modification/optimization of an existing COA.

NIH
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-038.html
The purpose of this funding opportunity announcement is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities.

NIH
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-856.html

NIH
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-857.html
This announcement encourages innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications may include development of novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations or various age groups, including children and older adults; improved technology or applications of existing technology; statistical methods/modeling to improve assessment and/or to correct for measurement errors or biases; methods to investigate the multidimensionality of diet and physical activity behavior through pattern analysis; or integrated measurement of diet and physical activity along with the environmental context of such behaviors.

NIH
Discovering Novel Targets: The Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-120.html
This announcement encourages applications for research projects that identify, validate, and/or functionally characterize loci, genetic variations, and haplotypes that are associated with vulnerability to addiction and that potentially inform the likelihood of responsiveness to treatment. 

NIH
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-043.html
The purpose of this funding opportunity is to promote the discovery and validation of novel therapeutic targets to facilitate the development of pain therapeutics. Specifically, the focus of this opportunity is on the basic science discovery of targets in the peripheral nervous system, central nervous system, immune system, or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability. 

NIH
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-042.html
This program announcement is intended to encourage new exploratory and developmental research projects to discover and validate novel targets for pain treatment.

NIH
Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-315.html
The overarching purpose of this opportunity is to promote the discovery and/or early evaluation of strong candidate biomarkers and biomarker signatures that can be used as tools to facilitate the clinical development of neurotherapeutics and their use in clinical practice. Specifically, the focus of this opportunity is on the identification and initial biological, analytical and clinical evaluation of biomarkers and biomarker signatures for neurological and neuromuscular disorders/diseases.

NIH
Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-18-041.html
The purpose of this funding opportunity is to support the discovery of promising candidate biomarkers that will facilitate the development of non-opioid therapeutic options for the treatment of pain conditions. The goal of this opportunity is to encourage a biomarker discovery process that will result in the development of pain biomarkers that can withstand rigorous clinical and analytical validation. It is hoped that an increased availability of rigorous biomarkers for pain will facilitate the discovery and development of transformational non-opioid therapeutics for pain.

NIH
Discovery of cell-based Chemical Probes for Novel Brain Targets (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-335.html
This announcement will support investigators who have interest and capability to join efforts for the discovery of cell-based chemical probes for novel brain targets. 

NIH
Discovery of in vivo Chemical Probes for Novel Brain Targets (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-336.html
This announcement will support investigators who have interest and capability to join efforts for the discovery of in vivo chemical probes for novel brain targets. 

NIH
Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-331.html
The purpose of this announcement is to promote the discovery of novel small molecules that may enhance the ability of the immune system to selectively recognize and attack cancer cells. 

NIH
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-274.html
Application Deadline: October 5, 2019
This opportunity Announcement supports innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up and sustainability of evidence-based interventions, tools, policies, and guidelines. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce ("de-implement") the use of interventions that are ineffective, unproven, low-value, or harmful.

NIH
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-276.html#_3._Additional_Information
Application Deadline: October 16, 2019
This opportunity Announcement supports innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up and sustainability of evidence-based interventions, tools, policies, and guidelines. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce ("de-implement") the use of interventions that are ineffective, unproven, low-value, or harmful.

NIH
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-275.html
Application Deadline: October 16, 2019
This opportunity Announcement supports innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up and sustainability of evidence-based interventions, tools, policies, and guidelines. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce ("de-implement") the use of interventions that are ineffective, unproven, low-value, or harmful.

NIH
Drug Abuse Dissertation Research (R36)
http://grants.nih.gov/grants/guide/pa-files/PA-16-443.html
The goal of this announcement is to enhance the diversity of the drug abuse research workforce by providing dissertation awards on topics related to the study of basic and clinical neuroscience, development, epidemiology, prevention, treatment, services, or women and sex/gender differences as they relate to drug abuse. 

NIH
Drug Development Tools Research Grants (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-FD-19-028.html
Application Deadline: August 5, 2019
This opportunity supports research to continue the development of drug development tools that have an accepted Letter of Intent within the Center for Drug Evaluation and Research Drug Development Tool Qualification Program.

NIH
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-147.html
This funding opportunity intends to support investigators who have interest and capability in the discovery of novel compounds for the prevention and treatment of nervous system disorders. This opportunity is designed to stimulate research in: 1) identification, design, synthesis, and pre-clinical testing of compounds of candidate therapeutics; 2) initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) later stage lead optimization to improve efficacy and pharmacokinetics; and 4) initial drug metabolism and pharmacokinetics. Emphasis will be placed on projects that provide novel approaches to identify potential therapeutic agents 

NIH
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-146.html
This funding opportunity intends to support investigators who have interest and capability in the discovery of novel compounds for the prevention and treatment of nervous system disorders. This opportunity is designed to stimulate research in: 1) identification, design, synthesis, and pre-clinical testing of compounds of candidate therapeutics; 2) initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) later stage lead optimization to improve efficacy and pharmacokinetics; and 4) initial drug metabolism and pharmacokinetics. Emphasis will be placed on projects that provide novel approaches to identify potential therapeutic agents 

NIH
Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-853.html
The purpose of this funding opportunity is to support in vivo research to elucidate the chemical features of non-native molecules that facilitate passage across the blood-testis and/or blood-epidydimal barriers. 

NIH
Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimers Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-029.html
This announcement encourages research projects on the role of aging-related changes in systemic, peripheral, and/or non-neuronal factors individually or in combination to the pathogenesis, presentation, and/or progression of Alzheimers disease (AD). The goal of this FOA is to support innovative multidisciplinary research that will integrate the AD science with the basic biology of aging and clinical aging research. 

NIH
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-529.html
The purpose of this announcement is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. 

NIH
Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-531.html
The purpose of this announcement is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. 

NIH
Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-532.html
The purpose of this announcement is to stimulate research focused on the role of early-life factors (maternal-paternal, in utero, birth and infancy, puberty, adolescence, and young adult years) in cancer development later in life. 

NIH
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-294.html
This opportunity supports translational research that provides strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, and hematology.

NIH
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-305.html
This opportunity encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging and/or multiple chronic conditions in older people.

NIH
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-304.html
This opportunity encourages Exploratory/Developmental Phase II (R33) grant applications to facilitate early-stage T1 translation (bench-to-bedside) of discoveries from basic and applied research in aging into novel therapeutics for the prevention and treatment of clinical conditions related to aging or multiple chronic conditions in older people.

NIH
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-845.html
The purpose of this funding opportunity is to support basic research examining how Electronic Nicotine Delivery Systems aerosols affect normal and disease states relevant to human cells, tissues, and organs.

NIH
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-846.html
The purpose of this funding opportunity is to support basic research examining how Electronic Nicotine Delivery Systems aerosols affect normal and disease states relevant to human cells, tissues, and organs.

NIH
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical, and Applied Prevention of Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-847.html
The purpose of this funding opportunity announcement is to support studies on electronic nicotine delivery systems that examine population-based, clinical, and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, and benefits and impacts on other tobacco use behavior among different populations. 

NIH
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical, and Applied Prevention Research (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-848.html
The purpose of this funding opportunity announcement is to support studies on electronic nicotine delivery systems that examine population-based, clinical and applied prevention of disease, including etiology of use, epidemiology of use, potential risks, and benefits and impacts on other tobacco use behavior among different populations.

NIH
Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-898.html
This opportunity seeks to generate scientific advancements addressing the role of the autonomic nervous system in the regulation of peripheral metabolism and its role in diabetes, obesity, and related metabolic disease. 

NIH
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-045.html
The purpose of this opportunity is to stimulate research to examine the multi-dimensional foundations, experiences and management of complex, advanced signs and symptoms at the end of life.

NIH
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-044.html
The purpose of this opportunity is to stimulate research to examine the multi-dimensional foundations, experiences, and management of complex, advanced signs and symptoms at the end of life.  

NIH
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-153.html

NIH
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-398.html
This announcement encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems with improved fidelity to complex human brain, spinal, peripheral nervous system, and/or sensory end organ circuit physiology in vivo, which will ultimately facilitate analysis of higher order functional deficits relevant to complex nervous system disorders.

Standard application dates apply. See solicitation for details.

NIH
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-397.html
This announcement encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems with improved fidelity to complex human brain, spinal, peripheral nervous system, and/or sensory end organ circuit physiology in vivo, which will ultimately facilitate analysis of higher order functional deficits relevant to complex nervous system disorders.

Standard application dates apply. See solicitation for details.

NIH
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-263.html
The purpose of this announcement is to encourage interdisciplinary research aimed at promoting health, preventing and limiting symptoms and disease, and reducing health disparities across the lifespan for those living or spending time in non-traditional settings (i.e. playgrounds and nursing homes). 

NIH
Environmental Exposures and Health: Exploration of Non-Traditional Settings (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-273.html
The purpose of this announcement is to encourage interdisciplinary research aimed at promoting health, preventing and limiting symptoms and disease, and reducing health disparities across the lifespan for those living or spending time in non-traditional settings (i.e. playgrounds and nursing homes). 

NIH
Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Populations (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-250.html
The purpose of this opportunity is to advance our understanding of the impact of extreme weather and disaster events in aging human populations.

NIH
Environmental Influences on Aging: Effects of Extreme Weather and Disaster Events on Aging Processes (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-249.html
The purpose of this opportunity is to support research to explore the impacts of extreme weather and disaster events on the basic biology of aging.

NIH
Eradication of HIV-1 from Central Nervous System Reservoirs (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-084.html
This announcement invites research grant applications studying mechanisms of HIV-1 persistence and eradication strategies specifically focused on the central nervous system in the context of viral suppression. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. 

NIH
Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-178.html
The purpose of this Research Demonstration and Dissemination Projects (R18) announcement is to support research to evaluate large scale policies or programs related to healthcare delivery that are expected to influence diabetes prevention and care. This announcement is not intended to support the initiation and delivery of new policies or programs. Research support is for the evaluation of the effectiveness of healthcare programs and/or policies implemented independent of NIH grant funding. The goal is to support research that meaningfully informs clinical practice and health policy related to prevention or management of diabetes. 

NIH
Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-278.html
The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant phenotypes. It is expected that any genetic resources generated will be made broadly available to the scientific community to enable investigation of the relevant neurobiological mechanisms involved and provide critical foundational knowledge for the development of future prevention, diagnostic, and therapeutic strategies.

NIH
Exploiting In Vivo Precision Pharmacology Techniques to Understand Opioid Receptor Signaling in Specific Circuits, Cell Types, and Subcellular Compartments (R61/R33 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-019.html
Application Deadline: October 17, 2019
This opportunity aims to support the development and the application of novel pharmacological approaches to manipulate signaling mediated by endogenous opioid receptors in defined circuits, cell-types or subcellular compartments in live organisms.

NIH
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-282.html
This opportunity uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying Substance Use Disorders, including fundamental brain function relevant to substance use.

NIH
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-277.html
This opportunity encourages the submission of exploratory/developmental research grant (R21) applications for cancer epidemiologic research. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as improving data collection methods, developing and validating methods of exposures and biological effects, such as epigenetics and metabolomics, and their application in population-based research, functional assessment of genetic variants, and assessing recruitment methods for understudied populations. 

NIH
Extracellular Vesicles and Substance Use Disorders (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-250.html
The purpose of this announcement is to encourage research projects that investigate the interplay between extracellular vesicles (EVs) and substance use disorders (SUDs). In particular, NIDA is interested in the potential utility of EVs with respect to understanding neuroplastic mechanisms relevant to SUDs or as biomarkers or therapeutics.

NIH
Extracellular Vesicles and Substance Use Disorders (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-242.html
The purpose of this announcement is to encourage research projects that investigate the interplay between extracellular vesicles (EVs) and substance use disorders (SUDs). In particular, NIDA is interested in the potential utility of EVs with respect to understanding neuroplastic mechanisms relevant to SUDs or as biomarkers or therapeutics.

NIH
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-113.html
The purpose of this announcement is to stimulate and support investigator-driven collaborative research to: 1) probe how vaccine-elicited antibodies protect against viral acquisition via Fc receptor-mediated mechanisms and 2) determine the functional profiles of Fc receptor engagement in the context of immune responses elicited by protective vaccines, to inform advancement of similarly promising HIV vaccine candidates.

NIH
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-020.html
This opportunity invites applications for studies that address knowledge gaps in mechanisms of Fc-dependent, antibody-mediated killing of infected cells or aberrant cells or antibody-mediated therapeutic ablation of cells implicated in immune pathologies, including autoimmune and allergic diseases.

NIH
Feasibility of Novel Diagnostics for TB in Endemic Countries (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-030.html
Application Deadline: July 23, 2019
This funding opportunity supports the evaluation of early stage diagnostics and novel diagnostic strategies for Tuberculosis (TB) in the context of existing clinical algorithms in TB endemic countries.

NIH
Fertility Status as a Marker for Overall Health (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-091.html
The purpose of this announcement is to support research that explores the premise that fertility status can be a marker for overall health.

NIH
Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-727.html
The purpose of this announcement is to promote research on food specific molecular signatures and biomarkers of dietary consumption and to promote collaborative interactions among NIH- and USDA-supported nutrition researchers.

NIH
From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-252.html
The primary objective of this announcement is to stimulate innovative Convergent Neuroscience approaches to establish causal and/or probabilistic linkages across contiguous levels of analysis (e.g., gene, molecule, cell, circuit, system, behavior) in an explanatory model of psychopathology. 

NIH
From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (Collaborative U01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-176.html
The primary objective of this announcement is to stimulate innovative Convergent Neuroscience approaches to establish causal and/or probabilistic linkages across contiguous levels of analysis (e.g., gene, molecule, cell, circuit, system, behavior) in an explanatory model of psychopathology. 

NIH
From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-253.html
The primary objective of this announcement is to stimulate innovative Convergent Neuroscience approaches to establish causal and/or probabilistic linkages across contiguous levels of analysis (e.g., gene, molecule, cell, circuit, system, behavior) in an explanatory model of psychopathology. 

NIH
From Genomic Association to Causation: A Convergent Neuroscience Approach for Integrating Levels of Analysis to Delineate Brain Function in Neuropsychiatry (U01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-179.html
The primary objective of this announcement is to stimulate innovative Convergent Neuroscience approaches to establish causal and/or probabilistic linkages across contiguous levels of analysis (e.g., gene, molecule, cell, circuit, system, behavior) in an explanatory model of psychopathology.

NIH
Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-155.html
Genetic and genomic studies have identified genes and gene variants that may impact the fundamental biological mechanisms underpinning substance use disorders (SUDs). Discovery of these genes/variants, while extremely valuable, is only the first step in understanding the molecular processes that influence SUDs. This announcement encourages basic functional genetic and genomic research in two areas: (1) functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in SUDs and (2) detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in SUDs. 

NIH
Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-157.html
Genetic and genomic studies have identified genes and gene variants that may impact the fundamental biological mechanisms underpinning substance use disorders (SUDs). Discovery of these genes/variants, while extremely valuable, is only the first step in understanding the molecular processes that influence SUDs. This announcement encourages basic functional genetic and genomic research in two areas: (1) functional validation to determine which candidate genes/variants/epigenetic/non-coding RNA features have an authentic role in SUDs, and (2) detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in SUDs.

NIH
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-380.html
The purpose of this announcement is to encourage projects to generate fundamental knowledge of affective processes. Basic affective science projects should have key consequences for single (e.g., cancer screening) and multiple (e.g., adherence to oral chemotherapy regimen) event decisions and behaviors across the cancer prevention and control continuum. 

NIH
Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-323.html
This announcement encourages research grant applications to investigate the fundamental science of mind and body approaches, including mind/brain-focused practices (e.g., meditation, hypnosis), body-based approaches (e.g., acupuncture, massage, spinal manipulation/mobilization), meditative exercise (e.g., yoga, tai chi, qi gong), art and music therapies, or integrative approaches combining several components. 

NIH
Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-322.html
This announcement encourages exploratory /developmental research grant applications to investigate the fundamental science of mind and body approaches, including mind/brain-focused practices (e.g., meditation, hypnosis), body-based approaches (e.g., acupuncture, massage, spinal manipulation/mobilization), meditative exercise (e.g., yoga, tai chi, qi gong), art and music therapies, or integrative approaches combining several components. 

NIH
Generating New insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-725.html
The purpose of this announcement is to advance select areas of research recognized as critical in the National Action Plan for Combating Antibiotic-Resistant Bacteria, including research focused on understanding the nature of microbial communities, how antibiotics affect them, and how they can be harnessed to prevent disease, as well as research exploring combination therapies to address the emergence of resistance.

Standard application dates apply. See solicitation for details.

NIH
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-724.html
The purpose of this announcement is to advance select areas of research recognized as critical in the National Action Plan for Combating Antibiotic-Resistant Bacteria, including research focused on understanding the nature of microbial communities, how antibiotics affect them, and how they can be harnessed to prevent disease, as well as research exploring combination therapies to address the emergence of resistance.

Standard application dates apply. See solicitation for details.

NIH
Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-660.html
The goal of this announcement is to develop new hypotheses and common experimental framework(s) between human - animal model studies to better understand the genetic, genomic, and epigenetic factors contributing to and underlying biological bases for the development of tolerance and the progression to alcohol dependence.

NIH
Genomics of HIV/AIDS Drug Response and Co-Morbidities (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-435.html
The purpose of this announcement is to expand the use of high-throughput genotyping, genomic sequencing, and related genomic technologies, and generate resulting data resources widely available for research use to improve the efficacy and safety and ease of use of HIV/AIDS therapies and of non-HIV drugs used to treat HIV/AIDS patients and reduce HIV/AIDS-related comorbidities, coinfections, and complications.

NIH
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-411.html
The purpose of this announcement is to support grants to improve measurement and understanding of viral suppression and HIV transmission in the U.S. using population-level epidemiology and novel tools from Big Data science approaches and m/eHealth. The outcome of this research will uncover new knowledge from data to build more effective and context-specific HIV control strategies for the U.S. epidemic.

NIH
Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-835.html
This Funding Opportunity Announcement (FOA) encourages grant applications for the conduct of innovative, collaborative research projects between U.S. and low- and middle-income country (LMIC) scientists, on brain and other nervous system function and disorders throughout life, relevant to LMICs (including neurological, mental, behavioral, alcohol and substance use disorders and spanning the full range of science from basic to implementation research). Scientists in upper middle-income countries are also eligible to partner directly with scientists at other LMIC institutions with or without out a U.S. partner.

NIH
Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-835.html
This Funding Opportunity Announcement (FOA) encourages grant applications for the conduct of innovative, collaborative research projects between U.S. and low- and middle-income country (LMIC) scientists, on brain and other nervous system function and disorders throughout life, relevant to LMICs (including neurological, mental, behavioral, alcohol and substance use disorders and spanning the full range of science from basic to implementation research). Scientists in upper middle-income countries are also eligible to partner directly with scientists at other LMIC institutions with or without out a U.S. partner.

NIH
Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-836.html
This Funding Opportunity Announcement (FOA) encourages exploratory/developmental research grant applications, proposing the development of innovative, collaborative research projects on brain and other nervous system function and disorders throughout life, relevant to low- and middle-income countries (LMICs). Research on neurological, mental, behavioral, alcohol and substance use disorders may span the full range of science from basic to implementation research. Scientists in the United States or upper-middle income countries (UMICs) are eligible to partner with scientists in LMIC institutions. Scientists in UMICs are also eligible to partner directly with scientists at other LMIC institutions with or without out a U.S. partner. 

NIH
Global Brain and Nervous System Disorders Research Across the Lifespan (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-313.html
This announcement encourages exploratory/developmental research grant applications proposing the development of innovative, collaborative research projects on brain and other nervous system function and disorders throughout life relevant to low- and middle-income countries.

NIH
Grand Opportunity in Medications Development for Substance-Use Disorders (U01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-431.html
The purpose of this announcement is to accelerate the development of medication for the treatment of Substance-Use Disorders by encouraging research applications to support a diverse array of pre-clinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval. 

NIH
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-018.html
Application Deadline: October 2, 2019
The goal of this program is to provide support for early-career physician-scientists trained in medical or surgical specialties or early-career dentist-scientists to launch careers as future leaders in aging- or geriatric-focused research.

NIH
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-764.html
The purpose of this announcement is to promote research that transforms understanding of HIV transmission, the HIV care continuum, and HIV comorbidities using Big Data Science. This announcement will support projects to assemble diverse big data sources, conduct robust and reproducible analyses, and create meaningful visualizations of big data, as well as engage ethical experts where appropriate to ensure the development of this scientific area is guided by ethical principles.

Standard AIDS applications due dates apply. See solicitation for details.

NIH
Hearing Health Care for Adults: Improving Access and Affordability (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-202.html
This announcement encourages applications for research on hearing health care in adults in support of improving access and affordability. Further research is needed to strengthen the evidence base with a goal of delivering better hearing health care outcomes in adults.

NIH
Hearing Health Care for Adults: Improving Access and Affordability (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-382.html
This announcement encourages exploratory and developmental research applications for research on hearing health care in adults in support of improving access and affordability. Further research is needed to strengthen the evidence base with a goal of delivering better health care outcomes in adults.

NIH
High impact, Interdisciplinary Science in National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Research Areas (RC2 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-202.html
The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The interdisciplinary approach encouraged by this opportunity is envisioned to generate a research resource and/or foster discovery-based or hypothesis-generating science that can have a significant impact on the broader scientific community.  

NIH
High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAS-18-698.html
This announcement seeks to stimulate HIV/AIDS research within the mission of the NIDDK that addresses high priority HIV/AIDS research priorities outlined by the NIH Office of AIDS Research. These priorities are described in NOT-OD-15-137: NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding.

NIH
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-319.html
The purpose of this announcement is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive modeling of vaccine concepts in non-human primates may be included.

NIH
HIV-1 infection of the Central Nervous System (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-100.html
This announcement invites research grant applications focused on defining and understanding the pathogenic mechanisms involved in HIV-1 induced CNS dysfunction within the context of viral suppression and antiretroviral therapy. The announcement further supports research to identify therapeutic targets against which treatments may be developed to prevent neurobehavioral and neurological co-morbidities in HIV-1 infected individuals. Basic and translational research in domestic and international settings are of interest. Multidisciplinary research teams and collaborative alliances are encouraged but not required. 

NIH
HLA and KIR Region Genomics in Immune-Mediated Diseases (U19 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-044.html
Application Deadline: September 4, 2019
This opportunity solicits applications to participate in the HLA and KIR Region Genomics in Immune Mediated Diseases Consortium. This cooperative research group supports projects defining the association between variations in the human leukocyte antigen and natural killer cell immunoglobulin-like receptor genetic regions and immune-mediated diseases, including outcomes following cell, tissue, and organ transplantation.

NIH
Human Cell Biology of Alzheimer's Disease Genetic Variants (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-516.html
The goal of this announcement is to establish functional genotype-phenotype relationships of genetic variants suspected of altering the risk of Alzheimers disease (AD), in neural cells using human-induced pluripotent stem cells or other human cell reprogramming approaches. The causal linkage of AD-associated genetic variants identified in genome-wide association studies and genome sequencing studies to molecular and biological cell phenotypes in human neural cells is expected to give greater insight into molecular targets contributing to the etiology of AD. 

NIH
Imaging the Persistent HIV Reservoir (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-305.html
The purpose of this announcement is to support the development of imaging approaches to identify and characterize persistent HIV reservoirs in patients undergoing suppressive antiretroviral therapy and to quantify the nature and size of these reservoirs in response to therapeutic interventions.

NIH
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-264.html
This opportunity supports the development of state-of-the-art projects that include imaging, biomarkers, digital pathomic and other -omic integration strategies for improving current approaches for the earliest detection of premetastatic aggressive cancer as well as identifying precancerous lesions that will subsequently demonstrate an aggressive phenotype.

NIH
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-860.html
The purpose of this funding opportunity is to support short-term exploratory, developmental, and transdisciplinary research to understand the immunologic events that occur during blood feeding by hematophagous arthropods. The scientific objectives of this initiative are to (1) understand the immunological events in the vertebrate host, which occur during and after blood feeding by hematophagous arthropods, at the bite site (skin), and systemically; (2) identify and characterize the immune modulatory properties of arthropod salivary components; and (3) understand the immunological events in the hematophagous arthropods following a blood meal.

NIH
Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-028.html
Application Deadline: October 22, 2019
This opportunity invites applications proposing to conduct research involving pragmatic clinical trials on dissemination and implementation of practical approaches to hypertension treatment and control strategies among older adults with multimorbidity in order to prevent sequelae, including mild cognitive impairment and dementia.

NIH
Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-491.html
The goal of this announcement is to translate and adapt the most successful global, evidence-based HIV-related service provision strategies to marginalized populations in the U.S. with a substantial risk of HIV-infection and AIDS. The ultimate goal is to produce improvements in HIV-related health outcomes in these key populations through strategies that successfully and durably reach them with timely HIV testing, prevention, and treatment technologies that lead to the achievement of the UNAIDS 90-90-90 benchmarks.

NIH
Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-490.html
The goal of this announcement is to translate and adapt the most successful global, evidence-based HIV-related service provision strategies to marginalized populations in the U.S. with a substantial risk of HIV-infection and AIDS. The ultimate goal is to produce improvements in HIV-related health outcomes in these key populations through strategies that successfully and durably reach them with timely HIV testing, prevention, and treatment technologies that lead to the achievement of the UNAIDS 90-90-90 benchmarks.

NIH
Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-287.html
The purpose of this announcement is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech, and language.

NIH
Improving Outcomes for Disorders of Human Communication (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-139.html
The purpose of this announcement is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language.

NIH
Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-288.html
The purpose of this announcement is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech, and language.

NIH
Improving Outcomes for Disorders of Human Communication (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-140.html
The purpose of this announcement is to improve the health outcomes for individuals with deafness and other communication disorders through effectiveness and health services research in the NIDCD mission areas of hearing, balance, smell, taste, voice, speech and language.

NIH
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-19-112.html
This announcement encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. 

NIH
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-19-111.html
This solicitation encourages collaborative applications that will contribute to the identification and characterization of patients at risk of developing cancer treatment-related cardiotoxicity. 

NIH
Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAS-18-030.html
This announcement invites applications that address clinical and translational research gaps in the study of end-of-life care needs in order to improve quality of life at the end of life of people with Alzheimers disease and related dementias (ADRD) and their families. Research that either employs (a) secondary analysis of existing data from longitudinal cohort studies or from administrative records or (b) primary data collection for Stage I behavioral intervention development is particularly encouraged.

NIH
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-280.html
The purpose of this announcement is to (1) stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection to accelerate drug discovery/drug development in HBV/HIV co-infection and (2) stimulate and accelerate a better understanding of the immunopathogenic interactions between HBV and HIV. 

NIH
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-281.html
The purpose of this announcement is to (1) stimulate and accelerate development of novel in vitro and small animal models of HBV/HIV co-infection to accelerate drug discovery/drug development in HBV/HIV co-infection and (2) stimulate and accelerate a better understanding of the immunopathogenic interactions between HBV and HIV. 

NIH
In Vivo Synaptic Function in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-760.html
Funds through this program will support the study of in vivo synaptic structure and function in Alzheimer's and related dementia and advance development of methods to study synapses in animal models and humans.

Standard application dates apply. See solicitation for details.

NIH
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-005.html
The purpose of this announcement is to encourage applications to phenotype and/or perform research on embryonic lethal knockout mouse strains being generated through the International Mouse Phenotyping Consortium of which the NIH Knockout Mouse Phenotyping Program is a member. 

NIH
Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-079.html
This announcement encourages health services research designed to increase the public health impact of FDA-approved pharmacotherapies for the treatment of alcohol use disorder. 

NIH
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-932.html
This funding opportunity invites applications that seek to understand strategies to reduce disparities in the uptake of evidence-based screening (e.g., screening recommendations proven to be effective based on rigorous systematic review of scientific evidence by authoritative committees) across the adult lifespan. In this program announcement, screening is defined as a preventive service focused on detection of an undiagnosed disease in asymptomatic populations. 

NIH
Innovation for HIV Vaccine Discovery (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-263.html
The purpose of this announcement is to support high risk, high impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. 

NIH
Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-182.html
The health and preventive benefits of treatment for HIV/AIDS, regardless of CD4 count, are now unequivocal. In the United States and globally, ambitious goals have been targeted for HIV testing, adherence, and retention in care, to optimize HIV clinical outcomes and preventive benefit. Additional tools are needed to inform the gaps and strategies that are unique to particular populations, cities, regions, and countries. Applications appropriate for this announcement could include formative basic behavioral and social science to better understand a step in the care continuum and/or multiple steps in the HIV care continuum, initial development and pilot tests of innovative approaches for intervention, and intervention efficacy trials.

NIH
Innovations in HIV Testing, Adherence, and Retention to Optimize HIV Care Continuum Outcomes (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-181.html
The health and preventive benefits of treatment for HIV/AIDS, regardless of CD4 count, are now unequivocal. In the United States and globally, ambitious goals have been targeted for HIV testing, adherence, and retention in care, to optimize HIV clinical outcomes and preventive benefit. Additional tools are needed to inform the gaps and strategies that are unique to particular populations, cities, regions, and countries. Applications appropriate for this announcement could include formative basic behavioral and social science to better understand a step in the care continuum and/or multiple steps in the HIV care continuum and initial development and pilot tests of innovative approaches for intervention.

NIH
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-947.html
This funding opportunity will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies and blood biospecimens utilized as "liquid biopsies." Extramural research funded under this opportunity may include investigations of preanalytical variability associated with the procurement and study of small biopsies (core biopsies, small excision samples), pleural aspirates, and blood utilized for liquid biopsies. 

NIH
Integration of Individual Residential Histories into Cancer Research (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-298.html
The purpose of this announcement is to support substantive investigation of the role of individual residential histories in cancer etiology and outcomes and to encourage the development of complex analytical strategies in support of such investigation.

NIH
Integration of Individual Residential Histories into Cancer Research (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-295.html
The purpose of this announcement is to support substantive investigation of the role of individual residential histories in cancer etiology and outcomes and to encourage the development of complex analytical strategies in support of such investigation.

NIH
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-033.html
This announcement invites applications that apply a cross-disciplinary, team science approach to gain comprehensive, mechanistic understanding of the impact of sex differences on the trajectories of brain aging and phenotypes of Alzheimers disease risk and on the responsiveness to pharmacologic and non-pharmacologic interventions. 

NIH
Inter-organelle Communication in Cancer (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-203.html
The purpose of this announcement is to support research projects that examine how inter-organelle communication in cancer cells and/or tumor-associated cells affects cellular function, adaptation, and phenotypic plasticity.

NIH
Inter-organelle Communication in Cancer (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-204.html
The purpose of this announcement is to support research projects that examine how inter-organelle communication in cancer cells and/or tumor-associated cells affects cellular function, adaptation, and phenotypic plasticity.

NIH
Interpersonal Processes in Alzheimer's Disease and Related Dementias Clinical Interactions and Care Partnerships (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-006.html
Application Deadline: October 23, 2019
This opportunity invites applications focused on interpersonal processes in the context of triadic interactions in clinical contexts involving caregivers, individuals with Alzheimer's disease and Alzheimer's disease related dementias, and health care practitioners and the impact of those processes on patient outcomes.

NIH
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-496.html
The purpose of this announcement is to encourage research to improve Native American health. Such research can include: conducting secondary analysis of existing data (such as databases that the Tribal Epidemiology Centers have collected); merging various sources of data to answer critical research questions; conducting pilot and feasibility studies; and/or assessing and validating measures that are being developed and/or adapted for use in Native American communities.

NIH
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-712.html
The purpose of this announcement is to advance the discovery and characterization of primary immunodeficiency diseases, understand the causes and mechanisms of disease, enable early detection and molecular diagnosis, and support the development of strategies to treat and eventually cure these disorders.

NIH
Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-844.html
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All proposals should address how the methods would scale to address larger and larger data sets.

NIH
Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-843.html

NIH
Large Research Projects for Prevention of Healthcare-Associated Infections (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-17-008.html
This announcement invites grant applications for funding to conduct Large Research Projects that propose to advance the base of knowledge for detection, prevention, and reduction of Healthcare-Associated Infections.

NIH
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 - Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-008.html
Application Deadline: November 14, 2019
The purpose of this opportunity is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis through big data science approaches. It is expected that the development and application of novel computational, bioinformatics, statistical, and analytical approaches can be leveraged to reveal the effects of the interaction of the HIV virus and drugs of abuse on viral activity, latency, and disease progression, as well as new aspects of addiction biology.

NIH
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 - Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-009.html
Application Deadline: November 14, 2019
The purpose of this opportunity is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis through big data science approaches. It is expected that the development and application of novel computational, bioinformatics, statistical, and analytical approaches can be leveraged to reveal the effects of the interaction of the HIV virus and drugs of abuse on viral activity, latency, and disease progression, as well as new aspects of addiction biology. 

NIH
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 - Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-006.html
Application Deadline: November 14, 2019
The purpose of this opportunity is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with the development and application of novel computational, bioinformatics, statistical, and analytical approaches, previously inaccessible insights will reveal new aspects of addiction biology.

NIH
Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21-Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-007.html
Application Deadline: November 14, 2019
The purpose of this opportunity is to attract data and computational scientists to propose novel ways to integrate data of different types and scales to allow new types of analysis. It is expected that with the development and application of novel computational, bioinformatics, statistical, and analytical approaches, previously inaccessible insights will reveal new aspects of addiction biology.

NIH
Leveraging Existing Cohort Studies to Clarify Risk and Protective Factors for Alzheimer's Disease and Related Dementias (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-054.html
This announcement invites applications that will combine multiple cohorts in order to improve statistical power and clarify risk and protective factors for Alzheimers disease and related dementias.

NIH
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-289.html
The goal of this announcement is to efficiently use the existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer. 

NIH
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-288.html
The goal of this announcement is to efficiently use the existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer. 

NIH
Limited Competition Cohort Studies of HIV/AIDS and Substance Abuse (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-005.html#_3._Additional_Information
Application Deadline: August 15, 2019
This opportunity supports the maintenance and expansion of existing NIDA-funded cohorts to continue addressing new emerging and/or high priority research on multidisciplinary aspects of HIV/AIDS and substance abuse in alignment with NIH-HIV research priorities. 

NIH
Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-301.html
This opportunity encourages applications for support of national or regional resources that will provide access to state-of-the-art facilities, equipment, technologies, research tools, software, and/or service to a substantial user base at institutions across multiple states (regional) or the country (national).

NIH
Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-039.html
Application Deadline: February 3, 2020
This opportunity aims to encourage innovative research programs designed to improve and expand our understanding of novel regulatory mechanisms governing lipid metabolism and signaling in the context of aging and age-associated conditions.

NIH
Lucidity in Dementia (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-016.html
Application Deadline: February 3, 2021
This opportunity intends to advance scientific understanding of lucidity in dementia by supporting an initial set of retrospective and/or prospective studies that will lay the groundwork for further research on this topic. Studies supported will use the R21 mechanism to support initial exploratory/developmental aims that will serve as the foundation for future studies.

NIH
Lucidity in Dementia (R21/R33 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-017.html
Application Deadline: February 3, 2020
This opportunity intends to advance scientific understanding of lucidity in dementia by supporting an initial set of retrospective and/or prospective studies that will lay the groundwork for further research on this topic. Studies supported will use the R21/R33 phased innovation mechanism to support initial exploratory/developmental aims during the R21 phase followed by further expanded aims during the R33 phase.

NIH
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-196.html
Despite significant scientific advancements made in substance use disorder research over the last century, the causes and consequences of drug use in later life remain poorly understood. The intent of this announcement is to support innovative research that examines aspects of marijuana and prescription opioid and benzodiazepine use in adults aged 50 and older. 

NIH
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03)
https://grants.nih.gov/grants/guide/pa-files/PA-17-198.html
Despite significant scientific advancements made in substance use disorder research over the last century, the causes and consequences of drug use in later life remain poorly understood. The intent of this announcement is to support innovative research that examines aspects of marijuana and prescription opioid and benzodiazepine use in adults aged 50 and older. 

NIH
Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-197.html
Despite significant scientific advancements made in substance use disorder research over the last century, the causes and consequences of drug use in later life remain poorly understood. The intent of this announcement is to support innovative research that examines aspects of marijuana and prescription opioid and benzodiazepine use in adults aged 50 and older. 

NIH
Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-776.html
This announcement encourages applications to improve health outcomes for women, infants and children by stimulating interdisciplinary research focused on maternal nutrition and pre-pregnancy obesity. Maternal health significantly impacts not only the mother but also the intrauterine environment, and subsequently fetal development and the health of the newborn.

Standard and AIDS application dates apply. See solicitation for details.

NIH
Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-021.html
This opportunity invites applications to stimulate exploratory research relevant to the mission of the Food and Drug Administration Center for Tobacco Products using existing publicly available biospecimens currently stored in repositories in the United States. Proposed research should seek to maximize the scientific value of these stored collections and to provide researchers with an opportunity to generate preliminary data for subsequent research proposals.

NIH
Maximizing the Scientific Value of the NHLBI Biorepository: Scientific Opportunities for Exploratory Research (R21)
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-022.html
This announcement will support meritorious exploratory research relevant to the NHLBI mission using the existing biospecimen collections that are stored in the NHLBI Biologic Specimen Repository (Biorepository), thereby maximizing the scientific value of the stored collections and providing researchers with an opportunity to generate preliminary data for subsequent research proposals.

NIH
Mechanisms Mediating Osteoarthritis in Aging (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-239.html
This announcement invites applications intended to encourage and accelerate the characterization of new or underutilized models and the testing of hypotheses that will lead to an improved understanding of the mechanisms of initiation and progression of osteoarthritis and the role of aging in the process.

NIH
Mechanisms Mediating Osteoarthritis in Aging (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-240.html
This announcement invites applications intended to encourage Exploratory/Developmental applications to accelerate the characterization of new paradigms to test hypotheses that will lead to an improved understanding of the mechanisms of initiation and progression of osteoarthritis and the role of aging in the process. 

NIH
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-659.html
The intent of this announcement is two-fold: (1) develop new hypotheses about key factors and pathways in sensitivity and tolerance to alcohol and (2) develop a common framework of mechanisms underlying the development of tolerance and the progression to alcohol dependence. These objectives will be accomplished with a Phased Innovation (R21/R33) mechanism, in which secondary data analysis or pilot studies can occur during the R21 phase and research testing the hypotheses can be expanded in the R33 phase.

NIH
Mechanisms of Alcohol-associated Cancers (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-220.html
This announcement invites applications investigating the cellular and molecular mechanisms by which alcohol increases cancer risk. 

NIH
Mechanisms of Alcohol-associated Cancers (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-219.html
This announcement invites applications investigating the cellular and molecular mechanisms by which alcohol increases cancer risk. 

NIH
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-258.html
This announcement invites innovative pilot projects or feasibility studies to stimulate research aimed to better understand the complex interaction of biological, cognitive, behavioral, and sociocultural factors that contribute to cancer and treatment related symptoms and toxicities throughout the cancer care trajectory. 

NIH
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-018.html
This initiative will support multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations. 

NIH
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-019.html
This initiative will support exploratory and developmental multidisciplinary research to understand the underlying causal factors and mechanisms that result in lung cancer disparities in U.S. health disparity populations.

NIH
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-307.html
This opportunity supports innovative studies to identify and understand the immune responses that mediate protection from Mycobacterium tuberculosis infection or progression to active tuberculosis disease.

NIH
Mechanisms of Tolerance (R21/R33 - Clinical Trial Required)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-311.html
This funding opportunity focuses on sensitivity and tolerance mechanisms underlying the development of alcohol use disorder. The intent of this opportunity is to: (1) develop hypotheses about cellular, molecular or network mechanisms that regulate sensitivity and tolerance to alcohol, and (2) develop quantitative models to predict the development of tolerance and the progression to alcohol use disorder.

NIH
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-201.html
The purpose of this opportunity is to encourage mechanistic research to investigate the impact of sleep disturbances on pain.

NIH
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-20-001.html
This opportunity solicits applications that propose to conduct time-sensitive mechanistic ancillary studies related to the National Institution of Arthritis and Musculoskeletal and Skin Diseases mission in conjunction with privately or publicly funded, ongoing clinical projects.

NIH
Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-039.html
Application Deadline: August 14, 2019
The purpose of this opportunity is to support hypothesis-testing research to elucidate cellular and molecular mechanisms that underlie diffuse white matter disease and small vessel disease in the brain and how they may contribute to cognitive impairment and dementia.

NIH
Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-051.html
This announcement invites applications for human studies to elucidate the etiology and pathogenesis of the increased risk for neurocognitive impairment associated with type 2 diabetes. 

NIH
Metabolic Contributions to the Neurocognitive Complications of Diabetes: Ancillary Studies (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-333.html
This announcement invites applications for human studies to elucidate the etiology and pathogenesis of the increased risk for neurocognitive impairment associated with type 2 diabetes. 

NIH
Metabolic Reprogramming to Improve Immunotherapy (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-228.html
The goal of this announcement is to encourage R01 grant applications to (a) generate a mechanistic understanding of the metabolic processes that support robust anti-tumor immune responses in vivo, (b) determine how the metabolic landscape of the tumor microenvironment affects immune effector functions, and (c) then use this information to manipulate (reprogram) the metabolic pathways used by the tumor, the immune response, or both to improve cancer immunotherapy.

NIH
Metabolic Reprogramming to Improve Immunotherapy (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-229.html
The goal of this announcement is to encourage R21 exploratory/developmental grant applications to (a) generate a mechanistic understanding of the metabolic processes that support robust anti-tumor immune responses in vivo, (b) determine how the metabolic landscape of the tumor microenvironment affects immune effector functions, and (c) then use this information to manipulate (reprogram) the metabolic pathways used by the tumor, the immune response, or both to improve cancer immunotherapy. 

NIH
Microbial-based Cancer Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-193.html
The overall purpose of this funding opportunity announcement is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. Utilizing bacteria, archaebacteria, bacteriophages, and other non-virus microorganisms, this initiative will support research projects designed to study the underlying mechanisms of the complex interactions between microorganisms, tumor, and immune system. 

NIH
Microbial-based Cancer Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-194.html
The overall purpose of this funding opportunity announcement is to stimulate exploratory development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. Utilizing bacteria, archaebacteria, bacteriophages, and other non-virus microorganisms, this initiative will support research projects designed to study the underlying mechanisms of the complex interactions between microorganisms, tumor, and immune system. 

NIH
Modeling HIV Neuropathology Using Microglia from Human iPSC and Cerebral Organoids (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-023.html
Application Deadline: November 12, 2019
This opportunity invites grant applications to study mechanisms underlying the neuropathophysiology of HIV-associated neurological disorders using induced microglia and cerebral organoids generated from human derived induced pluripotent stem cell lines.

NIH
Modular Budget Research Project Grant for NIH Nurse Scientist Scholars (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-256.html
This funding opportunity encourages modular budget R01 grant applications from nurse scientists who are currently or were supported within the last 3 years by an NIH Career Development (K) award. This opportunity is limited to those K awardee nurse scientists who have NIH New Investigator status.

NIH
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-869.html
This funding opportunity invites applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science.

NIH
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-198.html
The purpose of this funding opportunity is to support research that can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.  

NIH
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/par-19-199.html
The purpose of this funding opportunity is to support research that can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation. 

NIH
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-078.html
The purpose of this funding opportunity is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. 

NIH
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-079.html
The purpose of this funding opportunity is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. 

NIH
Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-20-004.html
Application Deadline: October 9, 2019
The goal of this opportunity is to elucidate the mechanistic links between blood brain barrier (BBB) dysfunction, Alzheimer's Disease (AD) and AD-Related Dementias, and how related comorbidities impact the basic molecular mechanisms of BBB health and function.

NIH
Multidisciplinary Studies of HIV/AIDS and Aging (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-321.html
This announcement encourages applications at the intersection of HIV and aging by addressing two overarching objectives: (1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment and (2) to improve approaches for testing, prevention, and treatment of HIV infection and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. 

NIH
Multidisciplinary Studies of HIV/AIDS and Aging (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-320.html
This announcement encourages exploratory/developmental research applications at the intersection of HIV and aging by addressing two overarching objectives: (1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment and (2) to improve approaches for testing, prevention, and treatment of HIV infection and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science. 

NIH
National Eye Institute Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-260.html
The purpose of this opportunity is to support secondary data analysis using existing data sets from vision-related clinical trials, epidemiologic, and other clinical research studies. This opportunity may be used to develop new statistical methodologies or test hypotheses using existing data, but must not be used to support the collection of new data.

NIH
National Institute of Aging Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-302.html
This opportunity invites applications for implementation of investigator-initiated multi-site interventional clinical trials (all phases). The trials should be hypothesis-driven, milestone-defined, and related to the National Institute of Aging's research mission.

NIH
National Institute of Neurological Disorders and Stroke Child Neurologist Career Development Program (K12 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-NS-19-040.html
Application Deadline: September 10, 2019
The purpose of this program is to facilitate and support the research career development of child neurologists who have made a commitment to independent research careers.

NIH
National Institute on Aging (NIA) Program Project Applications (P01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-314.html
NIA invites the submission applications addressing scientific areas relevant to the NIA mission. Each application submitted to this opportunity must include at least three related research projects that share a common central theme, focus, and/overall objective and an administrative core to lead the project.

NIH
NCI Program Project Applications (P01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-290.html
The National Cancer Institute invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. 

NIH
NCI Small Grants Program for Cancer Research (NCI Omnibus R03)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-416.html
This announcement supports small research projects on cancer that can be carried out in a short period of time with limited resources. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. 

NIH
Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-060.html
Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is still needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. 

NIH
Neuroscience Research on Drug Abuse (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-111.html
Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. The overarching goals of the research areas described in this announcement are to understand the neurobiological mechanisms underlying substance use disorders, with special emphasis on identifying changes and neuroadaptations that occur during dependence, withdrawal, and relapse to chronic substance use. An understanding of the basic mechanisms underlying substance use disorders can help to identify targets for prevention and treatment interventions. Research utilizing basic, translational, or clinical approaches is appropriate.

NIH
Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-078.html
Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is still needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. The overarching goals of the research areas described in this announcement are to understand the neurobiological mechanisms underlying substance use disorders, with special emphasis on identifying changes and neuroadaptations that occur during dependence, withdrawal, and relapse to chronic substance use. 

NIH
Neuroscience Research on Drug Abuse (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-112.html
Long-term misuse and chronic exposure to abused substances can produce widespread changes in brain structure and function. Although much progress has been made, additional research is still needed to identify the neurobiological changes that result from substance use, and how these changes contribute to substance use disorders. The overarching goals of the research areas described in this announcement are to understand the neurobiological mechanisms underlying substance use disorders, with special emphasis on identifying changes and neuroadaptations that occur during dependence, withdrawal, and relapse to chronic substance use. An understanding of the basic mechanisms underlying substance use disorders can help to identify targets for prevention and treatment interventions. Research utilizing basic, translational, or clinical approaches is appropriate.

NIH
New Onset Depressive Symptoms in Acute Illness (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-17-488.html
The purpose of this announcement is to encourage research on the etiology of depressive symptoms that occur in the context of a sudden onset acute illness. Although it is known that depressive symptoms may linger and affect functional recovery long after physical recovery from an acute insult, there is a gap in knowledge about the pathobiology that may underlie these incident depressive symptoms. A greater understanding of the etiological factors that contribute to and/or mitigate a trajectory of depressive symptoms may inform a personalized, holistic approach to managing recovery from acute illness.

NIH
New Onset Depressive Symptoms in Acute Illness (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-17-487.html
The purpose of this announcement is to encourage research on the etiology of depressive symptoms that occur in the context of a sudden onset acute illness. Although it is known that depressive symptoms may linger and affect functional recovery long after physical recovery from an acute insult, there is a gap in knowledge about the pathobiology that may underlie these incident depressive symptoms. A greater understanding of the etiological factors that contribute to and/or mitigate a trajectory of depressive symptoms may inform a personalized, holistic approach to managing recovery from acute illness.

NIH
New Paradigms in Tissue Communication from Mediators to Metabolic Function (RC2 Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-886.html

NIH
New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-049.html
This opportunity will support pilot studies by R01-funded investigators in areas of research that advance high priority studies of normal biology and resilience as described by Objective 1 of the NHLBI Strategic Vision. The development of more effective means for diagnosing and treating heart, lung, blood, and sleep disorders is often aided by a detailed understanding of normal biology, specifically the nature and operations of the molecular systems and cells that are affected by those diseases. Areas of research interest include studies of fundamental processes that explain "resilience" - the capability of some individuals to maintain or restore normal function despite aging or exposure that causes disease in others.

NIH
NHLBI Program Project Applications (P01 - Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-405.html
This grant supports research related to fundamental processes and diseases of the heart, blood and lymphatic vessels, lungs, and blood, including transfusion medicine, blood resources, and sleep disorders, as well as other programs including implementation science, health disparities, and translation research that address the mission of the Institute. This announcement requires a minimum of three interrelated research projects that investigate a complex biomedical theme or research question. The projects may be supported by core units to facilitate economy of effort, space, and equipment.

NIH
NIA Late Onset of Alzheimer's Disease Family-Based Study (U24)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-205.html
This announcement invites applications specific to infrastructure to support the Alzheimer's Disease Sequencing Project related to the collection, longitudinal follow-up, ascertainment of antecedent risk factors, and the characterization of additional relatives from families multiply affected with Alzheimer's disease (AD) in order to expand the existing NIA late onset of AD family-based study sample set.

NIH
NIA Program Project Applications (P01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-297.html
The National Institute on Aging (NIA) invites the submission of investigator-initiated program project applications. The applications should address scientific areas relevant to the NIA mission. Each application must include at least three related research projects that share a common central theme, focus, and/overall objective and an administrative core to lead the project.

NIH
NIA Program Project Applications (P01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-358.html
The National Institute on Aging (NIA) invites the submission of investigator-initiated program project applications. The applications should address scientific areas relevant to the NIA mission. Each application submitted must include at least three related research projects that share a common central theme, focus, and/overall objective and an administrative core to lead the project.

NIH
NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-281.html
This opportunity encourages applications that propose to complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. The trials should be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high-priority by the Institute.

NIH
NIBIB Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-433.html
This announcement will support exploratory/developmental research projects of interest to the NIBIB. These studies are expected to lead to breakthroughs in development of innovative techniques, agents, methodologies, models, or applications. These studies may involve considerable risk that should be balanced by the potential high impact on human-health and related research. Applicants are expected to propose novel biomedical research approaches for which there is no preliminary data to demonstrate the feasibility of the proposed project. A project may be exploratory, developmental, proof of concept, or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-driven.

NIH
NICHD Exploratory-Developmental Research Grant (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-259.html
The NICHD Exploratory-Developmental Grant program supports exploratory and developmental research projects that fall within the NICHD mission by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

NIH
NICHD Exploratory/Developmental Research Grant (R21 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-482.html
The NICHD Exploratory/Developmental Grant program supports exploratory and developmental research projects that fall within the NICHD mission by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

NIH
NICHD Small Grant Program (R03 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-481.html
Application Deadline: January 8, 2021
The NICHD Investigator-Initiated Small Research Grant (R03) funding opportunity supports small research projects that can be carried out in a short period of time with limited resources. The R03 activity code supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

NIH
NIDCD Hearing Healthcare for Adults: Improving Access and Affordability (R21/R33 Clinical Trials Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-19-001.html
This funding opportunity encourages Exploratory/Developmental Phased Innovation (R21/R33) grant applications to support research and/or infrastructure needs in emerging scientific areas leading to more accessible and affordable hearing health care for adults with mild to moderate hearing loss. The proposed research aims should be milestone-driven and lead to better hearing healthcare, targeting enhanced access and affordability, in an effort to improve outcomes for adults with hearing loss.

NIH
NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-184.html
This announcement provides an avenue for basic scientists, clinicians, and clinical scientists to jointly initiate and conduct translational research projects that translate basic research findings into clinical tools for better human health.  

NIH
NIH Exploratory/Developmental Research Grant Program ( Parent R21 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-053.html
The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. 

NIH
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-056.html
The NIH Research Project Grant supports a discrete, specified, circumscribed project in areas representing the specific interests and competencies of the investigator(s). The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers based on their scientific missions. 

NIH
NIH Small Research Grant Program (Parent R03 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-052.html
The NIH Small Research Grant Program supports small research projects that can be carried out in a short period of time with limited resources. This program supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. 

NIH
NINDS CREATE Bio Optimization Track for Biologics (U01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-456.html
This announcement supports the optimization of potential therapeutic biotechnology products and biologics (e.g., peptides, proteins, oligonucleotides, gene, and cell therapies) for disorders identified under the NINDS mission. This track supports the further characterization and optimization of therapeutic lead(s) that showed promise as a potential therapeutic agent as evidenced by convincing animal proof-of-concept studies. Therefore, at the end of this funding period, successful projects will have delivered and optimized therapeutic candidate with demonstrated bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and should be eligible for entry into the CREATE Bio Development track. The CREATE Bio Development track is a later stage program focused on the development of optimized therapeutic candidates through Investigational New Drug (IND)-enabling studies and submission of an IND package to the Food and Drug Administration (FDA).

NIH
NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-358.html
The NINDS Exploratory Neuroscience Research Grant program supports exploratory and innovative research projects that fall within the mission of the NINDS. Awards will provide support for the early and conceptual stages of projects. These studies often assess the feasibility of a novel avenue of investigation and involve considerable risk, but have the potential to bring about breakthroughs in the understanding of important areas of neuroscience or to the development of novel techniques, agents, methodologies, or models of high value to the neuroscience community.    

NIH
NIOSH Occupational Safety and Health Research (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-769.html
The purpose of the R01 grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. Applicants must concisely describe the occupational health burden(s) being addressed in their proposal while also linking the need for the proposed research activities to planned outputs that will help address or alleviate this burden. Applicants should clearly articulate the anticipated impacts of the proposed research, both during the project period and beyond.

Standard application due dates apply. See solicitation for details.

NIH
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-114.html
The purpose of this announcement is to support multidisciplinary, hypothesis-driven research on Natural Killer (NK) cells, leading to the discovery of pathways relevant for early immune responses and immune regulation impacting the potential protective immunity to be induced by HIV vaccination. Secondary objectives include the development of novel technologies to allow for more definitive studies of human immune monitoring in the context of vaccine clinical trials and the recruitment of innate immunologists to the HIV vaccine field.

NIH
Non-healing Ulcerative Wounds in Aging (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-230.html
This announcement invites applications that propose basic, clinical, or translational research on non-healing ulcerative wounds and their consequences in aging and in older persons. Applications are encouraged that focus on the (1) biology, etiology and pathophysiology of non-healing ulcerative wounds in animal models and/or older adults; (2) translation of basic/clinical research into clinical practice and health decision-making; and (3) diagnosis, prevention, management and clinical outcomes of non-healing wounds in older adults. 

NIH
Non-healing Ulcerative Wounds in Aging (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-231.html
This announcement invites applications that propose basic, clinical, or translational research on non-healing ulcerative wounds and their consequences in aging and in older persons. Applications are solicited that focus on the (1) biology, etiology and pathophysiology of non-healing ulcerative wounds in animal models and/or older adults; (2) translation of basic/clinical research into clinical practice and health decision-making; and (3) diagnosis, prevention, management, and clinical outcomes of non-healing wounds in older adults.

NIH
Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-298.html
The goal of this opportunity is to encourage applications for studies using non-invasive neurostimulation/neuromodulation in the treatment of Alzheimer's disease or Alzheimer's disease-related dementias.

NIH
Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-868.html
Genome-wide association studies and other disease studies have found many variants that are statistically associated with disease risk, disease protection, or other traits. However, such studies do not show which variants in genomic elements cause these effects or how they result in differences in function. Similarly, clinical genomic sequencing studies have identified many variants in healthy and diseased individuals. However, the pathogenicity of such variants is often unknown, leading to their classification as variants of uncertain significance, which makes clinical implementation difficult. 

NIH
Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-867.html
Genome-wide association studies and other disease studies have identified many variants that are statistically associated with disease risk, disease protection, or other traits. However, such studies do not generally show which specific variants in genomic elements cause these effects or how they result in differences in function. Similarly, genomic sequencing studies in clinical settings have identified many variants in healthy and diseased individuals. However, the pathogenicity of such variants is often unknown, leading to their classification as variants of uncertain significance, which makes clinical implementation difficult. 

NIH
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-082.html
The purpose of this funding opportunity is to support research activities that will contribute to the overall understanding of coccidioidomycosis, commonly known as Valley Fever, and other select endemic fungal diseases including histoplasmosis and blastomycosis. This research opportunity encourages studies that address diverse scientific areas such as: 1) pathogenesis; 2) host response; 3) disease transmission; 4) natural history and environmental factors contributing to disease; 5) vaccines; 6) diagnostics; and 7) therapeutics; with the ultimate goal of advancing the field toward solutions for the improved detection, prevention, and treatment of select endemic mycoses.

NIH
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-083.html
The purpose of this funding opportunity is to support research activities that will contribute to the overall understanding of coccidioidomycosis, commonly known as Valley Fever, and other select endemic fungal diseases including histoplasmosis and blastomycosis. This research opportunity encourages studies that address diverse scientific areas such as: 1) pathogenesis; 2) host response; 3) disease transmission; 4) natural history and environmental factors contributing to disease; 5) vaccines; 6) diagnostics; and 7) therapeutics; with the ultimate goal of advancing the field toward solutions for the improved detection, prevention, and treatment of select endemic mycoses.

NIH
Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-243.html
The purpose of this announcement is to support research that will contribute to the overall understanding of Lyme disease and co-infections transmitted by Ixodes ticks. This research opportunity encourages studies that address diverse scientific areas such as (1) pathogenesis, (2) host response, (3) disease transmission, (4) vector biology and natural history, (5) vaccines, (6) diagnostics, and (7) therapeutics. 

NIH
Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-244.html
The purpose of this announcement is to support research that will contribute to the overall understanding of Lyme disease and co-infections transmitted by Ixodes ticks. This research opportunity encourages studies that address diverse scientific areas such as (1) pathogenesis, (2) host response, (3) disease transmission, (4) vector biology and natural history, (5) vaccines, (6) diagnostics, and (7) therapeutics. 

NIH
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-753.html
This announcement invites R01 applications to support the development of novel biomarkers and improved HIV incidence assays and algorithms with increased specificity for distinguishing recent (within the first 12 months) from chronic HIV infections.

NIH
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-754.html
This announcement invites R21 applications to support the development of novel biomarkers and improved HIV incidence assays and algorithms with increased specificity for distinguishing recent (within the first 12 months) from chronic HIV infections.

NIH
Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-237.html

NIH
Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-055.html
Application Deadline: August 30, 2019
This opportunity supports the development of technology tools that will facilitate, accelerate, and/or enhance research using advanced human-derived next generation cancer models such as organoids, conditionally reprogrammed cells, and others. 

NIH
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-034.html
The purpose of this announcement is to promote application of nutrigenetics and/or nutrigenomics approaches to nutrition research through collaborative interaction among nutrition researchers and experts in omics technologies.

NIH
Nutrition and Alcohol-Related Health Outcomes (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-211.html
This announcement encourages applications that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this program announcement is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol use disorder and chronic disease.

NIH
Nutrition and Alcohol-Related Health Outcomes (R03)
https://grants.nih.gov/grants/guide/pa-files/PA-17-212.html
The solicitation encourages applications that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models, with the goal of stimulating a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol use disorder and chronic disease.

NIH
Nutrition and Alcohol-Related Health Outcomes (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-213.html
This announcement encourages applications that propose to examine associations between nutrition and alcohol-related health outcomes in humans and animal models, with the goal of stimulating a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of alcohol-related health outcomes including alcohol use disorder and chronic disease.

NIH
Occupation Safety and Health Exploratory/Developmental Grant Program (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-798.html
The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. NIOSH sponsors exploratory and developmental research projects by providing support for the early and conceptual stages of projects. Applicants must concisely describe the occupational health burden(s) being addressed in their proposal while also linking the need for the proposed research activities to planned outputs that will help address or alleviate this burden. Applicants should clearly articulate the anticipated impacts of the proposed research, both during the project period and beyond.

NIH
Occupational Safety and Health Research (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-812.html
The purpose of this program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.

Application dates vary. See solicitation for details.

NIH
Occupational Safety and Health Small Research Grant Program
https://grants.nih.gov/grants/guide/pa-files/PAR-18-797.html
The purpose of this grant program is to develop an understanding of the risks and conditions associated with occupational diseases and injuries, explore methods for reducing risks and preventing or minimizing exposure to hazardous conditions in the workplace, and translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries. The R03 grant mechanism supports small occupational safety and health research projects that can be carried out with limited resources such as pilot and feasibility studies, secondary data analysis, or development of research methods.

NIH
Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-088.html
Application Deadline: May 8, 2019
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of oocyte mitochondrial function in relation to fertility, aging, and mitochondrial disease transmission to offspring. The overarching goal is to gain fundamental insight into the role of mitochondria and long-term consequences of their dysfunction in the oocyte, and to develop therapeutic or alternative approaches to treat mitochondrial dysfunction for improving oocyte quality and competency, and health of the resultant offspring.

NIH
Oocyte Mitochondrial Function in Relation to Fertility, Aging, and Mitochondrial Diseases (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-087.html
Application Deadline: May 8, 2019
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of oocyte mitochondrial function in relation to fertility, aging, and mitochondrial disease transmission to offspring. The overarching goal is to gain fundamental insight into the role of mitochondria and long-term consequences of their dysfunction in the oocyte, and to develop therapeutic or alternative approaches to treat mitochondrial dysfunction for improving oocyte quality and competency, and health of the resultant offspring. 

NIH
Optimizing HIV Phylodynamics to Target and Interrogate Clusters (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-306.html
The purpose of this announcement is to support exploratory basic research to develop innovative phylodynamic approaches to identify and prioritize the most rapidly growing HIV transmission clusters within a given population of individuals in near-real time. 

NIH
Oral Health in People Living with HIV and Additional Non-Communicable Diseases (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DE-20-001.html
Application Deadline: July 29, 2019
This funding opportunity encourages research to address gaps in our knowledge of the oral health status of people living with HIV (PLWH) with an emphasis on PLWH who also have non-communicable diseases.

An optional letter of intent is due June 29, 2019. 

NIH
Oscillatory Patterns of Gene Expression in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-040.html
Application Deadline: October 23, 2019
This opportunity invites applications that seek to enhance existing transcriptome and proteome data sets by revealing oscillatory patterns of gene expression in aging and in Alzheimer's disease (AD), by uncovering their molecular significance, and by identifying rhythmic gene and/or protein profiles associated with the risk for AD.

NIH
Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-015.html
Application Deadline: October 2, 2019
This opportunity invites applications to participate as a Research Center in the Pediatric Cardiac Genomics Consortium (PCGC). The PCGC's mission is to identify genetic causes of human congenital heart disease (CHD) and to relate genetic variants in patients with CHD to clinical outcomes through collaborative, multi-center studies.

NIH
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-893.html
This announcement encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. 

NIH
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-892.html
This announcement encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. 

NIH
Pilot and Feasibility Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-903.html
The purpose of this funding opportunity is to foster the advancement of the research mission of the Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases by inviting research concepts for clinical pilot and feasibility research studies; and translational research studies in digestive diseases and nutrition.

NIH
Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-615.html
This announcement invites applications for innovative basic and translational research projects examining HIV infection, persistence, and comorbidities as they relate to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases and consistent with the scientific priorities outlined by the NIH Office of AIDS Research in NOT-OD-15-137.

NIH
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-011.html
Application Deadline: October 28, 2019
The goal of this opportunity is to solicit applications for pilot projects on Common Fund Program "Illuminating the Druggable Genome (IDG)" -eligible understudied proteins (non-olfactory GPCRs, protein kinases, and ion channels) in order to study them beyond what the IDG's Centers can accomplish and to validate and demonstrate the utility of IDG-generated reagents, data, and approaches.

NIH
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-180.html
The purpose of this announcement is to encourage research applications to develop and pilot test approaches to improve diabetes and obesity prevention and/or treatment that are adapted for implementation in healthcare settings where individuals receive routine medical care. 

NIH
Population Dynamics Research Infrastructure Program FY 2020 (P2C Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-20-015.html
Application Deadline: August 30, 2019
The goal of this opportunity is to advance the field of population dynamics research by increasing research impact, innovation, and productivity; developing junior scientists; and maximizing the efficiency of research support.

NIH
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-177.html
The purpose of this announcement is to encourage research applications to test innovative approaches to improve diabetes and obesity prevention and/or treatment that are adapted for implementation in healthcare settings where individuals receive their routine medical care. 

NIH
Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-849.html#_3._Additional_Information
This funding opportunity announcement seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and well-being as individuals age and prevent illness and disability in later years. 

NIH
Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-850.html#_3._Additional_Information
This funding opportunity announcement seeks to stimulate research on mid-life adults (those 50 to 64 years of age) that can inform efforts to optimize health and well-being as individuals age and prevent illness and disability in later years. 

NIH
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-067.html
This funding opportunity invites applications to characterize antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands presented by classical and non-classical MHC class I and class II molecules and to determine the contribution of these unique antigenic ligands to: protective immune responses to infectious pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or in the induction/progression or prevention of immune-mediated diseases. 

NIH
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-066.html
This opportunity invites applications to determine antigen processing and presentation mechanisms used in the generation of novel peptidic and non-peptidic ligands and to determine the contribution of these unique antigenic ligands to: protective immune responses against infectious disease pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or limit progression or induction of immune-mediated diseases.

NIH
Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-262.html
The purpose of this announcement is to stimulate HIV/AIDS research by addressing scientific areas of primary interest to the National Institute of Child Health and Human Development, Maternal and Pediatric Infectious Disease Branch, and the Office of AIDS Research.

NIH
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-032.html
The purpose of this funding opportunity is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying HIV infection or Acquired Immune Deficiency Syndrome (AIDS). This opportunity involves a set of six PQs. Each research project proposed in response to this opportunity must be focused on addressing one particular research problem defined by one specific PQ selected from the list. 

NIH
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-279.html
The National Cancer Institute (NCI) invites applications for exploratory/developmental research projects designed to solve specific problems and paradoxes in multiple myeloma and disparities research identified as the NCI Multiple Myeloma Disparities Provocative Questions. These problems and paradoxes phrased as questions are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of multiple myeloma and disparities research that are deemed important but have not received sufficient attention.

NIH
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-280.html
The National Cancer Institute (NCI) invites applications for exploratory/developmental research projects designed to solve specific problems and paradoxes in multiple myeloma and disparities research identified as the NCI Multiple Myeloma Disparities Provocative Questions. These problems and paradoxes phrased as questions are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of multiple myeloma and disparities research that are deemed important but have not received sufficient attention.

NIH
Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimer's Disease (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-042.html
Application Deadline: October 23, 2019
This opportunity invites innovative research focused on understanding the regulation of brain regional and cell-type-specific proteome dynamics in Alzheimer's disease (AD). Specifically, this opportunity encourages collaborative approaches to design and implement novel, single-cell-based proteomic platforms to comprehensively characterize the dynamics of neuronal proteomes during the course of aging and AD.

NIH
Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimer's Disease (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-041.html
Application Deadline: October 23, 2019
This opportunity invites early stage innovative and exploratory research focusing on understanding the regulation of brain regional and cell type-specific protein dynamics in Alzheimer's disease (AD). In particular, this opportunity seeks applications proposing to develop novel proteomic platforms and animal models to further understanding of the alteration of a single-cell neuronal cell proteome in the central nervous system during the course of aging and AD.

NIH
Research Grants Using the Resources from the Osteoarthritis Initiative (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-409.html
This announcement encourages applications for research awards that are focused on the use of the Osteoarthritis Initiative database, clinical data, and images. 

NIH
Research Grants Using the Resources from the Osteoarthritis Initiative (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-408.html
This announcement encourages applications for research awards that are focused on the use of the Osteoarthritis Initiative database, clinical data, and images. 

NIH
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-367.html
This announcement invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. Specifically, this announcement will use the NIH Phased Innovation Award mechanism to provide up to two years of R21 support for initial developmental activities, and up to three years of R33 support for expanded activities. Through this award, investigators will develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions. 

NIH
Research Innovations for Scientific Knowledge (RISK) for Musculoskeletal Diseases (R61/R33 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-013.html
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Research Innovation for Scientific Knowledge (RISK) for Musculoskeletal Diseases initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This opportunity is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This opportunity intends to support disease-focused translational studies and invites research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies.

NIH
Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-012.html
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This opportunity is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This opportunity intends to support disease-focused translational studies and invites research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies. 

NIH
Research on Autism Spectrum Disorders (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-388.html
The purpose of this announcement is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders. 

NIH
Research on Autism Spectrum Disorders (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-16-387.html
The purpose of this announcement is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders. 

NIH
Research on Autism Spectrum Disorders (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-386.html
The purpose of this announcement is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, treatment, and optimal means of service delivery in relation to Autism Spectrum Disorders. 

NIH
Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-937.html
The purpose of this funding opportunity is to encourage epidemiological, clinical, and translational research that will increase our understanding of the natural history, prevalence, biological mechanisms, psychological variables, and clinical risk factors responsible for the presence of multiple chronic pain conditions in people with pain.

NIH
Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/pa-18-939.html
The purpose of this funding opportunity is to encourage epidemiological, clinical, and translational research that will increase our understanding of the natural history, prevalence, biological mechanisms, psychological variables, and clinical risk factors responsible for the presence of multiple chronic pain conditions in people with pain.

NIH
Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional)
https://grants.nih.gov/grants/guide/pa-files/PAS-18-557.html
HIV+ alcohol users remain at high risk for medication non-adherence and rapid disease progression, medication toxicities, organ failure, and poor viremic control, leading to increased risk of transmission and premature death. Recent advances in technology and biomedical science (e.g., new pharmacological agents, alcohol and inflammation biomarkers, internet and mobile technology) open new opportunities for strengthening the quality of HIV/alcohol-related implementation research through utilization of novel technology and biomarkers. This initiative seeks to advance knowledge on implementation and comparative effectiveness of alcohol-focused interventions among HIV+ individuals. 

NIH
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-070.html
The purpose of this funding opportunity is to invite applications proposing research on current topics in Alzheimer's disease and its related dementias.

NIH
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/par-19-071.html
The purpose of this funding opportunity is to invite applications proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's disease and its related dementias and which need additional preliminary data with broader dissemination to establish them for more general use in this research field.

NIH
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-729.html
This announcement calls for research on the health of transgender and gender nonconforming people of all ages, including both youth and adults who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.

Standard and AIDS application dates apply. See solicitation for details.

NIH
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-728.html
This announcement calls for research on the health of transgender and gender nonconforming people of all ages, including both youth and adults who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.

Standard and AIDS application dates apply. See solicitation for details.

NIH
Research on Transgender Health (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-478.html
This announcement calls for research on the health of transgender and gender nonconforming people of all ages, including both youth and adults who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.

NIH
Research on Transgender Health (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-477.html
This announcement calls for research on the health of transgender and gender nonconforming people of all ages, including both youth and adults who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex. 

NIH
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-287.html
The National Cancer Institute's Cancer Systems Biology Consortium (CSBC) supports systems biology approaches to cancer research. CSBC research projects proposed in response to this funding opportunity must be based upon explicit integration of experimental biology and computational modeling to test and validate novel hypotheses in cancer research.

NIH
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-248.html
The purpose of this opportunity is to support research to improve existing animal models or develop novel animal models that more accurately represent influenza immunity in humans, with an emphasis on increasing the predictive value of models for evaluating novel universal influenza vaccines.

NIH
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-247.html
The purpose of this opportunity is to support research to improve existing animal models or develop novel animal models that more accurately represent influenza immunity in humans, with an emphasis on increasing the predictive value of models for evaluating novel universal influenza vaccines.

NIH
Research to Advance Hepatitis B Virus (HBV) Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAS-19-097.html
The purpose of this funding opportunity is to invite applications for support of innovative basic, translational, and clinical research to identify and address the challenges to achieving HBV cure in the presence or absence of HIV.

NIH
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-873.html
The purpose of this opportunity is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity encourages studies that address scientific areas potentially relevant to vaccine safety, such as: 1) characterization of physiological and immunological responses to vaccines and vaccine components, including different adjuvants; 2) how genetic variations affect immune/physiological responses that may impact vaccine safety; 3) identification of risk factors (e.g., infection history, predisposition to or presence of allergic and/or autoimmune disease and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines; 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources, such as passive reporting systems or healthcare databases; or 5) the application of genomic/molecular technologies and systems biology approaches to evaluate vaccine safety.

NIH
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-872.html
The purpose of this opportunity is to support research that will contribute to the overall understanding of vaccine safety. This research opportunity encourages studies that address scientific areas potentially relevant to vaccine safety such as 1) characterization of physiological and immunological responses to vaccines and vaccine components, including different adjuvants; 2) how genetic variations affect immune/physiological responses that may impact vaccine safety; 3) identification of risk factors e.g., infection history, predisposition to or presence of allergic and/or autoimmune disease and biological markers that may be used to assess whether there is a relationship between certain diseases or disorders and licensed vaccines; 4) creation/evaluation of statistical methodologies for analyzing data on vaccine safety, including data available from existing data sources such as passive reporting systems or healthcare databases; or 5) the application of genomic/molecular technologies and systems biology approaches to evaluate vaccine safety. 

NIH
Research to Improve Native American Health (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-464.html
The purpose of this announcement is to encourage exploratory developmental research to improve Native American health. Such research can include conducting secondary analysis of existing data (such as databases that the Tribal Epidemiology Centers have collected); merging various sources of data to answer critical research questions; conducting pilot and feasibility studies; and/or assessing and validating measures that are being developed and/or adapted for use in Native American communities. 

NIH
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-369.html
This announcement encourages grant applications aimed at developing, characterizing, or improving animal models of human diseases; improving access to data and information about or generated from the use of animal models of human disease; or improving diagnosis and control of diseases of laboratory animals. The animal models and related materials to be developed must address the research interests of two or more of the categorical NIH Institutes and Centers. Applications to develop models that relate strictly to a specific disease or category of research will not be considered acceptable. Projects that predominantly address the research interests of one NIH Institute or Center but are peripherally related to the research interests of other Institutes and Centers will not be considered appropriate. 

NIH
Role of Age-Associated Metabolic Changes in Alzheimer's Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-031.html
This announcement encourages innovative experimental approaches to explore the molecular and cellular bases for age-related change in metabolism that impact the development of Alzheimer's disease.

NIH
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living With and Without HIV (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-838.html
The purpose of this funding opportunity announcement is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reproductive and metabolic failure. 

NIH
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living With and Without HIV (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-839.html
The purpose of this funding opportunity announcement is to encourage applications from the scientific community to support outstanding research related to the role of the gut microbiome in regulating metabolism and reproduction and its impact on the fertility status. The overarching goal is to gain fundamental insight into the possible role of the gut microbiome in regulating reproduction through HPG, HPA, and HPT axes in the brain. The results of the study could lead to development of diagnostic markers (signature microbiomes) for reproductive and metabolic failure.

NIH
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-311.html
The purpose of this announcement is to (1) promote preclinical, translational, clinical, and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments.

NIH
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-16-313.html
The purpose of this announcement is to (1) promote preclinical, translational, clinical, and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatments. 

NIH
Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-312.html
The purpose of this announcement is to (1) promote preclinical, translational, clinical, and epidemiological research in pain medications use in children or in pregnant women to fill knowledge gaps in the safe use of the pain medications in these special populations; and (2) develop effective instruments or approaches to assess and evaluate maternal and child outcomes of pain medication treatment.

NIH
SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging (U24 Clinical Trials Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-043.html
Application Deadline: July 22, 2019
This opportunity will support a new, centralized infrastructure to aggregate, harmonize, manage, and share existing and future neuroimaging data collected in National Institute of Aging-supported Alzheimer's Disease Research Centers.

NIH
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-18-741.html
This announcement encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases.

NIH
Secondary Analyses of Alcohol and Chronic Disease (R03)
http://grants.nih.gov/grants/guide/pa-files/PA-16-394.html
This announcement encourages applications that propose to conduct secondary analyses of alcohol as it relates to chronic disease etiology and epidemiology. The goal of this program is to facilitate innovative yet cost-effective research utilizing previously collected data.

Standard application dates apply. See solicitation for details.

NIH
Secondary Analyses of Existing Alcohol Research Data (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-467.html
This announcement encourages the submission of investigator-initiated research grant applications to support the secondary analysis of existing data sets with the goal of enhancing our understanding of patterns of alcohol consumption and the epidemiology and etiology, including genetics, of alcohol-related problems. 

NIH
Secondary Analyses of Existing Alcohol Research Data (R03)
https://grants.nih.gov/grants/guide/pa-files/PA-17-468.html
This announcement encourages the submission of investigator-initiated research grant applications to support the secondary analysis of existing data sets with the goal of enhancing our understanding of patterns of alcohol consumption and the epidemiology and etiology, including genetics, of alcohol-related problems. 

NIH
Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-004.html
The goal of this opportunity is to stimulate the use of existing human datasets for well-focused secondary analyses to investigate novel scientific ideas or new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the NHLBI mission. 

NIH
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-022.html
This opportunity invites applications proposing the innovative analysis of existing publicly available nationally representative U.S. cross-sectional and longitudinal data, to investigate novel scientific ideas and/or to generate new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the Food and Drug Administration Center for Tobacco Products.

NIH
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-239.html
This announcement encourages applications that propose to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate the genetic architecture of cancer risk and related outcomes. 

NIH
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-243.html
This announcement encourages applications that propose to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate the genetic architecture of cancer risk and related outcomes. 

NIH
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PA-19-068.html

NIH
Secondary Data Analyses to Explore NIMH Research Domain Criteria (R03)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-158.html
This solicitation seeks applications that propose secondary analyses of existing clinical research data sets to investigate constructs identified in the NIMH's Research Domain Criteria Initiative and to test novel hypotheses using the Criteria framework.

NIH
Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-706.html
The goal of this announcement is to define and characterize neural cell populations, neural circuits, and brain networks and regions that are vulnerable to brain aging and Alzheimers disease (AD). Understanding mechanisms underlying selective vulnerability from cells to networks in AD is critical to fully define the disease process and to develop effective therapies.

NIH
Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-17-047.html
The goal of this announcement is to define and characterize neural cell populations, neural circuits, and brain networks and regions that are vulnerable to brain aging and Alzheimers disease (AD). Understanding mechanisms underlying selective vulnerability from cells to networks in AD is critical to fully define the disease process and to develop effective therapies. 

NIH
Sensory and Motor System Changes as Predictors of Preclinical Alzheimers Disease (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-519.html
The purpose of this announcement is to encourage applications that propose either basic, clinical, or a combination of basic and clinical studies to investigate how functional changes in the sensory and/or motor systems impact the development and progression of Alzheimers disease. 

NIH
Serious Adverse Drug Reaction Research (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-275.html
This announcement will support research grants that will advance the state of knowledge of serious adverse drug reactions. Applications across the spectrum of research are encouraged. 

NIH
Serious Adverse Drug Reaction Research (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-274.html
This announcement will support research grants that will advance the state of knowledge of serious adverse drug reactions. Applications across the spectrum of research are encouraged. 

NIH
Service Centers for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-009.html
Application Deadline: November 12, 2019
The purpose of this initiative is to advance the application of cryoelectron tomography (cryoET), a powerful new method for directly visualizing macromolecular associations and organization in native cells. This opportunity will establish four service centers that will specialize in cryoET specimen preparation.

NIH
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-222.html
The purpose of this funding opportunity announcement is to provide support for New Investigators: 1) from diverse backgrounds, including from groups nationally underrepresented in biomedical and behavioral research to conduct small research projects in the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Human Genome Research Institute; and 2) who at the time of award will have/have had less than $125,000 direct cost of combined research funding (excluding NIH training and NIH career awards). 

NIH
Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens (R03)
https://grants.nih.gov/grants/guide/pa-files/PA-17-299.html
This announcement encourages applications that propose to conduct secondary analyses of publicly available NICHD-funded data sets or stored biospecimens. The goal of this program is to facilitate innovative yet cost-effective research utilizing data and biospecimens collected with NICHD resources. 

NIH
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-069.html
This opportunity is intended to support meritorious small research projects focused on the development and analyses of childhood cancer and/or structural birth defects datasets that are part of the Gabriella Miller Kids First Data Resource or could be included in the Kids First Data Resource. Development of statistical methodology appropriate for analyzing genome-wide data relevant to childhood cancer and/or structural birth defects may also be proposed. 

NIH
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-313.html
This announcement invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPOREs). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a related group of cancers. 

NIH
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAS-19-105.html

NIH
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-309.html
This opportunity provides support for the development of innovative interventions that improve cancer-related health behaviors across diverse racial/ethnic populations. Specifically, this opportunity is intended to stimulate research aimed at 1) testing new theories and conceptual frameworks; 2) developing and evaluating novel strategies to improve cancer-related health behaviors; 3) investigating multi-level and multi-behavioral approaches; and 4) utilizing innovative research designs, methodologies, and technologies.

NIH
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-430.html
The purpose of this announcement is to support research that advances compounds toward FDA approval by leveraging NIDA funds with the strengths and resources of outside organizations, such as for-profit and not-for-profit entities, including academic institutions, pharmaceutical and biotechnology companies, private and public foundations, and small businesses. 

NIH
Symptom Cluster Characterization in Chronic Conditions (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-462.html
The purpose of this initiative is to encourage preclinical and clinical research and secondary data analysis on symptom cluster characterization that has potential to inform treatment and interventions that improve functional outcomes and quality of life in patients with chronic conditions.

NIH
Symptom Cluster Characterization in Chronic Conditions (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-461.html
The purpose of this initiative is to encourage preclinical and clinical research and secondary data analysis on symptom cluster characterization that has potential to inform treatment and interventions that improve functional outcomes and quality of life in patients with chronic conditions.

NIH
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-143.html
The announcement invites research applications focused on developing, adapting and testing innovative cost-effective strategies to prevent, identify and manage symptoms of HIV-associated Non-AIDS conditions and other comorbidities among older adults with prolonged HIV infection.

NIH
Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-161.html
The announcement invites research applications focused on developing, adapting, and testing innovative cost-effective strategies to prevent, identify, and manage symptoms of HIV-associated Non-AIDS conditions and other comorbidities among older adults with prolonged HIV infection.

NIH
Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural Birth Defects (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-454.html
The purpose of this announcement is to promote systems developmental biology. In the context of this announcement, systems developmental biology is defined as research focused on understanding how biological components work together to produce the complex biological phenomena encompassing embryonic development.

Applications are due December 6, 2017; December 6, 2018; and December 6, 2019.

NIH
Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-194.html
This announcement encourages implementation research projects designed in partnership with global and domestic service providers to target the particular needs in the selected community to achieve the 90/90/90 HIV prevention and treatment targets identified by HIV/AIDS global leadership. The targets for HIV testing are that 90% of all persons living with HIV know their status, for treatment initiation that 90% of those diagnosed receive timely and effective antiretroviral treatment, and for optimal treatment and preventive benefit that 90% of those on treatment achieve sustained viral suppression. 

NIH
Targeted Implementation Science to Achieve 90/90/90 Goals for HIV/AIDS Prevention and Treatment (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-195.html
This announcement encourages implementation research projects designed in partnership with global and domestic service providers to target the particular needs in the selected community to achieve the 90/90/90 HIV prevention and treatment targets identified by HIV/AIDS global leadership. The targets for HIV testing are that 90% of all persons living with HIV know their status, for treatment initiation that 90% of those diagnosed receive timely and effective antiretroviral treatment, and for optimal treatment and preventive benefit that 90% of those on treatment achieve sustained viral suppression. 

NIH
Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/pa-19-073.html
The purpose of this funding opportunity is to stimulate clinical research that examines the role of telomeres in wellness and disease and to advance the incorporation of telomere studies into biobehavioral programs of research. A body of research has demonstrated the contribution of telomeres to health-related outcomes; however, additional studies are needed to achieve the full potential for incorporating telomere-guided approaches for maintaining wellness, reducing the risk and burden of disease, and for advancing symptom and self-management strategies.

NIH
Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-19-074.html

NIH
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-306.html
The purpose of this announcement is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity and 2) that could be made scalable and sustainable for broad use across the nation. 

NIH
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-324.html
The purpose of this announcement is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity and 2) that could be made scalable and sustainable for broad use across the nation. 

NIH
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-440.html
The purpose of this announcement is to stimulate research in the interplay between cell death pathways in nave and drug resistant cancers. 

NIH
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-449.html
The purpose of this announcement is to stimulate research in the interplay between cell death pathways in nave and drug resistant cancers. 

NIH
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-830.html
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known. The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), and the National Eye Institute (NEI).

NIH
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-831.html
The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either poorly understood or not known. The goal of the FOA is to promote research into the role of RNA chemical modifications in the initiation and progression of various developmental processes and disease states and conditions relevant to the scientific mission of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NIH
The Role of Mobile Genetic Elements in Cancer (R01)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-227.html
The goal of this announcement is to encourage applications to investigate mechanisms regulating the expression and activity of mobile genetic elements, including long terminal repeat (LTR) and non-LTR retroelements, in cancer. 

NIH
The Role of Mobile Genetic Elements in Cancer (R21)
http://grants.nih.gov/grants/guide/pa-files/PAR-16-226.html
The goal of this announcement is to encourage applications to investigate mechanisms regulating the expression and activity of mobile genetic elements, including long terminal repeat (LTR) and non-LTR retroelements, in cancer. 

NIH
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-283.html
The purpose of this announcement is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection. 

NIH
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-282.html
The purpose of this announcement is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB) re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection. 

NIH
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-189.html
The purpose of this announcement is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the announcement are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. 

NIH
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R03)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-188.html
The purpose of this announcement is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the announcement are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. 

NIH
Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-187.html
The purpose of this announcement is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation. The overall goals of the announcement are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. 

NIH
Trophoblast Differentiation and Function (R01)
http://grants.nih.gov/grants/guide/pa-files/PA-16-445.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of trophoblast differentiation and function in relation to fertility and pregnancy, including the role of the immune system. 

NIH
Trophoblast Differentiation and Function (R21)
http://grants.nih.gov/grants/guide/pa-files/PA-16-444.html
The purpose of this announcement is to encourage applications from the scientific community to support outstanding research in the area of trophoblast differentiation and function in relation to fertility and pregnancy, including the role of the immune system. 

NIH
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-466.html
A rich body of evidence suggests that optimal cognitive, affective, and social processes are associated with highly coordinated neural activity. These findings suggest that oscillatory rhythms, their co-modulation across frequency bands, spike-phase correlations, spike population dynamics, and other patterns might be useful drivers of therapeutic development for treatment of cognitive, social, or affective symptoms in neuropsychiatric disorders. This funding opportunity supports projects that test whether modifying electrophysiological patterns during behavior can improve cognitive, affective, or social processing. 

NIH
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21)
https://grants.nih.gov/grants/guide/pa-files/PAR-17-463.html
A rich body of evidence suggests that optimal cognitive, affective, and social processes are associated with highly coordinated neural activity. These findings suggest that oscillatory rhythms, their co-modulation across frequency bands, spike-phase correlations, spike population dynamics, and other patterns might be useful drivers of therapeutic development for treatment of cognitive, social, or affective symptoms in neuropsychiatric disorders. This funding opportunity supports projects that test whether modifying electrophysiological patterns during behavior can improve cognitive, affective, or social processing. 

NIH
Understanding Senescence in Brain Aging and Alzheimer's Disease (R01 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-025.html
Application Deadline: October 17, 2019
This opportunity supports research focused on understanding the role of senescence in brain aging and in Alzheimer's disease, with a focus on research projects addressing critical knowledge gaps in our understanding of the neurobiology of senescence through cutting-edge techniques, cross-disciplinary collaborations, and/or conceptual innovation.

NIH
Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-333.html
The purpose of this announcement is to support studies on the very early development of the immune system and the humoral and cellular communication that exists between the mother and fetus that may shape or impact immune system development and maturation. 

NIH
Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
https://grants.nih.gov/grants/guide/pa-files/PA-17-330.html
The purpose of this announcement is to stimulate research on the identification of new and novel targets and mechanisms involved in tumor immune evasion, which may be amenable to analysis by small molecules, pharmacological, or molecular genetics approaches. A specific focus is to encourage cross disciplinary collaborations between immunologists, cell biologists, medicinal chemists, pharmacologists, and molecular biologists.

NIH
Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-18-007.html
The purpose of the updated ViCTER program is to foster and promote early-stage transdisciplinary collaborations and/or translational research efforts among fundamental (technology and mechanism oriented), clinical (patient-oriented) and population-based researchers in the environmental health field. The newly established collaborative teams will come together in common interest to investigate potential linkages between human health and one or more environmental stressor(s). 

NIH
Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PA-18-048.html
The purpose of this announcement is to provide support for research on Zika virus and its complications. This announcement replaces PAR-16-106, which had used rolling application due dates to facilitate the rapid review and award of particularly urgent or time-sensitive projects. The last date for submitting an application to PAR-16-106 is January 13, 2017.

NIH
Zika Virus (ZIKV) Complications (R21)
https://grants.nih.gov/grants/guide/pa-files/PA-17-085.html
The purpose of this announcement is to provide support for research on Zika virus (ZIKV) and its complications. This announcement replaces PAR-16-106, which had used rolling application due dates to facilitate the rapid review and award of particularly urgent or time-sensitive projects. The last date for submitting an application to PAR-16-106 was January 13, 2017.

NSF
Biological Anthropology
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5407
The Biological Anthropology Program supports basic research in areas related to human evolution and contemporary human biological variation. Research areas supported by the program include, but are not limited to, human genetic variation, human and nonhuman primate ecology and adaptability, human osteology and bone biology, human and nonhuman primate paleontology, functional anatomy, and primate socioecology.

NSF
Biological Anthropology Program - Doctoral Dissertation Research Improvement Grants
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505067
The Biological Anthropology Program supports multifaceted research to advance scientific knowledge of human biology and ecology, including understanding of our evolutionary history and mechanisms that have shaped human and nonhuman primate biological diversity. These awards are intended to enhance and improve the conduct of dissertation research by doctoral students who are pursuing research in biological anthropology that enhances basic scientific knowledge.

NSF
High-Risk Research in Biological Anthropology and Archaeology
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314126
This program aims to support high-risk, exploratory proposals that can lead to significant new anthropological knowledge. As the definition of risk can vary by sub-discipline and because an assessment of the potential payoff is integral to the decision process, it is necessary to discuss topics with the appropriate program officer prior to submission.

NSF
Long Term Research in Environmental Biology
https://www.grants.gov/web/grants/view-opportunity.html?oppId=309109
The Long Term Research in Environmental Biology (LTREB) Program supports the generation of extended time series of data to address important questions in evolutionary biology, ecology, and ecosystem science. All proposals submitted through the LTREB solicitation are processed by 1 of the 3 clusters in the Division of Environmental Biology: Ecosystem Science, Population and Community Ecology, and Evolutionary Processes. Proposals must address topics supported by these clusters. 

NSF
Opportunities for Promoting Understanding through Synthesis (OPUS)
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13403
Application Deadline: August 28, 2019
The OPUS program seeks to provide opportunities for mid- to later-career investigators to develop new understanding of science in the fields supported by the Division of Environmental Biology through two tracks of synthesis activities: 1) OPUS: Mid-Career Synthesis: this track aims to provide a mid-career researcher with new capabilities to enhance their productivity, improve their retention as a scientist, and ensure a diverse scientific workforce that remains engaged in active research; and 2) OPUS: Core Research Synthesis: this track provides an opportunity for an individual or a group of investigators to revisit and synthesize a significant body of their prior research in a way that will enable new understanding of their research system and questions of interest.

NSF
Sustained Availability of Biological Infrastructure
https://www.grants.gov/web/grants/view-opportunity.html?oppId=314047
This program supports the continued operation of extant infrastructure that will advance basic biological research, with a focus on awards that ensure the continued availability of mature infrastructure resources critical to sustain the ability of today's scientific community to conduct leading edge research.

Tourette Association of America
Support for Research Consortia and Collaborative Research Projects
https://tourette.org/research-medical/support-for-research-consortia-and-collaborative-research-projects/
The Tourette Association of America is offering seed funding to research consortia working on large issues relevant to Tourette Syndrome and seeks to support research efforts that crossover different scientific and medical disciplines and that encourage collaboration among researchers and institutions.

NEA
Our Town
https://www.arts.gov/grants-organizations/our-town/grant-program-description
Application Deadline: August 8, 2019
This program supports creative placemaking projects that integrate arts, culture, and design activities into efforts that strengthen communities by advancing local economic, physical, and/or social outcomes. Successful projects will ultimately lay the groundwork for systemic changes that sustain the integration of arts, culture, and design into strategies for strengthening communities.

Applications require two subsequent submissions to Grants.gov and then to NEA, and the deadline for the first submission - the Grants.gov submission - is August 8, 2019.

An organization may submit as a lead applicant two applications to Our Town.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by June 10, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

Nebraska Arts Council
Arts Project Grants and Arts Learning Project Grants
http://www.artscouncil.nebraska.gov/grants/grant-categories/
Application Deadline: October 1, 2019
Arts Project Grants support arts programming, productions, or events open to the general public. Arts Learning Project Grants support programs with a strong educational emphasis in pre-K-12 schools or in community settings.

Each college/university department may only apply for either one Arts Project Grant or one Arts Learning Project Grant per deadline.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by April 8, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

Nebraska Arts Council
Mini Grants
http://www.artscouncil.nebraska.gov/grants/grant-categories/mini-grants.html
Mini Grants are designed to provide quick access to funds supporting a variety of arts projects. Examples of projects include exhibitions, performances, poetry readings, commissions and/or support of new work development, arts festivals, community murals, and cultural heritage projects.

Applications are accepted on a rolling basis.

Organizations may submit up to two Mini Grant applications per fiscal year (July 1 to June 30).

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by June 17, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NEH
Summer Stipends
https://www.neh.gov/grants/research/summer-stipends
Application Deadline: September 25, 2019
Summer Stipends support individuals pursuing advanced research that is of value to humanities scholars, general audiences, or both. Eligible projects usually result in articles, monographs, books, digital materials and publications, archaeological site reports, translations, or editions. Summer Stipends support continuous full-time work on a humanities project for a period of two consecutive months.

UNL may nominate two faculty members to apply.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by June 3, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NIH
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-031.html
Application Deadline: August 29, 2019
Through this funding opportunity announcement, the National Cancer Institute proposes and will support the CP-CTNet. See solicitation for Trials Network goals.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by July 22, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NIH
Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-021.html
Application Deadline: October 22, 2019
This opportunity invites applications to develop and maintain a Nathan Shock Centers (NSC) Coordinating Center. Major activities of the proposed center will include improving visibility of the NSC nationally and internationally, improving collaboration and coordination among NSC, enhancing NSC training activities, facilitating the sharing of resources, and interacting with the National Institute of Aging and NSC to develop strategies and plans for further development.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by July 22, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NIH
NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-19-008.html
Application Deadline: September 13, 2019
This award supports investigators who wish to pursue independent research essentially after completion of their terminal doctoral/research degree or end of post-graduate clinical training, forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. The receipt date of the terminal doctoral degree or end of post-graduate clinical training of the PD/PI must be between June 1, 2018 and September 30, 2020.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by May 20, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NSF
Advancing Informal STEM Learning (AISL)
https://www.nsf.gov/pubs/2017/nsf17573/nsf17573.pdf
Application Deadline: November 6, 2019
The AISL program seeks to advance new approaches to and evidence-based understanding of the design and development of STEM learning opportunities for the public in informal environments, provide multiple pathways for broadening access to and engagement in STEM learning experiences, advance innovative research on and assessment of STEM learning in informal environments, and engage the public of all ages in learning STEM in informal environments.
 
An institution may serve as lead on no more than three proposals submitted to the November deadline. However, an institution may partner as a subaward on other proposals submitted.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by July 22, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NSF
Critical-Zone Collaborative Network
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505628
Application Deadline: December 2, 2019
The National Science Foundation seeks proposals to establish an adaptive and responsive research network that supports investigations of the Earth's Critical Zone. This network will consist of two components that will work together to advance knowledge, education, and outreach in this convergent science: 1) Thematic Clusters of fixed or temporary locations will conduct basic research on significant, overarching scientific questions concerning the structure, function, and processes of the Critical Zone. These U.S.-based Clusters could include existing observatories engaged in collecting environmental data, other monitoring locations that have been in operation for extended periods of time, and new sites that will support the scientific goals of the Cluster. 2) A Coordinating Hub that will oversee the compatibility and archiving of the data resulting from the Thematic Clusters, coordinate outreach and community-building activities, support the use of network facilities by outside researchers, and plan for infrastructure needs of the network. 

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by June 24, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NSF
Physics Frontiers Centers
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5305
Application Deadline: January 30, 2020
The Physics Frontiers Centers program supports university-based centers and institutes where the collective efforts of a larger group of individuals can enable transformational advances in the most promising research areas. The program is designed to foster major breakthroughs at the intellectual frontiers of physics by providing needed resources such as combinations of talents, skills, disciplines, and/or specialized infrastructure, not usually available to individual investigators or small groups, in an environment in which the collective efforts of the larger group can be shown to be seminal to promoting significant progress in the science and the education of students. 

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by May 12, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NSF
Science and Technology Centers: Integrative Partnerships
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313811
This program supports exceptionally innovative, complex research and education projects that require large-scale, long-term awards, with a focus on potentially groundbreaking investigations at the interfaces of disciplines or highly innovative approaches within disciplines.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by April 22, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

Searle Scholars Program
2020 Searle Scholars Program
http://www.searlescholars.net/
Application Deadline: September 27, 2019
The Searle Scholars Program provides $300,000 awards to outstanding individuals who have recently begun their appointment at the assistant professor level and whose appointment is their first tenure-track position. Applicants are expected to be pursuing independent research careers in one of the following areas: biochemistry; cell biology; genetics; immunology; neuroscience; pharmacology; and related areas in chemistry, medicine, and the biological sciences.

The University of Nebraska (NU) system may submit one application to the 2020 competition. An internal competition is underway to determine which faculty members will be put forth by the University of Nebraska-Lincoln (UNL) to the system-wide applicant selection process being managed by the Office of the Provost. UNL may select up to three prospective applicants for consideration as NU's applicant.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by July 1, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

USDA
Children, Youth and Families at Risk (CYFAR) 4-H Military Partnership Professional Development and Technical Assistance Program
https://nifa.usda.gov/sites/default/files/rfa/20190612-CYFAR-4H-Military-RFA.pdf
Application Deadline: July 26, 2019
The purpose of the CYFAR 4-H Military Partnership Professional Development and Technical Assistance Program is to support the implementation and capacity of the 4-H Military Partnership and Outreach Support Program. Professional development and technical assistance are provided to the land-grant institutions and Cooperative Extension Systems, so that, in collaboration with other organizations, they are able to develop and deliver educational programs for military-connected youth. The educational programs are to equip military-connected youth in resiliency skills they need to lead positive, productive, and contributing lives. Only one application per land-grant institution will be accepted.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by July 1, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

USDA
Special Supplemental Nutrition Program for Women, Infants and Children (WIC) Telehealth Innovations Project
https://drive.google.com/file/d/10GGNLVBbOwPpEJU-fuVXxpCqXLLOrlH6/view?usp=sharing
Application Deadline: July 29, 2019
The purpose of this cooperative agreement is to support the implementation and evaluation of telehealth services in WIC. The majority of these funds shall be awarded as sub-grants through a competitive process to WIC State Agencies for the purpose of implementing telehealth innovations that supplement the nutrition education and breastfeeding support offered in the WIC clinic. The recipient of this cooperative agreement will carry out the competitive award process to select sub-grantees, design and conduct evaluations of each sub-grantee's telehealth innovation project, and produce reports and publications to disseminate the findings. 

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by June 10, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

William T. Grant Foundation
Institutional Challenge Grant
http://wtgrantfoundation.org/grants/institutional-challenge-grant
Application Deadline: September 6, 2019
The Institutional Challenge Grant encourages university-based research institutes, schools, and centers to build sustained research-practice partnerships with public agencies or nonprofit organizations in order to reduce inequality in youth outcomes. To do so, research institutions will need to shift their policies and practices to value collaborative research, build the capacity of researchers to produce relevant work, and build the capacity of agency and nonprofit partners to use research. Applications are welcome from partnerships in youth-serving areas such as education, justice, child welfare, mental health, immigration, and workforce development.

While there is no institutional limit on the number of applications that may be submitted to this program, UNL's Office of Research and Economic Development is holding an internal selection process to help ensure that UNL submits a single, strong Institutional Challenge Grant proposal.

If you are interested in developing a proposal in response to this funding opportunity, please complete a notification of intent to submit by May 27, 2019. For more information regarding the internal selection process, visit http://research.unl.edu/limited-submissions-funding-programs/ or contact Tisha Mullen, tgilreathmullen2@unl.edu, (472-2894).

NASA
ROSES 2019: Aura Science Team
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId={9DA2F863-BBC7-32ED-199D-8791C3E30BDE}&path=open
Application Deadline: September 19, 2019
This program element seeks proposals for the analysis of satellite remote-sensing data of the Earth's atmosphere, particularly those using data generated by the Earth Observing System (EOS) Aura satellite. These proposals should enable NASA research in the area of stratospheric and tropospheric chemistry, as well as improve the measurements of aerosols and trace gases, and determining the impacts of trace gasses and aerosols on climate and air quality. 

NASA
ROSES 2019: Cassini Data Analysis
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313790
This program solicits research proposals to conduct scientific investigations utilizing data obtained by the Cassini mission. All proposals to must identify and address a clear objective with science research that would be a significant, not incremental, advance in the state of knowledge of the research topic. 

NASA
ROSES 2019: Discovery Data Analysis
https://nspires.nasaprs.com/external/solicitations/summary.do?solId={334D0E7E-1D79-0E19-BEAA-CD9BA2A38A47}&path=&method=init
The objective of this program is to enhance the scientific return of Discovery Program missions and broaden the scientific participation in the analysis of data, both recent and archived, collected by Discovery missions. Proposed work responsive to this call may include (1) data analysis tasks, 2) tasks that are not data analysis but are necessary to analyze or interpret the data, and 3) tasks that are not data analysis but that significantly enhance the use or facilitate the interpretation of Discovery mission data.

NASA
ROSES 2019: Global Navigation Satellite System Research
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId={26E97B17-21F2-26AE-D907-0BF9B458A05F}&path=open
Application Deadline: August 30, 2019
This announcement seeks innovative approaches to the development and use of Global Navigation Satellite System (GNSS) data, remote sensing techniques, and algorithms to advance Earth system science objectives. Significant growth in the number of GNSS satellites and the expansion of signals and frequencies available to civil applications are providing new opportunities for Earth science research.

NASA
ROSES 2019: Heliophysics Flight Opportunities for Research and Technology
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId={713F46B1-5DFB-6924-C5A0-C02F0BA6C6AA}&path=open
Application Deadline: September 17, 2019
This program element seeks to enhance the ability to achieve significant progress toward the scientific and technical challenges in heliophysics in the coming years. See solicitation for required proposal characteristics.

NASA
ROSES 2019: Heliophysics Guest Investigators Open
https://www.grants.gov/web/grants/view-opportunity.html?oppId=313764
This program is for investigations whose primary emphasis is the analysis of data from currently operating missions. It provides support for analysis of observations from both extended missions and from missions in their prime phase.

NASA
ROSES 2019: Heliophysics Supporting Research
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId={08842443-35A7-7AB9-A73E-7CD168E78039}&path=open
This program replaces the former supporting research elements of the Geospace Science program and the Solar and Heliospheric Science program. investigations are solicited that include an element of a) theory, numerical simulation, or modeling, and an element of b) data analysis and interpretation of current or historical NASA-spacecraft observations, and should address one of the four Heliophysics Decadal Survey goals; see solicitation for details.

NASA
ROSES 2019: Heliophysics Technology and Instrument Development for Science
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId={1EBD8980-AC8A-D24E-4473-2BF9B3BE4C27}&path=open
Application Deadline: August 28, 2019
This program seeks to advance the development of technologies and their application to enable investigation of key heliophysics science questions through incubating innovative concepts and development of prototype technologies. 

NASA
ROSES 2019: Mars Data Analysis
https://nspires.nasaprs.com/external/solicitations/summary!init.do?solId={0E963EC7-8F4C-7711-A130-A59502687479}&path=open
The objective of this program is to enhance the scientific return from missions to Mars conducted by NASA and other space agencies. Any proposal may incorporate the investigation of data from more than one mission. See solicitation for additional information about these missions.